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ZUSAMMENFASSUNG 
 
 
Neue Weiterentwicklungen von Genvektoren für die Gentherapie sind dringend 
notwendig. Die meisten, derzeit in der Klinik angewandten, Genvektoren basieren auf 
Virusgenomen. Durch Infektion mit virusähnlichen Partikeln wird ein besonders 
effizienter Gentransport in die Zielzelle erreicht. Der virale Hintergrund bringt jedoch 
negative Effekte wie z.B. immunologische Reaktionen des Patienten oder die 
Aktivierung von Onkogenen durch Insertionsmutagenese und somit Krebsentstehung, 
mit sich. Eine Möglichkeit, die Probleme zu umgehen sind extrachromosomale, 
autonom replizierende und nicht-virale Genvektoren. Ziel dieser Arbeit war die 
Entwicklung eines neuen Genvektorsystems, dessen extrachromosomale Stabilität auf 
dem Protein CENH3 basiert. Das Zentromer-spezifische Histon 3 CENH3 (H.sapiens: 
CENH3
CENP-A
, D.melanogaster: CENH3
CID
) ist alleine ausreichend für die 
Zentromerausbildung. CENH3 etabliert eine stabile, epigenetisch vererbte Markierung 
auf dem Chromosom sowie auf Plasmiden. Mit Hilfe von CENH3 war es möglich den 
passiven Huckepack-Mechanismus von Epstein-Barr-Virus basierten Plasmiden in einen 
aktiven Segregationsprozess für Plasmid-DNA Vektoren zu verändern. Durch den 
neuen, aktiven Segregationsmechanismus wird die Vektorstabilität in der Zielzelle 
erhöht. Die Grundlagenforschung liefert uns hier wertvolle Informationen, die äußerst 
hilfreich für die Entwicklung neuer Genvektoren ist. 
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ABSTRACT 
 
 
New vectors for successful transgene delivery in patients are more than needed. Current 
gene therapeutic vectors are mostly based on virus genomes. A main reason is the very 
efficient administration of the vector into the target cells. The viral background of these 
systems also has severe side effects like e.g. immunological reactions of the patient or 
the activation of oncogenes due to insertional mutagenesis, which can result in cancer 
development. A possibility to overcome these problems is the establishment of 
extrachromosomally maintained, autonomously replicating and non-viral vectors. The 
goal of this work was to establish such a novel system with the help of the CENH3 
protein. The centromere-specific histone 3 variant CENH3 (H.sapiens: CENH3
CENP-A
, 
D.melanogaster: CENH3
CID
) is sufficient for centromere formation. It confers a stable 
and epigenetically heritable mark at the centromeric region and does this also on 
plasmids. With the help of CENH3 I changed the passive piggyback segregation 
mechanism of Epstein-Barr virus-derived vectors into an active segregation mechanism 
for plasmid DNA (pDNA) vectors. I demonstrated that the new and active pDNA vector 
segregation mechanism prolongs pDNA vector retention in cells. The information 
gained from basic research might have great impact in the field of gene-therapeutic 
research, as this mechanism might be a helpful tool in future gene therapeutic vectors. 
  1 INTRODUCTION 
1 
 
 
 
 
 
 
 
 
 
 
1 INTRODUCTION 
 
 
Gene therapy is a controversial topic due to the variety of problems that come along 
with its application, However, it might be the future hope and cure of many diseases, 
ranging from cancer, to autoimmune diseases and genetic disorders. One challenge in 
the field is the development of safe and efficient administration vehicles for transgenes, 
so-called gene vectors. But after years of intense research scientists are still dealing with 
basic questions of this therapeutic approach like e.g. safety, administration and long-
term stable and consistent transgene expression. Most currently used gene vectors have 
a viral background, mainly for the reasons of efficient administration into the target cell 
and stable transgene expression. Adenovirus-based vectors and vectors based on adeno-
associated virus (AAV) that have a depleted integrative potential, make up roughly one 
quarter of applied vectors for gene therapeutic approaches
1
 and offer the advantage of a 
non-integrating character. However, because adenovirus is a common human virus the 
application of adenovirus-based vectors can easily lead to immunological reactions of 
the patient. AAV-based vectors display low immunogenicity but this vector type has 
only a low transgene capacity up to a maximum of 4.7 kbp (Daya and Berns, 2008). 
Other vectors, like e.g. retro- and lentivirus-based vectors bring a big disadvantage 
along - integration into the host’s genome. The main problem of integration is 
                                                 
1
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insertional mutagenesis, which can lead to the activation of oncogenes and gene 
silencing (Baum et al., 2006). Progress was made here by mutating the integrase-coding 
genes of lentiviral vectors, which leads to episomal maintenance of the virus-like 
particle in the cell. Insertional mutagenesis is reduced to a minimum but still not 
prohibited with this approach (Escors and Breckpot, 2010). Furthermore, the nature of 
the virus as such can become a problem and immune responses of the patient can occur 
with severe or even fatal consequences (Thomas et al., 2003). 
However, as non-viral, extrachromosomal plasmid-based gene vectors provide 
transgene expression only for a very limited amount of time, integrating gene vectors 
are still considered to be the lesser evil over short-term transgene expression (Pich et 
al., 2008). 
 
1.1 Non-viral, extrachromosomal and plasmid-based gene 
vectors 
This work is dealing with the class of non-viral, extrachromosomally maintained and 
plasmid-based gene vectors. To avoid confusion due to the variety of synonyms, which 
are used in the field for this vector class, I will use the term “pDNA vector” (plasmid 
DNA vector) throughout this text to refer to gene vectors with the above-mentioned 
characteristics. 
In contrast to the large group of virus-derived gene vectors, which make up 66 % of all 
gene vehicles in clinical applications, naked DNA and pDNA vectors represent only a 
small group of 18.2 %
2
. Nevertheless, the advantages offered by non-viral pDNA 
vectors are striking. 
The lack of virus-derived material in these vectors avoids possible negative effects 
concerning recombination events and leads to less problems with immune responses of 
patients. This is why even a repeated administration of the pDNA vector raises no 
problems, because no specific immune responses against the gene vehicle occur 
(Prud'homme et al., 2007). Theoretically, episomal pDNA vectors are not assumed to 
integrate in the host genome (Lipps et al., 2003). Certainly, also non-viral gene vectors 
are able to integrate randomly, but methods for targeting the integration sites with the 
help of induced double strand breaks by zinc finger nucleases have been developed and 
                                                 
2
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help avoiding insertional mutagenesis (Moehle et al., 2007). Moreover, the likelihood of 
mutations after genomic integration of pDNA vectors is significantly lower than the 
endogenous mutation probability (Prud'homme et al., 2007). In addition, the non-
integrating character makes expression profiles and levels for these kind of gene vectors 
not as ambiguous as for integrating vectors (Lipps et al., 2003). Virus-based vectors 
take up only a certain amount of DNA depending on the choice of the virus background 
(Waehler et al., 2007). Most viruses, like e.g. retroviruses, lentiviruses and AAV can 
harbour a maximum transgene size of only 10 kbp. Other viral vectors are capable to 
take up bigger DNA sequences. With Epstein-Barr virus-derived vectors e.g. a 
transgene with 123 kbp in size was successfully delivered into B-cells (White et al., 
2002). Not only single transgenes, but also complete gene loci are transferrable with e.g. 
S/MAR-based episomal gene vectors (Lufino et al., 2007). Major problems with 
extrachromosomal pDNA vectors are factors concerning reliable transgene expression, 
efficient delivery and establishment of the pDNA vector as well as stable long-term 
maintenance in the target cell. For instance, only 1 - 3 % of cells establish a plasmid-
based vector over time, whereas the vast moiety of pDNA is lost quickly after 
administration due to degradation by nucleases (Pich et al., 2008). Additionally there 
remains the risk, that DNA is damaged or lost due to strand breakage events (Gill et al., 
2009). If we talk about plasmid maintenance in a cell we have to consider two key 
mechanisms: DNA replication and pDNA vector retention. In contrast to integrating 
vectors, which are replicated and retained stably in the target cell after administration, 
this is not the case for pDNA vectors. Proper pDNA vector replication must be 
guaranteed to achieve long-term maintenance in the cell; if this is not the case, plasmid 
DNA will be lost quickly after administration. Especially retention is not so efficient for 
extrachromosomal pDNA vectors and therefore they are subsequently lost from cells. 
Even though some vector types are present in very high copy numbers in transfected 
cell, these gene vehicles are lost over time and the very high initial amount of vectors in 
cells can cover up for increasing numbers of lost vectors only for a limited amount of 
time. Chromosome-like episomal vectors (e.g. mammalian artificial chromosomes) are 
retained by the same mechanism as the chromosomes of the host cell, which is a rather 
efficient mechanism. Last but not least autonomous pDNA vectors can be maintained in 
cells via a so-called piggyback mechanism. In this case the pDNA vector is attached to 
the host cell chromosome and gets replicated and segregated to the daughter cells 
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passively (Ehrhardt et al., 2008). Detailed information about the different retention 
mechanisms of episomal, non-viral pDNA gene vectors is given in the following 
chapters. 
For designing the best possible pDNA gene vector many different factors have to be 
taken into account. For instance, it was shown that the conformational state – 
supercoiled, open circular or linear - of pDNA is important for its stability in a cell. 
Stability varies in combination with the “under- or overwinding” of the supercoiled 
status of the DNA (Ribeiro et al., 2008) and the supercoiled state is achieved after de-
chromatinization of the circular pDNA vector. The idea, that maybe linearized plasmids 
are better maintained in cells was tested in yeast. It was demonstrated that the 
linearization of the transfected DNA was of no advantage and that the plasmids were 
lost faster from cells than in their circular state (Martin Dani and Zakian, 1983). A 
linearized vector in human cells showed similar transgene expression compared to the 
parental plasmid. The slightly better transfection efficiencies of the linearized vector 
were explained simply with its smaller size (Schakowski et al., 2001). 
Also the choice of the promoter type and its combination with enhancers can have a 
rather big impact on the safety of a pDNA vector. Tissue specific promoters avoid an 
ubiquitous expression of the transgene and the use of endogenous promoters limits 
transgene expression to a physiological level (Gill et al., 2009). 
To avoid a fast decrease in transgene expression, bacterial backbone sequences of 
pDNA vectors certainly deserve more attention in the future, especially because they 
impact on gene silencing (Gill et al., 2009). The importance of this factor is reflected in 
the exciting progress that was made in the field of the minicircle technology during the 
last few years (Mayerhofer et al., 2009) (see also chapter 1.1.3). 
Vector administration is less efficient for naked pDNA vectors compared to virus-
derived particles (Nishikawa and Huang, 2001a). The latter use the mechanisms of the 
virus they derive from for efficient transduction and also for their processing inside of 
the cell (Ehrhardt et al., 2008). Non-viral vectors, however, have to encompass several 
obstacles in regards to cell entry and intracellular processing and are very much in 
danger of degradation by nucleases before even reaching the target cell (Nishikawa and 
Huang, 2001a). 
Although clinicians are facing many problems with the currently available instruments, 
and autonomous pDNA vectors offer various advantages, it was not yet possible to find 
  1 INTRODUCTION 
5 
a safer but equally efficient alternative to viral vectors. What are the reasons for this? 
Certainly the rather inefficient pDNA vector retention in cells is a big obstacle. 
As pointed out before, plasmid retention, together with DNA replication, are the key 
factors in providing stable pDNA vector maintenance. Only if both factors function 
reliably with high efficacy, autonomous pDNA vectors are maintained in a cell over a 
prolonged period of time. Different vectors are using different strategies to maintain 
their genomic information in the cells over several generations and vectors can be 
segregated to daughter cells by either active or passive mechanisms (Figure 1.1 A-B) 
 
 
Figure 1.1 Segregation mechanisms of different vector types. 
A) Active segregation mechanism of a mammalian artificial chromosome (MAC). MACs are 
segregated like chromosomes and are entirely integrated into the cell cycle. Other episomal 
vectors, like EBV or S/MAR pDNA vectors, are segregated to daughter cells via a passive 
piggyback mechanism (B). The exact mechanism of EBV-based vector segregation is illustrated 
in Figure 1.5 A in more detail. C) shows the theoretical basis of an active “quasi-chromosome”, 
which is a combination of a minichromosome (A) and an EBV-based vector (B). 
(Lufino et al., 2008) 
 
Not all strategies are similarly effective and, therefore, it can happen that the pDNA 
vector is not maintained in the target cell forever, even though DNA replication and 
retention work properly. In particular for the design of new gene therapeutic vectors, 
retention mechanisms have to be optimised to ensure prolonged and stable transgene 
expression. It has to be mentioned, that especially an efficient pDNA vector 
establishment in the cells during the first few days and weeks after administration 
contribute to long-term stability (Leight and Sugden, 2001). It is known that a major 
challenge in autonomous pDNA gene vector design is the rapid loss of 
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extrachromosomal vectors from the target cells shortly after administration. This issue, 
however, has to be addressed separately and not together with retention. 
In the following chapters different pDNA vector systems and their respective retention 
mechanisms are described in more detail. 
 
1.1.1 S/MAR3-based vectors – pEPI and pEPito 
S/MAR structures are usually AT
4
-rich sequences (approx. 70  %) and play important 
roles in cellular mechanisms like replication, establishment and maintenance of higher 
chromosomal structures. In 1999 an artificial pDNA vector was constructed, which 
replicates extrachromosomally in human cells (Piechaczek et al., 1999). This pDNA 
vector represents one of the first non-viral gene vectors that is efficiently maintained in 
cells for a prolonged amount of time even in the absence of selection (Gill et al., 2009). 
In vivo experiments with transgenic pigs demonstrated an episomal maintenance of the 
pEPI vector in all different tissues tested and active transcription of the transgene was 
detectable in nine out of twelve transgenic animals (Manzini et al., 2006). pEPI was 
furthermore successfully applied in an in vivo study focussing on the transdifferentiation 
of liver cells towards pancreatic -cells in rats. Among five tested vectors, pEPI and a 
CpG-depleted vector scored best in regards to high and long-lasting expression of the 
three encoded reporter transgenes Pdx1, Ngn3 and MafA (Cim et al., 2012). 
The so-called pEPI vector (Figure 1.2), the prototype of S/MAR-based vectors, is 
6692 bp in size and consists most importantly of a non-essential SV40
5
-origin, a 
resistance cassette and a S/MAR sequence derived from the 5´-region of the human 
interferon- gene (Bode et al., 1992). The S/MAR sequence is essential for the 
extrachromosomal status of the vector and substitutes the function of the large T-
antigen when it’s actively transcribed (Piechaczek et al., 1999). For this it is essential, 
that a transcription unit extends into the MAR region (Stehle et al., 2003). Only if this is 
the case, pEPI is stably maintained in the nucleus attached to the chromosomes (Baiker 
et al., 2000) via an interaction with the nuclear matrix protein SAF-A in vivo (Jenke et 
al., 2002). It was demonstrated that pEPI replicates in S-phase once per cell cycle and 
components of the origin recognition complex (Orc1, Orc2 and Mcm3) bind the pEPI 
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vector sequence-independently (Schaarschmidt et al., 2004). It was furthermore 
demonstrated by FISH
6
 and ChIP
7
 experiments that pEPI is located predominantly at 
transcriptionally active chromatin in the nucleus (Stehle et al., 2007). 
 
 
Figure 1.2 The pEPI vector. 
The most important feature for maintenance of the extrachromosomal status of pEPI is the 
S/MAR element, which is responsible for the vectors attachment to the host cell chromosome. 
Furthermore pEPI comprises a non-essential SV40 origin of replication, a Neomycin/kanamycin 
resistance cassette and the eGFP sequence under the control of a CMV promoter. 
(Stehle et al., 2007) 
 
A second generation of pEPI - the so-called pEPito vector - has been established with 
optimised features. The most important difference between pEPI and pEPito is the 
depletion of about 60 % of all present CpG
8
 sites in the latter (Haase et al., 2010). This 
brings two advantages along: first, silencing effects due to CpG-methylation are 
decreased and second, innate immune responses of the recipient cells, triggered by the 
TLR9
9
 and downstream products, are reduced and therefore significantly less 
inflammatory cytokines are produced. Additionally, pEPito leads to increased transgene 
expression levels in vitro and in vivo due to the substitution of the CMV
10
-immediate 
early promoter with the human CMV enhancer/human elongation factor 1 alpha 
(hCMV/EF1P) promoter, which is CpG-methylation insensitive and therefore not 
silenced (Haase et al., 2010). However, it was demonstrated in the same publication, 
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that this effect is cell type-specific. Quite recently it was demonstrated that the tissue-
specific expression of a transgene from the episomal S/MAR-based pEPito vector was 
successfully established for targeting hepatocellular carcinomas (Haase et al., 2013) 
1.1.1.1 S/MAR-based vectors are attached to the host chromosomes via the S/MAR 
element 
S/MAR-based vectors are segregated via a passive piggyback mechanism attached to 
the host’s chromosomes. Via the S/MAR region the pDNA vectors are tethered to 
chromatin and replicated and segregated together with the chromosomes during S-phase 
(Figure 1.1 B). Immunoprecipitation experiments demonstrated that e.g. pEPI forms a 
specific interaction with the nuclear matrix protein hnRNP-U/SAF-A
11
 in vivo (Jenke et 
al., 2002). Regarding the integration of S/MAR-based vectors it has been shown that the 
preferential state of maintenance is extrachromosomal, although an occasional 
integration event cannot be excluded (Wong et al., 2011). 
Following administration of pEPI in cells as naked DNA, the vectors get lost fast and 
only a very small fraction (approx. 0.5 - 5 %) of cells is able to maintain the vector for a 
longer period of time (Haase et al., 2010) and this effect was similarly observed in in 
vivo experiments (Wong et al., 2011). However, after successful vector establishment in 
the cell, the plasmid DNA is maintained for a prolonged period of time even without 
selection pressure in vitro (Haase et al., 2010). 
 
1.1.2 The Epstein-Barr virus origin of latent replication, oriP, and the 
conditional vector system pCON 
Epstein-Barr virus is a double-stranded DNA -herpesvirus with 172 kb in size, which 
efficiently infects resting B-cells and establishes a lifelong persistent infection. Like all 
herpesviruses, the viral genome of EBV
12
 is maintained in an extrachromosomal state 
(Yates et al., 2000). More than 90 % of the adult population worldwide are infected 
with this virus and carry it in its latent form without showing any symptoms of a disease 
(Delecluse and Hammerschmidt, 2000). Furthermore it is known for a long time that 
EBV is associated with tumour development like nasopharyngeal carcinoma and 
Burkitt’s lymphoma (Nonoyama et al., 1973) as well as Hodgkin’s lymphoma and 
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leukaemia (Gotlieb-Stematsky et al., 1975), non-Hodgkin’s lymphoma (Wutzler et al., 
1986) and gastrointestinal carcinomas (Shibata and Weiss, 1992). The oncogenic 
potential of EBV is even more pronounced in immunodeficient individuals (Delecluse 
and Hammerschmidt, 2000). Primary infection with EBV later in life may cause the 
infectious mononucleosis syndrome (Diehl et al., 1968). 
Epstein-Barr virus is interesting as blueprint for pDNA gene vector development as it 
shares several important features with potent gene vehicles in its endogenous form. 
First, EBV is a large virus and transgenes with sizes up to 140 kb of genomic DNA can 
be transferred in an EBV-derived pDNA vector (Delecluse and Hammerschmidt, 2000). 
Additionally these vectors are known to remain stable and extrachromosomally in the 
infected cell when kept under selection over long-term periods (Delecluse and 
Hammerschmidt, 2000; Ehrhardt et al., 2008). Moreover, on EBV-derived vectors DNA 
replication and extrachromosomal maintenance are regulated separately from each other 
in cis. The respective elements for both functions are called the family of repeats and 
the dyad symmetry element. Both entities together make up the latent origin of plasmid 
replication (oriP) of EBV, which is the cis-component of EBV used in gene vector 
design of plasmid DNA vectors (Pich et al., 2008) (Figure 1.3). 
 
 
Figure 1.3 Schematic of origin of latent replication (oriP) of Epstein-Barr virus. 
The latent replication origin comprises two elements: the family of repeats, FR, confers pDNA 
vector retention and the dyad symmetry element, DS, is responsible for DNA replication. Both 
elements depend on the viral transactivator EBV nuclear antigen 1 (red circles, black dots: 
binding sites of the transactivator at oriP). 
(Schepers et al., 2001) 
 
The latent replication origin oriP is 1.7 kbp in size (Yates et al., 2000). Both oriP 
modules have binding sites for the viral transactivator EBNA1
13
. The FR
14
 element 
harbours 20 EBNA1 binding sites and is responsible for virus retention (Yates et al., 
2000). It was shown that seven of these binding sites are sufficient for 
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extrachromosomal maintenance (Wysokensko and Yates, 1989). The second module of 
oriP is the DS
15
 element with four EBNA1 binding sites. DS supports DNA replication 
by recruiting the origin recognition complex, ORC, through a direct interaction between 
EBNA1 and the complex (Schepers et al., 2001). EBNA1 is the transactivator for both 
functions of oriP and for pDNA vector retention the presence of the protein in the cell is 
crucial (Krysan et al., 1989). 
Introduction of oriP on a pDNA vector and transfection of this vector in EBNA1 
expressing cells provides the pDNA vector with replication and retention capacity. The 
so-called pCON system, which constitutes a conditional plasmid system based on the 
interaction of a scTetR:fusion protein and TetOperator sites on a pDNA reporter vector, 
enables the dissection of the two functions of oriP (Pich et al., 2008). With the help of 
pCON, DNA replication and retention can be investigated separately and the potential 
of endogenous (non-viral) proteins to support DNA replication, nuclear retention or 
both can be determined. 
pCON is the first generation of gene vectors, which are extrachromosomally maintained 
and regulated by an allosteric switch inducible with doxycycline (Pich et al., 2008). To 
this end fusion proteins are generated with the following composition: the protein of 
choice replaces the N-terminal domain of EBNA1 and two scTetR elements replace the 
DNA binding domain of EBNA1. scTetR is a single chain derivate of the prokaryotic 
DNA binding protein (TetR). Two scTetR elements form homodimers like EBNA1 and 
bind with very strong affinity to TetOperator motifs; on the pDNA reporter vectors the 
respective element of oriP (either DS, FR or both) is replaced by a number of 
TetOperator sites. Via the scTetR-TetOperator binding the protein being investigated 
for its replicative potential or the potential to support pDNA vector retention, is bound 
at the respective sites of the pDNA reporter vector (Figure 1.4). Comparable to the 
cellular function, also in the plasmid system EBNA1 is needed as transactivator of the 
potentially remaining wildtype DS or FR element on the reporter. 
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Figure 1.4 Illustration of the pCON system. 
The depicted set-up illustrates the situation for testing the ability of a protein to support pDNA 
vector retention. The two function of oriP can be separated in cis and investigated 
autonomously. By replacing the family of repeats with TetOperator sites and expression of a 
protein fused to two scTetR elements, one is able to investigate the potential of the protein of 
choice to support pDNA vector retention. The same principle is applied for testing the 
replicative potential of a protein. In this case the FR element is maintained in its wildtype 
conformation and the DS element is replaced with TetOperator sites. 
(Pich et al., 2008) 
 
First experiments with fusion proteins were performed in the Kieff lab and revealed that 
pDNA vector maintenance is achieved with fusion proteins of HMGA1a
16
 or histone H1 
and the DBD
17
 of EBNA1 (Hung et al., 2001). With the same experimental set-up our 
lab was able to confirm that the proteins HMGA1a and Orc6
18
 have replicative 
potential, and that both, HMGA1 and HP1
19
, support pDNA vector retention (Thomae 
et al., 2011; Thomae et al., 2008) (HP1 data not published). 
The usage of EBV and wt-oriP as pDNA gene vector is limited by the fact, that EBNA1 
shows enhancement of B-cell immortalization (Humme et al., 2003). Another reason is, 
that the virus, and even the small version of it (mini-EBV), encode for many viral genes 
(Ehrhardt et al., 2008). 
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1.1.2.1 EBV and EBV-derived vectors segregate via EBNA1-mediated attachment to the 
host cell chromosome 
Once per cell cycle Epstein-Barr virus DNA is duplicated in proliferating B-cells using 
the replication machinery of the host cell. It was demonstrated that EBV recruits the 
human ORC complex to the dyad symmetry element of oriP via an EBNA1-mediated 
interaction (Schepers et al., 2001). Virus replication happens in synchrony with host 
chromosome replication during S-phase. When EBV is segregated to the daughter cells 
after cell duplication, the virus remains attached to the host cell chromosome (Sears et 
al., 2003). The link between oriP (either on the EBV genome or on a EBV-derived 
pDNA vector) and the chromosome is mediated by EBNA1 (Figure 1.5 B). As 
described before the family of repeats is responsible for virus retention, however, if FR 
is missing, DS is partially capable to mediate this function although to a much lesser 
degree (Aiyar et al., 1998; Yates et al., 2000). With its C-terminus, EBNA1 binds the 
respective binding sites at oriP and two linking regions (LR1 and LR2) located in 
EBNA1´s N-terminus mediate the attachment to the chromosome (Middleton and 
Sugden, 1992). It has already been shown before that R-bands of chromosomes in 
metaphase contain the same sequences as found in interphase chromosomes, so-called 
AT-rich S/MAR
20
-sequences (Saitoh and Laemmli, 1994). Only at these rare sites on 
the chromosome the EBNA1-mediated interaction between FR and the chromosomes is 
possible and pDNA vector retention is ensured (Figure 1.5 A) (Sears et al., 2004). 
Similar to the host cells chromosomes, pDNA vectors are distributed to the daughter 
cells in a nearly symmetrical order (Nanbo et al., 2007). The pDNA vector remains 
attached to the chromosome during mitosis and since this mechanism is a passive 
retention mode in which the pDNA vector “sits” on the chromosome, it is also referred 
to as piggyback mechanism (Calos, 1998). 
Like all herpesviruses EBV is maintained in infected cells extrachromosomally 
(Morissette and Flamand, 2010). Also oriP-based gene vectors are considered to be 
maintained in the cells as extrachromosomal elements (Ehrhardt et al., 2008). 
Unfortunately, stable maintenance of EBV genomes without selection is only shown for 
EBV-transformed cell lines, whereas oriP-based vectors are rapidly lost when lacking 
selection pressure. 
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Figure 1.5 Mechanism of EBNA1-mediated, passive retention of oriP vectors. 
A) Via EBNA1 oriP vectors are tethered to SAR sequences at chromosomes and are replicated 
like the chromosomes during S-phase and partitioned in synchrony with the host chromosomes 
through a passive piggyback mechanism. After duplication of the host cell chromosome also 
oriP vectors are doubled and segregated to both daughter cells. B) Scheme of EBNA1. The C-
terminal part of EBNA1 is needed for DNA binding and dimerization of the protein. The N-
terminal part is used for chromosome binding via the two linking regions LR1 and LR2 (red 
boxes). G-R: Glycin-Arginin repeats, G-A: Glycin-Alanin, LR: linking region, NLS: nuclear 
localization signal. 
(Sears et al., 2004). 
 
It was found out before, that, when following a parental HEK 293 cell line and five sub-
clones of this cell line over 100 generations for the former and 25 generations for the 
latter, respectively, the average pDNA vector number was stable in all clones. The 
distribution of EBV-derived plasmids in these cells was determined with FISH analysis 
and from the results it seems reasonable to assume that the number of pDNA vectors is 
predetermined and that a critical number of pDNA vectors in a cell is needed to avoid 
the complete loss of vectors. This critical number of pDNA vectors in the cell is referred 
to as “threshold level” and in HEK 293 cells on average between six and ten EBV 
episomes were found in investigated cells. If the number of pDNA vectors falls below 
the threshold, the selective pressure will become too intense and pDNA vectors are lost 
from the cells and if the copy number of the pDNA vector is higher than the threshold 
limit, pDNA vectors are not lost that easily from the cell (Nanbo et al., 2007). 
The establishment capacities of wt-oriP vectors are poor. Only 1 - 5 % of transiently 
transfected cell undergo an efficient establishment of the pDNA vector and can maintain 
the vector for a long time. After establishment, withdrawal of selection results in a loss 
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rate of wt-oriP vectors in the range of around 4 % in established cell lines per 
generation over time (Leight and Sugden, 2001). It was demonstrated in EBNA1 
positive HeLa cells without selection pressure, that only 84 % of all EBV-derived 
pDNA vectors were duplicated during S-phase. The equal distribution of pDNA vectors 
into two daughter cells was obtained for 88 % of these co-localised (duplicated) pDNA 
vectors. All other pDNA vectors (12 %) segregated unevenly to only one daughter cell. 
16 % of pDNA vectors carrying wt-oriP that were transfected into HeLa cells were 
unable to replicate in this study maybe due to a reduced efficacy of DS. These vectors 
segregated randomly and only few of them got lost from the cells (0.3 %) (Nanbo et al., 
2007). 
 
1.1.3 Minicircles, mammalian/human artificial chromosomes and 
minichromosomes 
The youngest members in the group of transgene vehicles are so-called minicircles. 
These molecules derive from conventional plasmid DNA (parental plasmid) but they 
entirely lack any bacterial backbone sequences, like antibiotic resistance genes and 
replication origins. In short - minicircles are circular DNA molecules depleted of all 
unnecessary components in regards to transgene expression (Gracey Maniar et al., 
2013; Kobelt et al., 2013). The depletion of bacterial sequences is usually achieved by 
site-directed mutagenesis (Gill et al., 2009). This results in a smaller size of minicircles 
compared to other gene therapeutic vehicles (Kobelt et al., 2013) and has advantages 
compared to conventional plasmid-based vectors (Gill et al., 2009). The depletion of 
sequences of bacterial origin leads to a decreased probability of DNA degradation and 
in turn to a prolonged stability of the pDNA vector. Additionally the problem of 
antibiotic resistance dissemination is circumvented by deletion of the resistance 
cassette, as well as of immunogenic CpG motifs (Kobelt et al., 2013). It is also known, 
that minicircle DNA is less prone to integration and usually no concatemer formation is 
observed (Nehlsen et al., 2006). Furthermore, by limiting DNA amounts, gene transfer 
rates and expression of the transgene are enhanced in minicircles compared to the 
parental pDNA vector (Kobelt et al., 2013). For instance a 45 - 560-fold increase for 
serum human factor IX and alpha1-antitrypsin was observed with non-replicating 
minicircles compared to standard pDNA vectors (Chen et al., 2003). 
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It was demonstrated by Kobelt et al., that minicircles exhibit an enhanced transgene 
mRNA
21
 transcription compared to parental pDNA vectors in A375 cells. Because it 
was excluded that this increase is a consequence of higher minicircle copy in these cells, 
the reason is most likely a better recruitment of the transcription machinery (Kobelt et 
al., 2013). In the future a recently established technology for industrial-scale production 
established by Kobelt et al. will provide sufficient amounts of minicircles to perform in-
vivo applications as well as clinical studies. They also monitored an enhanced 
expression of minicircle-transfected cells in six different cell lines and observed, that 
gene transfer rates were higher with minicircles than with controls (Kobelt et al., 2013). 
Similar to other non-viral the problem of low transfer-rates, compared to viral vectors, 
remains to be solved (Nishikawa and Huang, 2001b). 
Mammalian and human artificial chromosomes are rather big episomal DNA elements 
containing the functional elements of chromosomes, namely telomeres, centromeres and 
several replication origins. Artificial chromosomes behave like endogenous 
chromosomes in a cell, with respect to their mechanism of segregation (Larin Monaco 
and Moralli, 2006). The major difference between a minichromosome and a 
MAC/HAC
22
 is size; minichromosomes cover sizes from 0.5 - 6 Mb and sizes of 
MACs/HACs range from 1 to 10 Mb (Lipps et al., 2003). Advantages of MACs/HACs 
over retro- and adenoviral vectors are stable maintenance and in turn, no need for 
integration of the vector into the host genome. This is due to the presence of a 
functional centromere on the artificial chromosome itself. Transgene size in these 
vectors is not limited, but the fact, that gene copy numbers and the location of the gene 
on the MAC/HAC are not predictable is problematic. This means that transgene 
expression profiles and levels are not entirely controllable which resulted in only few 
applications of artificial chromosomes in practice (Kim et al., 2011). Gene expression is 
checkable by construction of a HAC with 6000 TetOperator sites located in an alphoid 
DNA repeat. Targeting of scTetR-fusion proteins to the site leads to an inactivation of 
the centromere and therefore an inducible loss of the HAC (Nakano et al., 2008). 
Recently human artificial chromosomes have been tested in vitro and in vivo in stem 
cell culture and mouse models and positive effects were reported for the treatment of 
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e.g. Duchenne muscular dystrophy and glioma by usage of this “pluripotent” gene 
vector (Kazuki et al., 2011). 
However, also the rather big size of MACs/HACs brings some problems along: first, 
only small amounts of the gene vector are available due to its complicate construction. 
MACs/HACs, in combination with the gene of interest, have to be co-transfected and 
the gene has to be inserted into the chromosome by site-specific recombination using 
Cre-LoxP or FLP-FRT (Lipps et al., 2003). Second, due to the very large size, delivery 
of HACs and MACs to cells is difficult and rather laborious (Glover et al., 2005; Larin 
Monaco and Moralli, 2006). For instance, microinjection, a technique, which is often 
used for the delivery of artificial chromosomes, enables only the treatment of one cell at 
a time and is limited to ex vivo application (Telenius et al., 1999).  
An advantage of artificial chromosomes and minichromosomes is, that they are not 
connected to the host chromatin. The problems that arise due to the unknown position 
and subsequent unknown expression of the transgene, that is characteristic for 
integrating vectors, is therefore of no significance in this case (Lipps et al., 2003). 
1.1.3.1 Segregation of minicircles, MACs/HACs and minichromosomes 
Artificial chromosomes segregate via an active mechanisms based on the centromere on 
the vector. The presence of the functional centromere on MACs/HACs and 
minichromosomes is the reason, why they pass through mitosis like endogenous 
chromosomes and this also confers maintenance in the cell. During anaphase 
microtubules attach to the kinetochore on the HAC/MAC and the artificial chromosome 
are segregated symmetrically to both daughter cells (Figure 1.1 A). 
The segregation mechanisms of minicircles depends on the type of vector they derive 
from. Minicircles are maintained in the cell extrachromosomally and are segregated e.g. 
like S/MAR-based vectors via the S/MAR element (Argyros et al., 2011) or in case of 
EBV-derived vectors via EBNA1 attachment to the host cell chromosome (Zuo et al., 
2011). As discussed in chapter 1.1.1.1 and 1.1.2.1 these mechanisms are passive 
retention mechanisms, during which the DNA remains attached to the host cell 
chromosome (Figure 1.1 B). 
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1.1.4 The optimal extrachromosomal, plasmid-based gene vector 
Summing up the positive and negative aspects of extrachromosomal and non-viral gene 
vectors, the following criteria seem to play important roles in the design of future 
vectors: (1) long-term guarantee of episomal retention, (2) high transgene size 
capabilities, (3) low immunogenicity, (4) small vector size and simple production, (5) 
vector administration into the target cell and (6) pDNA conformation. 
Each of the described vectors above provides some of these factors, but only the 
combination of most - or even better all - of these factors will lead to the optimal gene 
transfer vehicle. 
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1.2 Centromeric DNA structures 
Centromeres are defined as sites of kinetochore assembly and are absolutely essential 
for stable chromosome inheritance (Bergmann et al., 2012). Although this function is 
crucial during cell division, centromeres do not contain evolutionary conserved 
structures in different species, e.g. they have no underlying DNA sequence that 
determines their location (Allshire and Karpen, 2008). Instead, considerable differences 
are found concerning centromeric structures among species (Figure 1.6) (Torras-Llort et 
al., 2009). 
 
 
Figure 1.6 Centromeric structures among species. 
Centromeric structures are classified in three main classes. The simplest version of a centromere 
is found in C.elegans where the complete genome represents the centromere (class I). In 
S.cerevisiae a 125 bp region consisting of highly conserved elements (CDEI, CDEII and 
CDEIII) has been identified as the area of centromere formation (class II). Higher organisms 
show rather large but very diverse centromere composition (class III).  
(Torras-Llort et al., 2009) 
 
The most clear and conserved sequence defined centromeric structures are found in the 
budding yeast S.cerevisiae. Proper centromere function and thus genome stability in this 
organism depend on three elements, called centromere DNA elements (CDEI, CDE II 
and CDE III). Together these three elements form a 125 bp sequence (Cottarel et al., 
1989). Multi-cellular organisms do not exhibit such a defined centromeric region 
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(Wiens and Sorger, 1998) but they share the similarity, that centromeres are exclusively 
embedded in heterochromatin (Allshire and Karpen, 2008). It is important to note, that 
not only the centromeric core domain, but also the flanking pericentric heterochromatin, 
plays a role in the functionality of the centromere (Chan and Wong, 2012). Due to its 
heterochromatic state it was believed, that centromeric regions are not transcribed, but 
recent studies have shown that centromeres (pericentric regions and the core domain) 
are not only highly transcribed regions, but that transcription is also important for 
centromere chromatin identity (Chan and Wong, 2012). 
 
1.2.1 Chromatin status of centromeric DNA 
The diversity of centromeres in higher eukaryotes raises many questions about 
underlying chromatin structures and possible epigenetic regulators. The centromere 
specific histone H3 variant CENH3 plays a pivotal role in this context since it has been 
found at endogenous but also at neocentromeres, which establish at ectopic non-
centromeric sites (Heun et al., 2006). It has been demonstrated that CENH3 deposition 
is restricted to centromeric regions on chromosomes (Torras-Llort et al., 2009). In most 
organisms the centromere specific histone CENH3 was identified in the mid 90s (Table 
1.1) and are conserved mostly in their sequence (Figure 1.7 A). 
 
Table 1.1 CENH3 variants among different species. 
Organism CENH3 isoform Original publication 
C.elegans HCP3 (Buchwitz et al., 1999) 
A.thaliana HTR12 (Copenhaver et al., 1999) 
S.pombe Cnp1 (Clarke et al., 1993) 
S.cerevisiae Cse4 
 
(Stoler et al., 1995) 
D.melanogaster CID (Henikoff et al., 2000) 
X.laevis XCENP-A (Edwards and Murray, 2005) 
M.musculus CENP-A (Rattner, 1991) 
H.sapiens CENP-A (Palmer et al., 1991) 
 
Recently a discussion about the nomenclature of the centromere specific histone 3 
variant emerged. In contrast to a before published paper that suggests to name all 
centromere specific histone 3 variants across species CENH3 (Talbert et al., 2012) it 
was recommended to keep with the original nomenclature of the histones, i.e. CENP-A 
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for the human variant and CID for the Drosophila variant (Earnshaw et al., 2013). 
During this thesis I made use of CENH3 of two species and to avoid confusion I use 
“CENH3” to refer to the centromere specific histone variant in general. If I specifically 
talk about one variant I use the terms “CENH3
CENP-A
” (H.sapiens) and “CENH3
CID
” 
(D.melanogaster) to discriminate between the two variants. 
1.2.1.1 Chromatin status of centromeric DNA in D.melanogaster 
As there is no consensus sequence known to account for centromeric regions the 
question remains where these functional elements establish on chromosomes. 
Experiments with the minichromosome Dp1187 in D.melanogaster showed that the 
composition of the centromere-underlying DNA is primarily composed of -satellites 
and, to a much lesser extent, transposons (Sun et al., 1997). However, the satellite 
sequences are also found at multiple other positions in the genome that lack centromeric 
function and consequently they do not seem to be the defining element in centromere 
formation. Accordingly, the transposable sequences were excluded for the same reason 
as major determinant for centromere definition (Sun et al., 1997). 
As DNA sequence was excluded to be the centromere defining element, epigenetic 
factors like DNA methylation or centromere specific histone variants came under 
scrutiny and the centromere specific histone 3 variant in D.melanogaster was found and 
named centromere identifier (CENH3
CID
) (Henikoff et al., 2000). CENH3
CID
 is a 
specialised histone variant present at centromeric hotspots in the fly genome (Henikoff 
et al., 2000). The heterochromatic environment of CENH3
CID
 is different in respect to 
conventional, heterochromatic histone modification marks and differs from both 
euchromatin and heterochromatin (Sullivan and Karpen, 2004). In D.melanogaster a 
specialised post-translational modification pattern might be the basis for centromeric 
chromatin formation. Centromeric histone modifications common for pericentric 
heterochromatin, H3K9 di- and trimethylation, are not found at centromeric chromatin 
during interphase and mitosis. Typical euchromatic reference marks (e.g. H3K9ac, 
H4K5ac, H4K8ac, H4K12ac, H4K16ac) are not detected at centromeric sites. However, 
the H3K4-dimethylation mark, which usually accounts for active chromatin, is detected 
between CENH3 spreads but not at pericentric heterochromatin. H3K4 trimethylation is 
not found although it is known to be an euchromatic marker. All of these findings also 
hold true for human centromeres (Sullivan and Karpen, 2004). 
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CENH3
CID
 is a 678-nucleotide long gene, which displays similarity to canonical H3 but 
has, like all other centromere-specific histone variants, an unique N-terminus (Henikoff 
et al., 2000). RNAi
23
-mediated depletion of CENH3
CID
 leads to compensation with H3 
(Blower et al., 2002). CENH3
CID
 is only localised at endogenous centromeres (Henikoff 
et al., 2000), but high overexpression also causes the induction of ectopic centromere 
formation (Heun et al., 2006). This results in a high number of mitotic defects and 
chromosome aberrations, like chromosome breakage. This observation provides 
evidence, that induced ectopic centromeres are functional and able to assemble all 
kinetochore components that are necessary for microtubule attachment (Heun et al., 
2006). In contrast to mammalian cells, deposition of CENH3
CID
 in D.melanogaster 
happens already during anaphase/metaphase (Mellone et al., 2011; Schuh et al., 2007). 
The proteins accounting for proper deposition of CENH3
CID
 at centromeres are CENP-
C
24
 and CAL1
25
. These are two key proteins at Drosophila centromers, which are 
recruited to centromeres in early mitosis (prophase) (Dunleavy et al., 2012; Mellone et 
al., 2011). The function of CAL1 is to limit CENH3
CID
 expression to avoid mitotic 
instability due to centromere expansion as a consequence of too high CENH3 
expression (Dunleavy et al., 2012). Furthermore CAL1 forms a complex with 
CENH3
CID
 and CENP-C and both proteins are responsible for CID deposition in 
prophase of meiosis (Dunleavy et al., 2012). Only CENH3
CID
 and CENP-C are 
symmetrically passed on to the daughter cells, whereas this is not true for CAL1 
(Mellone et al., 2011). Additionally, CAL1 is present in much lower levels than 
CENH3
CID
 and CENP-C (Dunleavy et al., 2012). 
1.2.1.2 Chromatin status of centromeric DNA in H.sapiens 
Heterochromatin is the basis for all endogenous human centromeres (Allshire and 
Karpen, 2008). In fact, centromeres are located on long tandem repeats of -satellite 
sequences. These AT-rich sequences are 171 bp-long monomer tandem repeats of -
satellite DNA (Choo et al., 1991; Waye and Willard, 1987) and make endogenous 
centromeres distinguishable from neocentromeres, which do not exhibit this type of 
underlying DNA structure (Warburton, 2004). The DNA sequence of centromeric loci is 
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not conserved (Black et al., 2004) and centromeric DNA is neither sufficient nor 
necessary for the formation of centromeres (Torras-Llort et al., 2009). 
The histone composition at centromeric regions comprises the canonical histones H2A, 
H2B, H3 and H4, with the intercalating histone 3 variant CENH3
CENP-A
 that replaces 
canonical H3. The epigenetic mark of centromeric DNA is definitely the accumulation 
of CENH3
CENP-A 
(Black et al., 2004). Proteins that assemble and build the kinetochore 
(chapter 1.2.2) are highly similar between organisms; e.g. CENP-A or CENP-C is 
always found at the respective sites (Houben and Schubert, 2003; Shen et al., 2001). 
Like CENH3
CID
, also CENH3
CENP-A
 is exclusively found at centromeric sites of human 
chromosomes. If overexpressed, CENH3
CENP-A
 also displaces at ectopic sites (Sullivan 
et al., 1994). The importance of CENH3
CENP-A
 in vivo is demonstrated in homozygous 
knock-out mice where the depletion of CENH3
CENP-A
 has lethal consequences (Howman 
et al., 2000). The N-terminal histone tail of CENH3
CENP-A
 consists of a unique sequence 
whereas the sequence similarity of the globular C-terminal part of CENH3
CENP-A
 is 
more than 60 % identical to the canonical histone H3 homologue (Sullivan et al., 1994) 
This domain is known as the histone fold domain and is found in all histones as the 
dimerization domain (Arents and Moudrianakis, 1995). In comparison to other histones, 
which share most of the sequences, CENH3
CENP-A
 is poorly conserved between species 
at the amino acid level (De Rop et al., 2012; Sarma and Reinberg, 2005). Especially 
those regions, which are not at all related to other histones, are supposed to determine 
CENH3
CENP-A
´s distinct function (Palmer et al., 1991). Unlike other histone 3 variants, 
which account for the histones with the most modified tails, CENH3
CENP-A
 only has one 
modification on the N-terminus identified so far (Stellfox et al., 2012). 
Besides the non-conserved N-terminus, the major difference between H3.3 and 
CENH3
CENP-A
 is the CENP-A targeting domain (CATD, Figure 1.7 B) which is missing 
in H3.3 and which targets CENH3
CENP-A
 specifically to future centromeric sites. If 
wildtype histone 3 is supplemented with a CATD, the centromeric function is rescued 
(Black et al., 2007). The CATD is located from loop1 to 2 helix of the histone fold 
domain of the protein and comprises 35 amino acids. Also in the budding yeast 
CENH3
Cse4p
, a CATD homologue, was identified but CENH3
CID
 does not seem to 
harbour this domain. 
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Figure 1.7 Sequence and structure alignments of histone 3 variants. 
A) The sequences of loop1 (L1) and α2 helix (H2) of histone 3.1 are conserved among species 
(h: H.sapiens, m: M.musculus, sc: S.cerevisiae, x: X.laevis, dm: D.melanogaster). CENH3 
sequences contain conserved motifs only in the region of L1 and H2, which represents the 
CENP-A targeting domain (CATD). The CATD is responsible for binding of CENH3
CENP-A
 to 
centromeric DNA and is the only difference between canonical histone 3.3 and CENH3
CENP-A
. 
Deviations from CENH3 to canonical histone 3 are conserved mostly among species (red 
lettering) or are otherwise substituted (green lettering) (Black et al., 2004). B) Specific 
differences of CENH3
CENP-A
 are shown in comparison to canonical histone 3. Additionally to the 
difference of the CATD, CENH3
CENP-A
 also has a binding site for its chaperon HJURP and 
kinetochore proteins like CENP-N and CENP-C. Interestingly, CENH3
CENP-A
 is much less 
modified by posttranslational modifications as compared to H3. 
(Stellfox et al., 2012) 
 
CENH3
CENP-A
 nucleosomes build up the fundamental platform for kinetochore assembly 
and are the determinant tool of chromosome segregation. Like all other histones, also 
CENH3
CENP-A
 has a histone fold domain and it builds heteronucleosomes with histone 
H4. CENH3
CENP-A
 is recruited in a cell cycle-dependent manner and is tethered to the 
centromeric site via its chaperon, the Holliday junction recognition protein (HJURP) 
(Dunleavy et al., 2009). This deposition of CENH3
CENP-A
 at centromeres takes place in 
late telophase and early G1 (Jansen et al., 2007) and it was shown that also all 
kinetochore proteins that are needed for a functional kinetochore are assembled after 
HJURP-mediated CENH3
CENP-A
 deposition (Barnhart et al., 2011). 
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1.2.2 Kinetochore composition 
The kinetochore is a protein structure, which is responsible for microtubule attachment 
to chromosomes and proper chromosome segregation (Santaguida and Musacchio, 
2009; Welburn and Cheeseman, 2008). The classical kinetochore is divided into two 
parts – the inner kinetochore, which assembles directly on centromeric DNA and the 
outer kinetochore, which is loaded on top of the inner kinetochore and provides the 
attachment platform for microtubules during cell division (Santaguida and Musacchio, 
2009) (Figure 1.8). 
 
 
Figure 1.8 Schematic of the centromere-kinetochore-microtubule structure. 
Left, grey panel: The section of a chromosome illustrates the structure of the centromere-
kinetochore-microtubule arrangement during mitosis. Right, coloured panel: The different 
elements are pseudo-coloured: inner (magenta) and outer (yellow) kinetochore structures; inner 
centromere (pink) and microtubules (green). The respective functions of each element are 
highlighted in the coloured boxes. 
(Cleveland et al., 2003) 
 
Overall more than 80 proteins are involved in kinetochore structure and function 
(Cheeseman and Desai, 2008). Inner kinetochores are always a prerequisite for 
assembly of the outer kinetochore components, like the KMN network
26
 (Santaguida 
and Musacchio, 2009). The constitutive centromere-associated network, CCAN, is built 
of a subset of proteins at the inner kinetochore close to centromeric DNA and remains at 
this position throughout the whole cell cycle. On the other side – the outer kinetochore – 
the KMN complex assembles (kinetochore-microtubule-attachment complex), which is 
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bound by microtubules during mitosis and is only assembled during this specific cell 
cycle stage (Maresca, 2011). A complete list of kinetochore proteins in H.sapiens and 
D.melanogaster is given in appendix 9.3. 
CENH3
CENP-A
 was identified as one of the first centromeric histones that build up the 
basis for kinetochore assembly and CENP-C was found to be a marker for the inner 
kinetochore. Furthermore, the three connected centromeric proteins CENH3
CENP-A
, 
CENP-B
27
 and CENP-C are only found at active centromeres (Earnshaw and Migeon, 
1985). The connection between the kinetochore and its binding factors was not entirely 
known for a long time. Only recently the inner kinetochore marker CENP-C was found 
to be not only the connecting link between the centromere and the inner kinetochore via 
its C-terminal tail, but also the interface between the outer and the inner kinetochore via 
its N-terminus in D.melanogaster and HeLa cells (Przewloka et al., 2011; Screpanti et 
al., 2011). Ectopic kinetochore formation usually takes place near heterochromatic 
regions or telomeres (Olszak et al., 2011). In this context, the N-terminus of CENP-C is 
again responsible for recruitment of the KMN network (Przewloka et al., 2011). 
 
1.2.3 Neocentromerization of chromatin 
The phenomenon, that a formerly non-centromeric region of the genome acquires 
centromeric function, including the formation of a kinetochore, is called 
neocentromerization (Warburton, 2004). Due to the fact that two functional centromeres 
on one chromosome lead to genome instability, neocentromeres are only formed in the 
case of chromosomal breakage and the centromere-lacking chromosomal fragment 
would otherwise be lost during mitosis or meiosis (Burrack and Berman, 2012). 
Formation of a neocentromere on these breakage products rescues these fragments from 
being lost (Rocchi et al., 2012). Another reason for neocentromerization is silencing of 
the endogenous centromere (Warburton, 2004). In this case the endogenous centromere 
remains unchanged, except for the fact that the site is devoid of CENH3
CENP-A
 and other 
CEN-proteins (Warburton et al., 1997). Under these circumstances the genome is not 
affected in any negative way (Rocchi et al., 2012). 
In 1993 the first case of human neocentromere formation was reported (Voullaire et al., 
1993) and until today more than 90 neocentromeres were described in human genomes 
(Marshall et al., 2008a). Usually neocentromeres are identified from patient samples as 
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they happen stochastically and are detectable by developmental delay or dimorphic 
patients (Warburton, 2004). Neocentromeres are not found directly in heterochromatic 
regions (Alonso et al., 2010) but only in close proximity to them (Olszak et al., 2011). 
In fact, they are located in euchromatic, highly transcribed regions of chromosomes and 
do not have a significant impact on protein expression (Marshall et al., 2008a; Rocchi et 
al., 2012). The structure-specific recognition protein 1 (SSRP1) and RNA polymerase II 
are found at enriched levels at active neocentromeres during mitosis (Chan et al., 2012). 
SSRP1 is a subunit of the FACT
28
 complex, which is believed to be involved in 
CENH3
CENP-A
 deposition (Okada et al., 2009). 
In contrast to endogenous centromeres, de novo formed neocentromeres are not 
characterised by the prerequisite that repetitive sequences (-satellites) are present at 
the site (Malik and Henikoff, 2000; Rocchi et al., 2012) and it actually seems that 
neocentromeres are actively avoiding repetitive regions of the genome. Just as for 
endogenous centromeres, also for neocentromeres no consensus DNA sequence was 
identified that determines their location on the genome. It is much more likely that again 
an epigenetic influence directs this mechanism (Warburton, 2004). 
CENH3
CENP-A
 localizes to neocentromeres no matter whether -satellite DNA is present 
or not (Warburton et al., 1997). However, the amount of CENH3
CENP-A
 at 
neocentromeres is reduced to one third of endogenous centromeres for yet unknown 
reasons (Irvine et al., 2004; Marshall et al., 2008a). The fact that CENH3
CENP-A
 is 
recruited to damaged DNA pieces substantiates the suspicion, that DNA repair and 
neocentromere establishment are tightly connected features – in fact the latter can 
happen because of the first event of recruitment (Zeitlin et al., 2009). It is not known if 
the role of the chaperone HJURP is the same at neocentromeres as for endogenous 
centromeres (Burrack and Berman, 2012). 
Neocentromeres exhibit large differences among each other like e.g. size and/or the 
presence of H3 nucleosomes in the underlying DNA sequence (Stimpson and Sullivan, 
2010). Most neocentromeres established at certain regions of the genome, with the 
highest indication at positions 3q, 8p, 13q, 15q and Yq (up to 16 neocentromeres are 
reported for these positions). At other chromosomal positions neocentromeres occur in 
much lower frequencies with a maximum of five cases in this group reported for 
chromosome 1 (Marshall et al., 2008a; Rocchi et al., 2012). In D.melanogaster the 
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proximity to a centromere is necessary for active neocentromere establishment (Maggert 
and Karpen, 2001). 
1.2.3.1 Artificial neocentromeres 
The centromere specific histone CENH3 is an epigenetic determinant for active 
centromeres and at functional neocentromeres the presence of CENH3 is a prerequisite. 
The fusion protein CENH3
CID
:GFP:LacI has been successfully recruited to an array of 
integrated LacOperators on chromosome 3R in D.melanogaster (Olszak et al., 2011). It 
was proven by immunofluorescence and ChIP analyses that a neocentromere establishes 
at the site similar to the endogenous centromere (Figure 1.9). 
 
 
Figure 1.9 Formation of artificial neocentromeres by CENH3:GFP:LacI targeting to 
chromosomes. 
A) 256 LacOperator sites (grey rectangles) integrated in the chromosomal arm of chromosome 
3R in D.melanogaster recruit the CENH3
CID
:GFP:LacI fusion protein to the site. Similarly to 
endogenous centromeres (white circles) neocentromeres (grey boxes) establish on the 
LacOperator arrays. These neocentromeres are able to recruit kinetochore proteins (red forms). 
Kinetochore assembly has been demonstrated in D.melanogaster and is expected to function in 
a similar manner in human cells. 
(Mendiburo et al., 2011) 
 
The ectopic neocentromeres function like an endogenous centromere and seem to 
assemble similar proteins for the inner and outer kinetochore to the site (like e.g. POLO, 
Ndc80, Mad2 and CENP-C). The neocentromeres are fully functional and work like the 
endogenous analogue. Recently Teo et al. were able to prove, that even just the N-
terminal domain of CENH3 fused to GFP:LacI:NLS is sufficient to provide targeting of 
the protein to integrated LacOperator sites in the chromosomal arms and to enable 
neocentromere formation in A.thaliana (Teo et al., 2013). 
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1.3 Aim – Establishment of a CENH3-dependent, active pDNA 
vector segregation mechanism 
Gene therapy is a field with great potential for the treatment of various diseases like 
cancer, genetic disorders or autoimmune diseases. The major goal in gene vector design 
is to improve transgene vehicles with regard to genome integrity and immunological 
issues of the patient and making them more efficient concerning retention and transgene 
expression. Viral vectors, which are currently used in most clinical applications, 
integrate into the host genome and permit a stable expression of the transgene. 
However, integration leads to genotoxic effects (e.g. the activation of oncogenes) and 
viral particles are always a potential source of immunological reactions by the patient. 
To avoid these side effects much effort is put on the development of non-viral and 
extrachromosomal pDNA gene vectors. 
Epstein-Barr virus derived vectors are one sub-group of plasmid-based, non-viral gene 
vectors. The essential tool of EBV-based vector is the use of oriP, a bipartite structure 
responsible for DNA replication and pDNA vector retention of the virus. The 
conditional plasmid system pCON
29
 was established and studies by Pich et al. led to the 
first generation of gene vectors in an oriP-based context (Pich et al., 2008). During 
earlier work in our laboratory the roles of HP1 and HMGA1a in regards to pDNA 
vector retention were investigated (Deutsch, M., unpublished) (Thomae et al., 2008). 
Both proteins are considered to be able to substitute the function of retention of oriP. 
Like oriP and pEPI vectors, they use the passive piggyback mechanism to distribute the 
pDNA vector to daughter cells. 
Based on these observations, the aim of this work was to establish an entirely new 
generation of non-viral gene vectors, which use an active segregation mechanism. By 
using CENH3 as segregation factor, I aimed to create a new pDNA vector family that 
behaves like a “quasi-chromosome” (in this respect like mammalian artificial 
chromosomes) with is own CENH3-induced centromere (Figure 1.10). 
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Figure 1.10 CENH3 induced formation of neocentromeres on pDNA vectors. 
Overexpression of the centromere specific histone variant CENH3
CID
 in cells leads to the 
ectopic deposition of the protein and the formation of neocentromeres (Heun et al., 2006). We 
transferred this system from the chromosomal level to the pDNA vector. With this set-up it is 
possible to test the functional relevance of CENH3 incorporation by targeting of the protein to 
usually non-centromeric sites. For experiments in D.melanogaster I used the LacO-LacI 
targeting system, for experiments in H.sapiens I used the TetO-scTetR targeting system. Due to 
the formation of neocentromeres and transforming the pDNA vector into “quasi-chromosomes”, 
pDNA vectors are maintained in the cell over a prolonged period of time by an active 
segregation mechanism that is independent of the host chromosomes as shown before in Figure 
1.1. The formation of neocentromeres is epigenetically conserved and maintains also in the 
daughter pDNA vectors after replication and segregation. 
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2.1 Materials 
2.1.1 Chemicals, antibiotics and buffers 
Table 2.1 shows all chemicals, antibiotics, buffers and other substances that were used 
during this work. 
 
Table 2.1 Substances used in this work. 
Substance Distributor 
Agarose Invitrogen GmbH, Karlsruhe 
Albumin, bovine Sigma-Aldrich Chemie, München 
Ampicillin sodium salt Carl Roth GmbH und Co KG, Karlsruhe 
ATX Poncau S red staining solution Fluka Analytical, Steinheim 
Bio-Rad Protein Assay Bio-Rad, München 
BSA, purified, 100x New England Biolabs, Schwalbach 
Caesium chloride AppliChem GmbH, Darmstadt 
Calciumchlorid (CaCl2) Merck-Eurolab GmbH, Darmstadt 
Chloroform Merck-Eurolab GmbH, Darmstadt 
dCTP -32P Hartmann Analytic GmbH, Braunschweig 
DNA loading dye, 6x New England Biolabs, Schwalbach 
Dimethylsulphoxide (DMSO) Carl Roth GmbH und Co KG, Karlsruhe 
Disodiumhydroxyphosphat AppliChem GmbH, Darmstadt 
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Dithiothreitol (DTT) Sigma-Aldrich Chemie, München 
Deooxycholic acid (DOC) Sigma-Aldrich Chemie, München 
Drosophila Schneider S2 medium PAN Biotech GmbH, Aidenbach 
Dulbecco’s Eagle modified medium Gibco Life Technologies GmbH, Darmstadt 
Ethylendiamintetraacetic acid 
(EDTA) 
Carl Roth GmbH und Co KG, Karlsruhe 
Ethanol Merck-Eurolab GmbH, Darmstadt 
Eosin Merck-Eurolab GmbH, Darmstadt 
G418/Geneticin Carl Roth GmbH und Co KG, Karlsruhe 
GeneRuler™ 1 kb DNA ladder MBI Fermentas, St. Leon-Rot 
Glycerin AppliChem GmbH, Darmstadt 
Glycin Carl Roth GmbH und Co KG, Karlsruhe 
Hydrochloric acid Merck-Eurolab GmbH; Darmstadt 
Hygromycin PAA-Laboratories, Wien, Austria 
Isoamyl alcohol Merck-Eurolab GmbH; Darmstadt 
Isopropanol (2-Propanol puriss.) Merck-Eurolab GmbH, Darmstadt 
Lipofectamine 2000 Invitrogen GmbH, Karlsruhe 
Manganese chloride (MnCl2) Fluka Analytical, Steinheim 
Methanol Merck-Eurolab GmbH; Darmstadt 
Milk powder Carl Roth GmbH und Co KG, Karlsruhe 
NP-40 (Igepal CA-630) Sigma-Aldrich Chemie, München 
Ortho-phosphoric acid Merck-Eurolab GmbH; Darmstadt 
PBS Dulbecco, pH 7.2 Biochrom AG, Berlin 
Piperazine-N,N’-bis(ethanesulfonic 
acid) 
ICN Biomedicals Inc., Aurora, Ohio, USA 
Polyacrylamide Carl Roth GmbH und Co KG, Karlsruhe 
Potassium hydroxide AppliChem GmbH, Darmstadt 
Puromycin AppliChem GmbH, Darmstadt 
RPMI-1640 cell medium Gibco Life Technologies GmbH, Darmstadt 
Select agar Invitrogen GmbH, Karlsruhe 
Sodium acetate Merck-Eurolab GmbH, Darmstadt 
Sodium dodecylsulfate (SDS) Serva Electrophoresis GmbH; Heidelberg 
Sodium chloride Merck-Eurolab GmbH, Darmstadt 
Sodium citrate Merck-Eurolab GmbH, Darmstadt 
Sodium hydroxide Carl Roth GmbH und Co KG, Karlsruhe 
,N‘,N‘,N‘,N‘-Tetramethylendiamine Carl Roth GmbH und Co KG, Karlsruhe 
Triton-X100 Sigma-Aldrich Chemie, München 
Trypsin-EDTA Gibco Life Technologies GmbH, Darmstadt 
Tween-20 AppliChem GmbH, Darmstadt 
Tryptone enzymatic digest from 
casein 
Carl Roth GmbH und Co KG, Karlsruhe 
Yeast extract Gibco Life Technologies GmbH, Darmstadt 
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2.1.2 Devices 
The following table (Table 2.2) files all devices used during this work. 
 
Table 2.2 Devices used in this work. 
Device Distributor 
Analysis balance sealtec (< 120 g) Bayrische Waagenwerkstätte, Utting a.A. 
Balance kern 470 (< 2000 g) Kern, Albstadt 
Bio photometer Eppendorf, Hamburg 
Biorupter UCD-200 Diagenode, Liège, Belgium 
Centrifuge 2K15 Sigma, Ostenrode am Harz 
Centrifuge Rotina 38R Hettich, Tuttlingern 
Developer machine CP100 AGFA, Köln 
Electroporation cuvettes 1mm Peqlab Biotechnologie GmbH, Erlangen  
Electroporation device Gene 
pulser II 
Bio-Rad Laboratories, Richmond CA, USA 
Film cassettes FujiFilm, Kleve 
Gel documentation system peqlab GmbH, Erlangen 
Gene Amp PCR system 2400 Perkin Elmer, USA 
High-speed centrifuge Avanti J-
26XP 
Beckman-Coulter, München 
Hotplate/magnetic stirrer RH 
basic 
IKA Labortechnik, Staufen 
Illustra Microspin G-50 columns GE Healthcare, München 
Incubator shaker innova 4400 New Brunswick Scientific GmbH, Nüttingen 
Incubator shaker innova 44 New Brunswick Scientific GmbH, Nüttingen 
Incubator kelvitron-t, 26.5 °C Heraeus, Hanau 
Incubator Napco L5410, 37 °C, 
CO2 
UniEquip, Martinsried 
Intensifier screen FujiFilm, Kleve 
Light-Cycler™ Roche Diagnostics GmbH, Mannheim 
Microcon filter device Millipore, Schwalbach 
Milli-RO 60 PLUS water filter 
Aquintus 
Millipore, Schwalbach 
NanoDrop® ND-1000 
spectrometer 
ThermoScientific, USA 
Optimax x-ray film processor Protec GmbH & Co KG, Oberstenfeld 
Phosphoimager FLA 5100 FujiFilm, Kleve 
Qubit fluorometer Invitrogen, Darmstadt 
SemiDry blotting system Hoefer Scientific Instruments, USA 
SevenEasy InLab413 pH-meter Mettler Toledo, Gießen 
Spectrometer DU 640 Beckmann, Heidelberg 
Syringe filter Asahi Techno Glass Co, Singapur 
Table centrifuge 5415R Eppendorf, Hamburg 
Thermomixer comfort Eppendorf, Hamburg 
Thermomixer AccuBlock Digital 
DryBath 
Labnet International Inc., USA 
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Ultracentrifuge Optima L-70 Beckman-Coulter, München 
UV transilluminator TS40 254 nm Herolab Inc., USA 
Vortex Genie 2 Scientific Industries Inc., USA 
Waterbath Acoline 100 Lauda Dr.R.Wobser GMBH & Co KG, Königshofen 
 
2.1.3 Kits 
Table 2.3 shows all kits that were used during this work. 
 
Table 2.3 Kits used in this work. 
Kit Distributor 
JETstar Maxi-prep kit Genomed GmbH, Löhne 
NucleoSpin Gel and PCR Clean-
up kit 
Macherey-Nagel, Düren 
CloneJET PCR Cloning kit MBI Fermentas, St. Leon-Rot 
Random primed DNA labelling 
kit 
Roche, Penzberg 
 
2.1.4 Enzymes 
All utilised restriction enzymes were purchased from New England Biolabs, 
Schwalbach and Fermentas, Thermo Scientific, USA. More enzymes are listed in Table 
2.4. 
 
Table 2.4 Enzymes used in this work. 
Enzyme Distributor 
T4 DNA ligase Affymetrix/usb products, UK 
Pwo polymerase Peqlab, Erlangen 
RNase, DNase-free Roche, Penzberg 
Proteinase K Carl Roth GmbH und Co KG, Karlsruhe 
Antarctic phosphatase New England Biolabs, Schwalbach 
Taq polymerase kindly provided by C.-E. Mayer 
 
2.1.5 Plasmids 
Plasmids listed in Table 2.5 were used in this thesis. Numbers indicate the Helmholtz 
Zentrum München (HMGU) database ID. *-labelled plasmids stem from the HMGU 
AGV plasmid collection and °-labelled plasmids were provided by other research 
groups. All other plasmids were cloned during this work. 
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Table 2.5 Plasmids used in this work. 
HMGU ID Characteristics Creator 
3230* wt-oriP (Gerhardt et al., 2006) 
3231* DS/20 TetOperator WH/AT
30
, HMGU 
3293.5* DS/40 TetOperator WH, HMGU 
3223.9* Puromycin-cassette WH, HMGU 
4201* scTetR: CENH3
CENP-A
 (mini-CMV - 53 + 74) M. Deutsch, HMGU 
4202* scTetR: CENH3
CENP-A
 (E-Cad - 178 + 92) M. Deutsch, HMGU 
4203* scTetR: CENH3
CENP-A
 (mini E-Cad - 21 + 92) M. Deutsch, HMGU 
4890 scTetR:H3.3 (E-Cad -178 + 92) S. Fülöp, M. Amman 
4892 scTetR: CENH3
CENP-A-
CATD
mut
 (E-Cad – 178 + 92) S. Fülöp, M. Amman 
5403° 256 x LacOperator P. Heun, MPI Freiburg 
 
2.1.6 Primer sequences 
Following tables (Table 2.6 - Table 2.8) list primers used during this work. Numbers 
before the primer name indicate for the primer ID in the Schepers group primer 
collection. 
 
Table 2.6 Primers used for qPCR. 
Primer ID Sequence (5´ > 3´) 
118 G418 fw ATGATTGAACAAGATGGATTG 
119 G418 rev TCAGAAGAACTCGTCAAGAAG 
 
Table 2.7 Primers used for cloning. 
Primer ID Sequence (5´ > 3´) 
033 5´CENP-A fw AGTCGGCCGGCCATGGGCCCGCGCCGCCGG 
034 3´CENP-A rev ATGCGCTAGCTCAGCCGAGTCCCTCCTC 
043 H3.3 fw CGACGGCCGGCCATGGCCCGAACCAAGCAGACT 
044 H3.3 rev CCCGCTAGCTTAAGCTCTCTCTCCCCGTAT 
151 HJURP s AAAACGGCCGCTATGCTGGGTACGCTGCGC 
152 HJURP as AATTCGGCCGCTACACACTTTTAGTTTCCAATTTTTCTAG 
 
Table 2.8 Primers used for sequencing. 
Primer ID Sequence (5´ > 3´) 
255 Amp 3´fw GGGATCATGTAACTCGCCTTG 
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256 Amp 5´rev CGACACGGAAATGTTGAATACTC 
317 Amp follow-up fw2 CGGGTTGGACTCAAGACGATAG  
321 Amp follow-up fw3 TGATCATCTCAGTGCAACTAAAGG 
 
2.1.7 Commercial bacteria strains 
- DH5 for cloning (preparation see chapter 3.2.3) 
F-; lacI-; recA1; endA1; hsdR17; (lacZYA-argF), U169, F80dlacZ M15; supE44; thi-1; 
gyrA96; relA1 (Hanahan, 1983). 
 
- Electromaxx DH10B for electroporation in plasmid rescue assays (Invitrogen, 
Karlsruhe) 
F-; mcrA; (mrr-hsdRMS-mcrBC), 80dlacZM15; lacX74; deoR; recA1; endA1; 
araD139; (ara, leu)7697; galU; galK; -;  rpsL; nupG 
 
2.1.8 Commercial cell lines 
- HEK 293 EBNA1 
human embryonic kidney cells; stably integrated EBNA1 
 
- Drosophila Schneider S2 (kindly provided by P. Heun) 
late stage (20-24h) D.melanogaster embryonic cells 
 
2.1.9 Antibodies 
The -CENH3
CENP-A
 antibody was stored at -20 °C, -TetR antibody was stored at 4 °C. 
Detailed information about the application of primary antibodies is shown in Table 2.9. 
 
Table 2.9 Primary antibodies used in this work. 
Specificity Origin Application Dilution Distributor 
-CENH3
CENP-A 
 
rabbit Western Blot 1:2500 LifeSpan (Biozol) Eching 
-TetR rabbit Western Blot 1:2000 C. Berens, Erlangen 
 
The secondary -rabbit antibody was purchased from Jackson Immuno Research Labs 
and applied in Western Blot in a 1:10000 dilution in 2.5 % milk in PBS-T. 
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2.1.10 Blotting membranes 
Amersham Hybond ECL for Western Blot (GE Healthcare, München) 
Nylon membrane for Southern Blot (Millipore, Bedford, UK) 
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3 METHODS 
3.1 Cell biological methods 
3.1.1 Cultivation of cells 
HEK 293-EBNA1-scTetR:CENP-A and HEK 293-EBNA1-scTetR cells were cultivated 
at 37 °C and 5 % CO2 in DMEM and RPMI-1640 medium, respectively. Schneider S2 
cells were cultivated at 26.5 °C in PAN Schneider’s Drosophila medium and did not 
require CO2 supply. All cell culture media were supplemented with 10 % FCS
31
 and 
1 % Penicillin/Streptomycin as standard practice. The respective antibiotic 
concentrations for selection are listed in Table 3.1. 
 
Table 3.1 Concentration of antibiotics for selection of cells. 
Antibiotic HEK 293 Drosophila Schneider S2 
Puromycin 300 – 700 ng/ml 2 µg/ml 
Neomycin/G418 220 ng/ml 1 mg/ml 
Hygromycin 150 µg/ml 100 µg/ml 
 
3.1.2 Cell number determination 
Cells were counted with the help of a Neubauer cell counting chamber. To differentiate 
between dead and living cells the samples were mixed with eosin in a 1:1 ratio. Eosin 
stains all dead cells and cell fragments whereas living cells do not take up the dye. The 
dilution must be considered in the calculation of the total cell count. Cells in the middle 
squares of two chambers were counted and according to the following equation the 
number of cells/ml was determined: 
 
[(n/N)]*d*2*10
4
= cells/ml 
n: number of counted cells in all counted squares 
N: number of counted squares 
d: dilution factor of the cell suspension 
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3.1.3 Cryopreservation 
Cells were frozen down in a suspension of 90 % FCS mixed with 10 % DMSO
32
 to -
80 °C in a 2 ml CryoTube (Nunc) and slowly cooled in a “Nalgen Nunc Cryo 1 °C 
Freezing Container” (Nunc) with a cooling rate of -1 °C/minute. After a few days cells 
were transferred to the liquid nitrogen tank (-196 °C) for long-term storage. 
For thawing cells were warmed to 37 °C, washed with 10 ml fresh medium to get rid off 
DMSO and plated on 15 cm cell culture dishes in 20 ml of fresh medium. 
 
3.1.4 Transfection of HEK 293 cells with Lipofectamine 2000 (Invitrogen) 
Transfections were performed according to manufacturer’s instructions. 1.5 x 10
5
 cells 
were seeded per well of a 6-well plate and transfected 24 h later. 1 µg of DNA and 2 µl 
of Lipofectamine (µl Lipofectamine = 2 x µg DNA) were diluted separately with Opti-
MEM medium to a final volume of 50 µl each and incubated for five minutes. 
Subsequently both solutions were mixed and incubated for 20 minutes at room 
temperature. The resulting 100 µl of transfection solution were applied to the cells in a 
drop-wise manner. Prior to this procedure FCS was removed from the cell culture 
medium to avoid interference with the complex formation reaction. 24 hours post 
transfection cells were transferred to a 15 cm cell culture dish and the medium was 
changed to serum-supplemented medium containing the according selection antibiotic 
(Table 3.1). 
 
3.1.5 Establishment of stable cell lines 
A plasmid encoding for the scTetR-fused protein of choice (CENH3 and H3.3) and one 
with a puromycin cassette were co-transfected in HEK 293 EBNA1 cells. Both plasmids 
were linearised prior to transfection to promote integration into the host genome. To 
increase the efficiency of selection, the scTetR-fusion protein was used in a higher 
concentration compared to the puromycin cassette plasmid (ratio 10:1). Transfections 
were performed as described in 3.1.4. After a selection period of two to three weeks 
single colonies were picked with autoclaved pieces of thin Whatman paper soaked in 
trypsin. The cells sticking on the paper pieces were transferred to 6-wells and cultivated 
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as described in 3.1.1. To confirm the expression of the fusion protein, Western Blot 
analysis was performed (see chapter 3.3.3). The following cell lines were established 
during this thesis: 
- HEK 293 EBNA1-scTetR:CENH3
CENP-A
 
three cell lines under the control of different promoters 
1. E-Cadherin promoter (- 178 + 92) 
2. mini-E-Cadherin promoter (- 21 + 92) 
3. mini-CMV promoter (- 53 + 74) 
HEK 293 EBNA1-scTetR:H3.3 
1. E-Cadherin promoter (- 178 + 92) 
 
3.2 Molecular biological methods 
General lab techniques like agarose gel electrophoresis, phenol-chloroform extraction 
and DNA precipitation were performed according to standard protocols as described in 
Sambrook et al. (Sambrook and Russell, 2001). 
 
3.2.1 Bacterial culture 
Culturing of Escherichia coli (E.coli) was performed in LB-broth (Luria-Bertani 
medium). For cloning purposes cells were grown as single colonies on LB-plates. After 
transformation cells were cultivated with the respective antibiotic (ampicillin 100 
µg/ml, carbenicillin 50 µg/ml, kanamycin 40 µg/ml). For long-term storage overnight 
cultures of bacteria were mixed with 25 % glycerol and stored at -80 °C. 
 
LB-broth: 
1 % NaCl, 1 % Tryptone enzymatic digest from Casein, 0.5 % yeast extract 
+ 1.5 % select agar (for plates only) 
 
3.2.2 Plasmid-DNA amplification and purification from bacteria 
400 ml of LB-broth were supplemented with the respective antibiotic and inoculated 
with E.coli carrying the plasmid of choice. After overnight incubation at 37 °C and 200 
rpm on orbital shakers, cells were harvested by centrifugation at 4500 rpm for 15 
minutes at 4 °C. The pellet was washed once with PBS
33
 and plasmid DNA was isolated 
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following the instructions of the JETstar Maxi-prep kit (Genomed). The DNA content 
of the sample was measured with the NanoDrop® at 260 nm. 
 
3.2.3 Preparation of chemically competent cells 
Preparation of competent cells was performed as described previously in Sambrook et 
al. Protocol 24: The Inoue Method for Preparation and Transformation of Competent 
E.coli: “Ultra-competent” cells (Sambrook and Russell, 2001). Previously prepared 
competent bacteria were used to inoculate 25 ml of a new starting culture. Cells were 
incubated on an orbital shaker for six to eight hours at 37 °C and 250 – 300 rpm. For 
overnight incubation a 250 ml culture was inoculated with 4 ml of the starting culture, 
OD
34
600 = 0,05, and kept on the shaker at 18 °C and 200 rpm. OD600 measurement was 
performed continuously until an OD600 of 0.55 was reached. The culture vessel was kept 
in an ice-water bath for 10 minutes and cells were harvested by centrifugation at 
2500 x g for 10 minutes at 4 °C. Medium was discarded and cells were resuspended in 
ice-cold Inoue transformation buffer. Cells were centrifuged as described before and 
resuspended in 20 ml of ice-cold Inoue transformation buffer. After addition of 1.5 ml 
of DMSO cells were kept at 4 °C for 10 minutes. After snap-freezing the aliquots in 
liquid nitrogen bacteria were stored at -80 °C until use. 
 
PIPES: 
0.5 M PIPES pH 6.7 (with 5M KOH) 
Inoue transformation buffer (sterile): 
55 mM MnCl2  4 H20, 15 mM CaCl2  2H20, 250 mM KCl, 10 mM PIPES (0.5 M, pH 6.7) 
 
3.2.4 Transformation of chemically competent cells 
- Heat-shock transformation 
E.coli DH5 were thawed on ice and 100 µl of bacteria were mixed with DNA. The 
mixture was incubated 30 minutes on ice, transferred to 42 °C for 90 seconds and again 
put on ice for five more minutes. Samples were diluted in 3 ml of LB-broth and put on 
the orbital shaker for 45 minutes at 37 °C. Overnight incubation was done on selective 
agar plates at 37 °C. 
- Electroporation 
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Electroporation was performed with the gene pulser II electroporator (Biorad) and 
Electromaxx DH10B bacteria (Invitrogen). All buffers and cuvettes were cooled 
throughout the experiment. 100 µl of bacteria were diluted 1:6 with ice-cold water and 
100 µl of this suspension were mixed with 50 µl DNA sample (150 ng and 350 ng). 
Electroporation was performed in 1 mm cuvettes at 25 µF and 2.5 kV. After 
electroporation cells were rescued in 3 ml of LB-broth on a shaker at 37 °C for 45 
minutes. Afterwards cells were spun down, plated on selective agar plates and incubated 
overnight at 37 °C. 
 
3.2.5 Primerdesign- and synthesis 
Primers were designed using the MacVector software. All oligonucleotides and primers, 
used in this work, were synthesised at Metabion (Martinsried, Germany). All relevant 
primer sequences for this work are found in chapter 2.1.6. 
 
3.2.6 Polymerase-chain reaction (PCR) 
Polymerase chain reaction is used for amplification of specific DNA fragments (Mullis 
et al., 1986). For standard reactions self-made Taq polymerase or Pwo polymerase were 
used and the annealing temperature of the reaction was set accordingly to the respective 
primer melting temperature. PCR products were purified with the Machery-Nagel PCR 
purification kit after the amplification was performed and samples were checked on 1 % 
agarose gels. 
 
3.2.7 Restriction digest 
With the help of specific endonucleases, DNA palindrome sequences were cut and 
samples can be investigated regarding their genomic integrity. Gel analysis was done to 
verify the reaction efficiency and correct band formation. Restriction digests were 
performed at 37 °C for one to two hours and the enzyme was heat inactivated at 65 °C 
for 20 minutes if the sample was not purified in an agarose gel.  
 
 
Restriction digest (V = 20 µl) 
500 ng  DNA 
    2 µl  10x buffer (NEB Buffer 1 - 4 according to enzyme) 
    0,2 µl BSA 
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    x µl  enzyme (depending on U/µl, restriction site and enzyme) 
add H20 to a final volume of 20 µl 
 
3.2.8 Dephosphorylation 
To avoid re-ligation of a DNA fragment after single-cut digestion a dephosphorylation 
of the vector was performed. Phosphate molecules are removed from the overhangs and 
prevent re-ligation. Prior to the phosphorylation reaction the sample was desalted by 
centrifugation through a G50-Sepharose column. Dephosphorylation of the vector 
backbone was performed at 37 °C for one hour. 
 
Dephosphorylation reaction with Antarctic Phosphatase (V = 50 µl) 
30 µl digested vector backbone (desalted) 
5 µl  10x buffer 
3 µl Antarctic Phosphatase 
add H20 to a final volume of 50 µl 
 
3.2.9 Fill-in reaction 
To create blunt-ends for ligation a fill-in reaction with Klenow enzyme was performed. 
After the Klenow-reaction the DNA was purified from an agarose gel and applied in a 
ligation reaction. The reaction was performed for 30 minutes at 37 °C and stopped by 
heat-inactivation of the enzyme at 75 °C for 20 minutes. 
 
Fill-in reaction with Klenow enzyme (V = 100 µl) 
30 µl purified digested DNA 
10 µl NEB buffer 2 
  5 µl Klenow enzyme (5 U/µl) 
  5 µl dNTPs (10 mM) 
add H20 to a final volume of 100 µl 
 
3.2.10 Ligation 
Ligases build up phosphodiester bonds between 3´-OH ends and a neighbouring 5´-
phosphate group in an ATP-dependent manner. Vector and insert are cut with enzymes 
that create compatible overhangs. Because of high error rates ligations have to be tightly 
controlled. To check for re-ligation of the vector, which happens if the vector is cut with 
a single enzyme (see dephosphorylation, chapter 3.2.8), the reaction was performed 
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without insert. The second control is checking the restriction efficiency of the digest. To 
do so insert and ligase were left out in the reaction. Each ligation was transformed into 
competent bacteria. The reaction was performed for two to three hours at room 
temperature or overnight at 16 °C. 
 
Ligation reaction with T4 ligase (V=15 µl) 
vector backbone:insert 1:1, 1:4 and 1:10 (ratio in pmol) 
1,5 µl 10x Rx buffer 
0,5 µl T4 ligase 
   1 µl ATP 100 mM 
add H20 to a final volume of 15 µl 
 
3.2.11 Isolation and purification of DNA/PCR products from agarose gels 
DNA was purified from gels according to manufacturer’s instructions with the 
NucleoSpin Gel and PCR
35
 Clean-up kit. DNA was eluted twice with 15 µl of elution 
buffer. 
 
3.2.12 Southern Blot 
Southern Blot was performed as described previously (Church and Gilbert, 1984; 
Southern, 1975). 10-15 µg of genomic DNA were digested with restriction enzymes and 
separated on a 0.8 % agarose gel. DNA integrity was checked with ethidiumbromide 
after the run. Depurination of the sample was achieved by washing the gel for 20 
minutes in 0,25 M HCl and was followed by washing the gel in denaturation buffer 
twice for 10 minutes. The samples were transferred from the gel to a nylon membrane 
via capillary forces for three to four hours and afterwards washed in 2x SSC for 10 
minutes. The membrane was pre-hybridised with Church buffer for 1 h at 65 °C. 
Subsequently the radioactive labelled probe was added and incubated overnight at 
60 °C. The following day the membrane was washed three times for 10 minutes with 
washing buffer. The membrane was wrapped up in plastic wrap, a film was put on the 
membrane and the cassette was stored at -80 °C. Duration of exposition depended on 
the intensity of signals. Alternatively, a phosphoimager screen can be used instead of a 
film and the cassette must then be stored at room temperature. 
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1x TAE buffer: 
40 mM Tris-HCl (pH 8.0), 5 mM NaAc, 1 mM EDTA 
Denaturation buffer: 
1,5 M NaCl, 0,5 M NaOH 
2x SSC: 
300 mM NaCl, 30 mM sodium citrate 
Church buffer (pH 7.2): 
Solution 1: 7 % SDS, 400 mM Na2HPO4, 100 mM Ortho-Phosphore acid, 1 mM EDTA pH 7.2 
heat up to dissolve ingredients 
Solution 2: 1 % BSA in H20 
mix solution 1 and 2 and fill up to 1 l with H20 
Washing buffer: 
0,2 x SSC, 1 % SDS 
3.2.12.1 Radioactive labelling of DNA probes for Southern blotting 
Labelling of 25-50 µg of DNA probe was performed according to manufacturer’s 
instructions with the “Random primed DNA labelling kit” (Roche). Removal of not 
incorporated labelled nucleotides was achieved by centrifugation of the sample through 
Sephadex-G50 columns. Prior to hybridization the probe was denatured (5 minutes at 
95 °C, 5 minutes on ice). 
 
3.3 Protein biological methods 
3.3.1 Preparation of whole cell protein lysates 
Cells were harvested with trypsin, washed twice with ice-cold PBS and centrifuged at 
1000 rpm for 8 minutes at 4 °C. The cell pellet was resuspended in 60-100 µl RIPA 
buffer, according to the pellet size. Lysed cells were incubated on ice for 30 minutes 
and centrifuged at full speed for 30 minutes at 4 °C. The protein containing supernatant 
was kept on -20 °C. Protein concentration was determined using the Bradford method 
(3.1.3.2). 
 
RIPA buffer: 
1 mM EDTA, 150 mM NaCl, 0,1 % SDS, 0.5 % DOC, 1 % NP-40, 50 mM Tris pH 8.0 
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3.3.2 Determination of protein concentration 
The protein concentration of RIPA extracts was determined according to the protocol of 
Bradford (Bradford, 1976). Protein assay solution was diluted 1:5 with PBS and 1 ml 
was mixed with 1 µl of the RIPA-extract in an appropriate cuvette. The mixture was 
incubated for 15 minutes in the dark and measured with the Eppendorf Biophotometer. 
 
3.3.3 Western Blot 
Proteins for Western blotting were run according to the standard procedure on SDS-
polyacrylamid gels (Laemmli, 1970). Samples were blotted on a nitrocellulose 
membrane following the protocol for semi-dry blotting (Towbin et al., 1979) vertical to 
the running direction of the gel. The proteins were stuck to the matrix due to 
hydrophobic interactions and intercalated SDS was washed out with methanol-
containing blotting buffer. Furthermore methanol enhances the binding of proteins to 
the membrane. To avoid the formation of air bubbles between the gel and the 
membrane, a glass pipette was rolled over the sandwich with little pressure. Blotting 
was performed with a semi-dry chamber for 1h at 15 V, 400 mA and 150 W. Proteins of 
interest were detected with specific primary antibodies, which in turn were detected 
with peroxidase-coupled secondary antibodies with ECL
36
-solution. 
 
Running buffer: 
192 mM Glycin, 24 mM Tris, 3.4 mM SDS, pH 7.4 
2x Concentration gel buffer: 
0.25 M Tris, 7 mM SDS, > pH 6.8 (HCl) 
5x Separation gel buffer:  
1.86 M Tris, 17 mM SDS, > pH 8.8 (HCl) 
5x Laemmli buffer: 
100 mM Tris pH 6.8, 25 % SDS, 50 % -mercaptoethanol, 0.5 % Bromphenolblue 
ECL solution: 
solution 1: 0,1 M Tris pH 8.8, 200 mM p-choumaric acid, 1.25 mM luminol 
solution 2: 3 % H2O2 
For usage 1 ml of solution 1 and 3 µl of solution 2 were mixed and applied on the membrane 
PBS-Tween20 (PBS-T): 
1x PBS, 0,1 % Tween-20 
5 % and 2.5 % milk-blocking solution: 
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5 g or 2.5 g milk powder in 100 ml 1xPBS-T 
1x Running buffer; 
192 mM Glycin, 24 mM Tris, 3.4 mM SDS, pH 7.4 
1x Blotting buffer: 
1x Running buffer + 20 % methanol 
 
To check the blotting efficiency, the membrane was stained with Ponceau S solution. 
Ponceau S is a red coloured azoic dye that stains all proteins on nitrocellulose or PVDF 
membranes by binding to the positive charged amino groups of proteins. The staining is 
reversible and the dye can easily be removed from the membrane by washing with 
water. 
The membrane was blocked with 5 % milk-blocking solution for 1h at room 
temperature to saturate all unspecific binding sites. The membrane was washed three 
times with PBS-T for 5 minutes and afterwards the primary antibody, diluted in 2.5 % 
milk-blocking solution, was added overnight at 4 °C or 1h at room temperature. The 
membrane was washed three times for 5 minutes with PBS-T. The peroxidase-coupled 
secondary antibody (1:10.000 in 2.5 % milk-blocking solution) was added and 
incubated for 45 minutes at room temperature and antibodies were visualised by 
incubation with ECL- solution. 
 
3.4 Plasmid rescue assay 
3.4.1 Human cells 
1.5 x 10
5
 cells were transfected with 1 µg of the respective pDNA reporter vector 
(DS/20 TetOperator, DS/40 TetOperator, wt-oriP) following the instructions for 
Lipofectamine 2000 (chapter 3.1.1.4). Hygromycin selection (150 µg/ml) was applied 
for three weeks. Low molecular weight extrachromosomal DNA was isolated at 
different time points by HIRT extraction as described before (Hirt, 1966). For 
harvesting, cells were washed with TEN buffer and afterwards resuspended in 1.5 ml 
TEN buffer and 1.5 ml 2x HIRT buffer. Proteins and chromatin were precipitated with 
750 µl of 5 M NaCl (end-conc 1.25 M) and samples were stored at 4 °C overnight. 
After centrifugation for 1h at 15.000 rpm and 4 °C, DNA was purified from the 
supernatant by phenol-chloroform extraction and 1 g of low-molecular-weight DNA 
was digested with DpnI and RNase. Digest of the extracted DNA with DpnI allows 
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eliminating the initially transfected plasmids, which retain the dam methylation pattern 
acquired during propagation in E. coli. 350 ng of digested DNA were electroporated 
into Electromaxx DH10B competent cells (Invitrogen) and after overnight incubation at 
37 °C ampicillin-resistant colonies were counted. 
 
TEN buffer: 
10 mM Tris-HCl pH 7.5, 1 mM EDTA, 150 mM NaCl 
2x HIRT buffer: 
1,2 % SDS, 20 mM Tris-HCl pH 7.5, 20 mM EDTA 
 
3.4.2 Schneider S2 cells 
1.4 g LacOperator reporter vector were transfected into S2 cells expressing 
CENH3
CID
:GFP:LacI and GFP:LacI protein. Cells were kept under selection with 1 
mg/ml G418 throughout the experiment. All further steps were performed as described 
for the human system in 3.1.4.1. Cells were lysed in 0.5 ml TEN buffer and 0.5 ml 
HIRT buffer (2x) and 150 ng of DNA were electroporated into Electromaxx DH10B 
bacteria (Invitrogen). 
 
3.5 BrdU-incorporation assay 
CENH3
CID
:GFP:LacI or GFP:LacI cells transfected with the LacOperator reporter 
vector. Selection with G418 (1 mg/ml) was applied for two weeks before cells were 
pulsed with 10 mM 5-bromodeoxyuridine (BrdU) for 48 hours. With the help of a CsCl 
gradient centrifugation cells with incorporated BrdU and cells without BrdU were 
separated due to their differences in buoyant density of replicated DNA (the gradient is 
adjusted to 1.403 refractive index). From 1.5 x 10
7
 cells DNA was isolated and applied 
on the gradient after BamHI digest. Gradients were spun in a Beckman SW41 rotor at 
48.000 rpm for 48 h. The refractive index of each fraction (250 µl) was determined and 
the samples were analysed by either quantitative PCR using PCR primer pairs 
recognizing the backbone of the plasmid (Table 2.7) or measuring the A260 index with 
the NanoDrop for the genomic DNA content in the sample. 
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pDNA vectors (i.e. plasmid-derived, non-viral and extrachromosomally maintained 
vectors) of different origin employ various mechanisms for their retention in target 
cells. They either integrate into the host genome and remain there for the lifetime of the 
cell, or are maintained in an extrachromosomal state. Examples for non-integrating 
vectors are e.g. the pEPI vector and EBV-derived gene vectors (Ehrhardt et al., 2008). 
The extrachromosomal EBV-derived wt-oriP vector is dependent on two components: 
oriP in cis and its transactivator EBNA1 in trans. In the absence of EBNA1 wt-oriP 
vectors as well as EBV genomes are lost rapidly from infected cells (Humme et al., 
2003). 
I explored a novel, artificial and CENH3-dependent mechanism of pDNA vector 
retention and investigated its efficiency. The idea was, to turn the pDNA vector into a 
“quasi-chromosome” by establishing a pivotal cellular feature for chromosome 
segregation also on the pDNA vector – a (neo)centromere. It was the first aim of this 
project to evaluate, whether or not a neocentromere on the pDNA vector is sufficient to 
prolong pDNA vector maintenance in the cell and in this way guarantee transgene 
expression and long-term stability of the pDNA vector. 
Previous experiments showed, that through artificial targeting of CENH3
CID
, functional 
kinetochores were established at ectopic sites in D.melanogaster (Heun et al., 2006). 
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These results were further validated with targeting experiments of a 
CENH3
CID
:GFP:LacI fusion protein to LacOperator arrays integrated into chromosome 
3R of D.melanogaster (Olszak et al., 2011). Due to the LacI-LacOperator interaction, 
formation of a neocentromere was specifically induced at the LacOperator sites on the 
chromosome. 
In respect to previous studies it seemed reasonable to test our hypothesis of inducible 
neocentromere formation first on pDNA vectors in a D.melanogaster model (Heun et 
al., 2006). Follow-up experiments were performed in human cells and results from these 
experiments are found in the Results II section (chapter 5). 
 
4.1 Rescue of autonomous pDNA vectors from cells 
Autonomous pDNA vector maintenance in a proliferating cell is dependent on two 
mechanisms: DNA replication and pDNA vector retention (Pich et al., 2008). The 
overall goal of this work was to develop a mechanism of pDNA vector retention, that is 
independent of host cell chromosome attachment and trans-acting factors like viral 
proteins (e.g. EBNA1 in the case of oriP-derived vectors). With the knowledge that was 
gained in the past (Heun et al., 2006; Pich et al., 2008) I wanted to test, if pDNA vector 
autonomy in the retention mechanism is obtained via the induction of a neocentromere 
on the pDNA vector itself. To investigate whether the centromere specific protein 
CENH3 has the ability to induce neocentromeres on pDNA vectors and might enhance 
pDNA vector retention, I used plasmid rescue assays. This assay is one possible way to 
detect exclusively extrachromosomal and self-propagating vectors in a cell. Figure 4.1 
illustrates the experimental set-up. 
 
 
Figure 4.1 Plasmid rescue assay – experimental procedure. 
Cells are transfected with a pDNA reporter vector (1) and kept under selection (2) until certain 
harvesting times. During selection two sets of pDNA vectors are present in the cells (3): first, 
plasmids derived from bacterial propagation, which are dam-methylation positive and digestible 
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by DpnI (input plasmids) and second, plasmids, which have been actively replicated in the cell 
after transfection (replicated plasmids). These plasmids do not carry the dam-methylation 
profile and are therefore not digested by DpnI. Cells are harvested following the HIRT protocol 
(4) (Hirt, 1966). During this step, plasmid DNA is enriched in the supernatant of the sample and 
bulk chromatin is precipitated with proteins (5). After phenol/chloroform extraction (6) the 
sample is digested with RNase and DpnI and the resulting solution contains only plasmids, 
which stem from propagation in human cells (7). Purified DNA is electroporated into competent 
bacteria and plated on Amp
+
 agar plates (8). Following overnight incubation at 37 °C the 
number of outgrown bacterial colonies are counted (9). 
 
Drosophila Schneider S2 cells, stably expressing either CENH3
CID
:GFP:LacI or 
GFP:LacI, were transfected with the pDNA reporter vector encoding for two antibiotic 
resistance genes and 256 LacOperator sites (Figure 4.2 B). The strong binding of the 
LacI-fusion protein to the LacOperator sites on the pDNA vector enables the site-
specific targeting of CENH3
CID
. Cells were selected with G418 (1 mg/ml) and harvested 
at indicated times during a period of one month (Figure 4.2 A). 
 
 
Figure 4.2 Plasmid rescue assay in D.melanogaster – experimental set-up. 
A) Schneider S2 cells (stably expressing CENH3
CID
:GFP:LacI or GFP:LacI) were transfected 
with a pDNA reporter vector and selected under high selective pressure (1 mg/ml G418). Bulk 
chromatin was precipitated with a high salt concentration and the plasmid-enriched supernatant 
was phenol/chloroform extracted. DNA was digested with DpnI (for elimination of dam-
methylated input plasmids derived from generation in bacteria) and RNase (for enhanced purity 
of DNA samples), 150 ng of DNA were electroporated into DH10B competent bacteria and 
plated on Amp
+
 agar plates. The read-out of the assay is the number of bacteria colonies 
growing after overnight incubation at 37 °C. B) The 14.2 kb pDNA reporter vector used in the 
assay encodes for an ampicillin-resistance cassette used for selection in bacteria and a G418 
resistance cassette for selection in Schneider S2 cells. 256 LacOperator sites, which are bound 
by the CENH3
CID
:GFP:LacI and GFP:LacI fusion proteins expressed in the transfected cells, 
occupy the main part of the plasmid. 
 
During selection two sets of pDNA vectors were present in the cells: first, input vectors 
derived from bacterial propagation and used for transfection in the beginning of the 
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experiment. They carry the DpnI-sensitive dam-methylation profile. Second, vectors are 
present, which have replicated in the cell only after transfection. These vectors have lost 
the bacterial methylation pattern and are distinguishable from input vector with a DpnI 
digest. Cells were lysed with 0.6 % SDS and proteins plus all chromatinised DNA were 
precipitated with 1.25 M NaCl. The sample was incubated overnight at 4 °C before 
most of the genomic DNA was removed by centrifugation. After phenol/chloroform 
extraction of the supernatant, the sample was highly enriched in plasmid DNA, even if 
the main part of DNA in the sample was still genomic DNA. Ethanol precipitation of 
DNA was followed by a DpnI digest in combination with RNase treatment. After re-
precipitation, 150 ng of purified DNA were electroporated in Electromaxx DH10B 
competent bacteria (Invitrogen) and plated on ampicillin agar plates. Colonies were 
counted after overnight incubation at 37 °C and represented the read-out of the 
experiment (Figure 4.2 A). 
 
4.2 Targeting of CENH3 to the pDNA vector confers 
autonomous and prolonged pDNA vector retention in cells 
The stability of extrachromosomal pDNA vector retention in a cell was analysed with 
plasmid rescue assays and quantified by the number of colonies growing on Amp
+
 agar 
plates after electroporation. The number of outgrowing colonies from plasmid rescue 
assays in cells expressing the CENH3
CID
:GFP:LacI fusion protein (Figure 4.3 A, green 
bars) and cells expressing GFP:LacI (Figure 4.3 A, grey bars) differed strongly after 
two weeks under selection. Results revealed prolonged pDNA vector retention in 
CENH3
CID
:GFP:LacI expressing cells compared to cells lacking CENH3
CID
:GFP:LacI 
(Figure 4.3 A, day 21 and 28, green bars). The only difference between the two samples 
was the presence and absence of targeted CENH3
CID
. Therefore, it is likely that the 
difference in pDNA vector numbers was caused by the CENH3
CID
:GFP:LacI -induced 
neocentromere formation on the vectors, which enabled them to segregate in a host cell 
independent mechanism. pDNA vectors in cells lacking CENH3
CID
:GFP:LacI did not 
establish neocentromeres and were lost from cells more rapidly. 
The high number of pDNA vectors in CENH3
CID
:GFP:LacI negative cells in the initial 
phase of the experiment (until day 14) was due to a delay in selection response of 
Schneider S2 cells to G418. Selection with G418 in these cells was becoming effective 
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only after two weeks (Figure 4.4). Until this point was reached, pDNA vectors were 
replicated. After passing that time frame pDNA vectors were lost rapidly from cells if 
no CENH3
CID
:GFP:LacI protein was expressed due to the fact that the pDNA vectors 
carrying the resistance cassette were lost (Figure 4.3 A, day 21, grey bars). 
Control experiments confirmed, that plasmid rescue assay experiments were started 
with an initial transfection efficiency being comparable between both cell lines. I 
checked this by performing plasmid rescue assays without the DpnI digest (DpnI- 
experiments in Figure 4.3 B – C). The background of the experiment was determined by 
performing plasmid rescue assays on cells missing the initial transfection of the pDNA 
reporter vector. The background here is considered as negligible (experiments with non-
transfected cells in Figure 4.3 B – C). 
 
 
Figure 4.3 Targeting of CENH3
CID
:GFP:LacI to pDNA vectors improved their retention in 
Schneider S2 cells. 
A) Cells expressing CENH3
CID
:GFP:LacI (green bars) and cells that express GFP:LacI (grey 
bars) were transfected with a pDNA reporter vector (Figure 4.2 B) and analysed in plasmid 
rescue assays (n = 3, +/- SEM). Experiments without DpnI digest (left columns in B) and C) 
show the initial transfection efficiency of the two cell lines. Experiments of non-transfected 
(n.tr.) cells show the background colony number of the experiment. Control experiments 
without DpnI digest and without transfection of the pDNA reporter vectors (n.tr.) are shown in 
B) for CENH3
CID
:GFP:LacI cells (n = 3, +/- SD) and C) for GFP:LacI cells (n = 3, +/- SD). 
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4.2.1 Selection features of Schneider S2 cells with G418 
The results that I obtained in plasmid rescue assays with CENH3
CID
:GFP:LacI and 
GFP:LacI cells were quite similar between the two cell lines during the first week of the 
experiment. I expected a faster loss of pDNA vectors in CENH3
CID
:GFP:LacI negative 
cells, but also after two weeks of selection still many pDNA vectors were rescued from 
these cells. A possible explanation for this observation is the growth behaviour of 
Schneider S2 cells under selection with G418. Therefore I wanted to find out, how 
Schneider S2 cell proliferation is influenced by selection pressure with G418 (1 mg/ml). 
Additionally proliferation assays of transfected and non-transfected cells with and 
without selection enable the determination of cell generation numbers and thus the 
calculation of plasmid loss rates. 
I seeded Schneider S2 cells (not transfected and transfected) with a density of 1 x 10
6
 
cells/ml in a total volume of 2.4 ml in 6-well plates and counted the cells repeatedly 
about every second day during one month. Cell numbers were determined by counting 
cell aliquots in a Neubauer cell counting chamber (chapter 3.1.2). 
 
 
Figure 4.4 Proliferation curves of Schneider S2 cells with and without selection pressure. 
CENH3
CID
:GFP:LacI and GFP:LacI cells were seeded with a density of 1 x 10
6
 cell/ml in a total 
volume of 2.4 ml. One set of cells was transfected with a pDNA reporter vector, whereas the 
other half of cells remained non-transfected. Non-transfected cells were cultivated in antibiotic 
free Schneider S2 cell medium and transfected cells were kept under selection with 1 mg/ml 
G418. Cells were counted in a Neubauer cell counting chamber and proliferation curves were 
determined (n = 1) tr.: transfected, n.tr.: not transfected. 
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The proliferation curves demonstrated, that proliferation in cells that were transfected 
and kept under selective pressure with G418 was slowed down strongly in comparison 
to non-transfected cells, which grew in medium lacking G418 (Figure 4.4). Cells under 
selection showed an increase in total cell numbers during the first two weeks of 
selection. The first evidence that selection hit in was observed at days 17/18. Afterwards 
cells under selective pressure were not able to recover and died whereas not transfected 
cells in non-selective medium proliferated constantly. 
Proliferation rates of individual cell lines are required to determine pDNA vector loss 
rates per generation. As the proliferation did not follow a linear curve, I was not able to 
determine the pDNA vector loss rates for the respective cell lines. 
 
4.3 Genetic integrity and conformational state of transfected 
pDNA vectors 
In regards to therapeutic pDNA vector design, genetic stability (i.e. no alterations in the 
DNA sequence) of the pDNA vector and its conformational state in the cell are very 
important aspects. From a clinical perspective, reliable transgene expression and genetic 
stability of the pDNA vector must be guaranteed throughout the complete medical 
procedure. While resting in a cell, the pDNA vector might recombine, lose important 
(regulatory) elements or take up foreign sequences. This can lead to problematic 
consequences especially in regards to transgene expression. If the pDNA vector is 
genetically unstable, the expression of the therapeutic protein from the pDNA vector 
might become irregular with potential impact on the therapeutic activity. It is also 
possible that the transgene is lost from the cell completely, if the genetic integrity of the 
pDNA vector is not ensured. 
To check genetic integrity of the pDNA vector I performed restriction digest analysis of 
colonies taken from rescued pDNA vectors (chapter 4.3.1). To elucidate the 
conformation in which the pDNA reporter vector was maintained in the cell, I 
performed Southern Blot analysis on DNA of transfected cells (chapter 4.3.2). 
 
4.3.1 Genetic integrity of the pDNA vector is preserved over time 
Single bacteria colonies from plates of plasmid rescue assays were taken and DNA was 
isolated. To confirm the genetic integrity of the rescued pDNA vector an analytical 
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restriction enzyme analysis was performed with the restriction enzymes XhoI and NdeI. 
Both of these enzymes are single cutters on the input pDNA vector (Figure 4.5). The 
predicted fragment sizes after the digest are shown in Table 4.1. 
 
Table 4.1 Fragment prediction of restriction digest of the LacOperator pDNA reporter vector 
with XhoI/NdeI. 
Predicted fragment size (kbp) Annotation 
  4.1 Amp- and G418 resistance cassettes 
10.1 LacOperator repeats 
 
 
Figure 4.5 Vector map of the LacOperator pDNA reporter vector displaying the cut sites of 
XhoI and NdeI. 
Both restrictions enzymes cut the pDNA vector at one site in close proximity to the 
LacOperator repeats. The predicted fragment sizes and annotations of the vector after the digest 
are given in Table 4.1 and Figure 4.6 illustrates the analytical restriction digest. 
 
For the analysis I picked three clones from agar plates at day 7 and day 21 and 
performed restriction digests. Additionally I picked one clone from plates deriving from 
experiments with CENH3
CID
:GFP:LacI negative cells at days 7 and 21 (Figure 4.6). 
On the agarose gel the input pDNA vector was loaded in undigested and digested form 
as reference. The analysis demonstrated, that the genetic integrity of the LacOperator 
pDNA vector was maintained throughout the experiment. One has to mention that the 
LacOperator fragment was detected at approx. 8 kb instead of 10.1 kb also in the input 
pDNA vector, indicating that some of the 256 LacOperator sites have been lost, most 
likely due to the high recombination activity of highly repetitive sequences during the 
propagation in bacteria. Nevertheless, the input pDNA vector restriction pattern was 
confirmed in all rescued pDNA vectors except for one (Figure 4.6, clone 
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CENH3
CID
:GFP:LacI, 21.1). This clone displayed a smaller band for the LacOperator 
fragment at approx. 5 kbp, indicating that even more of the LacOperator repeat 
sequences have been deleted due to recombination. More important is the fact, that the 
pDNA vector backbone, where a potential transgene is located, remained stable in all 
investigated pDNA vectors (detected at 4.1 kbp). 
 
 
Figure 4.6 Restriction digest of rescued bacteria colonies confirmed the genetic integrity of 
the pDNA vector. 
Clones picked from plates of plasmid rescue assays, and the transfected input pDNA vectors 
were analysed in a restriction digest with XhoI and NdeI and separated on an agarose gel. Three 
clones were analysed deriving from experiments with CENH3
CID
:GFP:LacI positive cells after 
one and three weeks and one clone was analysed for clones deriving from experiments with 
GFP:LacI cells. The digest led to a fragmentation of the pDNA vector into the backbone (4.1 
kb) and the fragment with the LacOperator sites (10.1 kb). 
 
4.3.2 pDNA vectors are maintained in cells in a concatemer conformation 
Plasmid DNA can be maintained in different states of DNA conformations in a cell – 
e.g. as concatemers, which are single circular DNA strands attached to each other, or in 
linearised form. To find out, which conformation was the preferred state of pDNA 
vectors in my system, I performed Southern Blot analysis with the radioactive probe 
directed against the backbone of the pDNA vector. To eliminate background signals at 
the predicted height of the pDNA vector, genomic DNA was digested with FseI, a non-
cutter enzyme on the pDNA vector sequence (Figure 4.7, lane 7). Transfected cells were 
lysed 16 days post transfection with 0.1 % SDS and DNA was isolated, digested with 
RNase and ProteinaseK and purified with phenol/chloroform extraction. Samples were 
loaded on a 0.7 % agarose gel and separated over night (70 V, 150 mA). 
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For quantification purposes I loaded different concentrations of input pDNA vector in 
the first five lanes (Figure 4.7, lanes 1 - 5). Amounts lower than 100 pg were not 
detectable in the analysis. 
In my experiments the preferred status of pDNA vectors was the concatemeric form. In 
Southern Blot analysis the concatemer structure is visible as an additional higher 
migrating signal at the upper end of the gel (Figure 4.7, dark green arrow). The bright 
green arrow in Figure 4.7 indicates the band for monomeric, supercoiled plasmid DNA. 
 
 
Figure 4.7 Southern Blot analysis illustrates the formation of concatemers 16 days post 
transfection. 
Undigested input pDNA vector was loaded in five different concentrations for quantification 
purposes (lanes 1 - 5). DNA amounts lower than 100 pg were not detected on the blot. 
Transfected CENH3
CID
:GFP:LacI cells were lysed with 0.1 % SDS after 16 days under 
selection. Prior to loading, the sample was digested with FseI, a non-cutter enzyme on the 
plasmid, to get rid off high background signal of genomic DNA (lane 7). Dark green arrow: 
concatemeric DNA molecule, bright green arrow: monomeric, supercoiled plasmid DNA. 
 
Replication of (EBV-derived) pDNA vectors follows the theta replication principle, a 
bidirectional replication model (Gahn and Schildkraut, 1989). I wanted to know if the 
CENH3
CID
:GFP:LacI expression in cells influences DNA replication of the 
LacOperator pDNA vector and performed Meselson-Stahl experiments, which are 
discussed in the following chapter. 
 
Lane Sample 
1 10 ng input plasmid 
2 1 ng input plasmid 
3 100 pg input plasmid 
4 10 pg input plasmid 
5 1 pg input plasmid 
6 empty lane 
7 CENH3
CID
:GFP:LacI 
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4.4 pDNA vector replication is independent of CENH3
CID
 
Replication and retention are the two main factors regulating pDNA vector 
maintenance. To confirm whether or not pDNA vector replication is integrated into the 
cell cycle and to find out if CENH3
CID
:GFP:LacI overexpression plays a role in DNA 
replication of the pDNA vector I performed Meselson-Stahl density transfer 
experiments. The Meselson-Stahl experiment is based on the weight differences that 
occur, when BrdU is incorporated instead of thymidine into the newly synthezised DNA 
strand during replication. One round of semi-conservative replication in the presence of 
BrdU increases the buoyant density of DNA strand from “light-light” (1.70 g/cm
3
) to 
“heavy-light” (hemisubstituted, 1.73 g/cm
3
). After separation of the samples on a CsCl-
gradient, DNAs are found in different density fractions of the gradient according to their 
respective weight, which correlates with the incorporation of BrdU. If the DNA is not 
actively replicated, BrdU incorporation does not occur. 
In order to investigate CENH3
CID
’s influence on pDNA vector replication 
CENH3
CID
:GFP:LacI cells and GFP:LacI cells were transfected with a LacOperator 
pDNA reporter vector (Figure 4.2 B) and selected for two weeks with G418 (1 mg/ml). 
Cells were pulsed with 10 mM BrdU for one generation (48 hours) to allow one 
complete substitution of thymidine with BrdU. Total DNA was isolated, digested with 
BamHI and separated on a CsCl gradient. The CsCl solution had a starting refractive 
index of 1.403 (corresponding 1.74 g/cm
3
). After centrifugation for 48 hours at 48.000 
rpm fractions of 250 µl were collected. The refraction indices were measured for every 
second fraction to determine the CsCl density. Refraction indices were measured for 
three gradients, indicating that the different gradients are comparable (Figure 4.8 A). 
Chromatin DNA of the individual samples was measured photometrically (Figure 4.8 
B), and pDNA vector DNA was quantified by quantitative PCR using primers for the 
pDNA vector backbone (Figure 4.8 C). DNA peaks were observed for both BrdU-
pulsed cell lines (with and without CENH3
CID
:GFP:LacI) in the identical fractions of 
the gradient (fractions 15-17, CsCl density: 1.4025 - 1.3990), whereas DNA from non-
labelled cells was found in higher fractions (fractions 17-21, CsCl density: 1.4000 – 
1.3965) (Figure 4.8 B-C). This experiment demonstrated, that the pDNA vector 
replicated once-per-cell-cycle and that CENH3
CID
:GFP:LacI was not required for 
pDNA vector replication. This also explains the result of plasmid rescue assays, in 
which pDNA vector DNA accumulated also in CENH3
CID
:GFP:LacI negative cells until 
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day 7 (Figure 4.3 A). pDNA vectors segregated CENH3
CID
:GFP:LacI-dependently 
became dominant after two weeks of selection. 
 
 
Figure 4.8 pDNA vector replication occurs independently of CENH3
CID
:GFP:LacI 
overexpression in the cell. 
Transfected cells were selected for two weeks and pulsed with BrdU for 48 hours. BrdU was 
incorporated in DNA during active replication and due to its higher molecular weight DNA with 
incorporated BrdU was heavier than DNA without BrdU. In CsCl gradients the density of the 
fractions increased from bottom to top and DNA with incorporated BrdU was found in lower 
fractions of the gradient than BrdU-free DNA. A) CsCl gradient refraction indices. B) 
Photometric bulk chromatin measurement at A260 and C) pDNA vector DNA measurement with 
RT-PCR using primers for the pDNA vector backbone. Green line: CENH3
CID
:GFP:LacI cells 
BrdU+, black line: GFP:LacI cells BrdU+, red line: CENH3
CID
:GFP:LacI cells BrdU-. 
 
4.5 Extrachromosomal pDNA vectors establish a functional 
spindle apparatus 
During mitosis chromosomes segregate following a strict time-schedule, guarded by 
several checkpoint control mechanisms. After duplication of the genome during S-
phase, the chromosomes separate during mitosis. Mitosis is divided into five sub-
phases: prophase, prometaphase, metaphase, anaphase and telophase. In prophase, 
mitotic spindles grow starting from the centrosomes, which finally attach to the 
centromeres of chromosomes. In prometaphase the chromosomes start to assemble at 
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the metaphase plate. This process is finished in metaphase and during anaphase the 
spindle tubules start pulling the chromosomes to the spindle poles. 
To illustrate the behaviour of pDNA vectors in the cells and to follow them during 
mitosis I transfected cells with the pDNA reporter vector. In principle the induction of a 
neocentromere on the pDNA vector leads to a segregation mechanism as it is illustrated 
in Figure 4.9 A. pDNA vectors behave like “quasi-chromosomes” and their segregation 
is integrated into the endogenous mechanism of chromosome segregation. 
Immunofluorescence is a powerful method to follow up this development in the cell and 
members of Patrick Heun’s group at the MPI Freiburg performed immunofluorescence 
microscopy of the transfected cells at different states during mitosis (Figure 4.9 B-C). 
 
 
Figure 4.9 Immunofluorescence staining of transfected cells in different cell cycle stages. 
A) Model of active pDNA vector segregation. pDNA vectors with functional centromeres and 
kinetochores behave like chromosomes. The functional kinetochore is recognised by 
microtubules and after attachment the pDNA vectors are pulled to the spindle poles and 
symmetrically segregated to the daughter cells. Immunofluorescence microscopy of transfected 
cells in prometaphase (B) and metaphase (C). Blue: DAPI, green: CENH3
CID
:GFP:LacI pDNA 
vectors, red: tubulin. 
(Lufino et al., 2008; Mendiburo et al., 2011) 
 
I transfected Schneider S2 cells with the same pDNA reporter vector as previously used 
in plasmid rescue assays. After nine days under selection prometaphase cells were used 
to stain DNA (DAPI), the transfected pDNA vector (CENH3
CID
:GFP:LacI; green) and 
microtubules (tubulin, red). Subsequently cells were analysed with a fluorescence 
microscope. In Figure 4.9 B the green arrow and the enlargement illustrate the 
attachment of microtubules to the neocentromeres on pDNA vectors. The white arrow 
indicates an endogenous microtubule attachment site. Similar to the chromosomes also 
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pDNA vectors with neocentromeres are recognised by the microtubules and 
subsequently pulled to the spindle poles depicted in Figure 4.9 C (metaphase spread). In 
contrary to the chromosomes, which were still assembled at the metaphase plate during 
this cell cycle stage, at least a part of the pDNA vectors was pulled to the spindle poles 
earlier. It is conceivable that pDNA vector segregation was not fully integrated into the 
mitotic checkpoints or that segregation was happening much faster for pDNA vectors 
possibly due to their smaller size. 
 
4.6 Epigenetic inheritance of the centromeric mark 
Another question that arose was, how stable the neocentromeric mark is maintained on 
the pDNA vector over several cell generations. To this end, members of the group of 
Patrick Heun at the MPI in Freiburg performed experiments, in which they 
microscopically checked cells under the microscope for CENH3
CID
/CENP-C positive 
foci after the transient co-transfection of the LacOperator pDNA reporter vector and a 
CENH3
CID
:GFP:LacI expression plasmid. To complete the information gained with my 
experiments I included this result for the matter of a better understanding of the process 
of CENH3-mediated neocentromere formation (Figure 4.10) (Mendiburo et al., 2011). 
 
 
Figure 4.10 Initial targeting of CENH3:GFP:LacI for the nucleation of centromere function. 
Cells were transiently co-transfected with the LacOperator pDNA reporter vector and a 
CENH3
CID
:GFP:LacI construct. The percentage of extrachromosomal CENH3
CID
/CENP-C foci 
was determined in mitotic cells with a fluorescent microscope. Black: GFP-negative cells 
containing CENH3
CID
/CENP-C foci, green: GFP-positive cells (at least one GFP-positive focus) 
containing CENH3
CID
/CENP-C foci. 
(Mendiburo et al., 2011) 
  4 RESULTS I – D.melanogaster 
62 
After an initial high number of GFP-positive cells (green bars) with positive signals for 
CENH3
CID
 and CENP-C (representing extrachromosomal pDNA vectors with 
functional neocentromeres) the fraction of these cells subsequently decreased to about 
50 % after one week and was finally lost after one month. Nonetheless, it was still 
possible to detect CENH3
CID
/CENP-C positive foci in these GFP-negative cells (black 
bars). This means, that even after the loss of the LacI-targeting system, centromere 
formation and kinetochore assembly worked efficiently pointing towards epigenetically 
inherited marks recognised by CENH3
CID
 at centromeres (Mendiburo et al., 2011). 
 
4.7 Summary – Results I 
The main question of my thesis was, if induced neocentromere formation on a pDNA 
vectors would turn the pDNA vector into a “quasi-chromosome” and enable an active 
segregation mechanism similar to the one of chromosomes. In D.melanogaster it was 
demonstrated that targeting of CENH3
CID
:GFP:LacI indeed led to the induction of 
neocentromeres on the pDNA vectors. Our collaborators provided impressive evidence 
that the pDNA vectors were recognised by microtubules during mitosis and segregated 
actively to the daughter cells. Induced neocentromere formation on pDNA vectors 
increased the stability of the pDNA vector in cells after transfection, compared to 
pDNA vectors lacking neocentromeres. 
I observed a pronounced difference in pDNA vector retention efficacy between the two 
systems (+/- CENH3
CID
:GFP:LacI targeting), which is due to the differences in 
segregation mechanisms of the pDNA vectors. Furthermore I was able to demonstrate 
that (1) pDNA vectors remain their genetic integrity throughout selection, (2) that the 
preferred conformational state of the pDNA vector in the cell is concatemeric and (3) 
that DNA replication is independent of CENH3
CID
:GFP:LacI-induced mechanism of 
pDNA vector segregation. Additionally, our collaborators demonstrated that the 
centromeric mark is epigenetically inherited. With these encouraging results in hands I 
tested the functionality of this principle also in the human system using HEK 293 cells. 
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5 RESULTS II – H.SAPIENS 
 
 
Our studies in D.melanogaster provided proof of principle that artificially targeted 
CENH3
CID
:GFP:LacI allows the formation of functional neocentromeres to support the 
active segregation of pDNA vectors. For all my experiments in human cells I used human 
embryonic kidney cells (HEK 293 cells). In the human system I also tested longer time 
spans of pDNA vector retention and additionally I characterised the system in regards to 
dose dependencies in cis and trans. Also an all-in-one pDNA vector system was 
established and I investigated the role of the CENH3
CENP-A
´s targeting domain in 
neocentromere formation. 
 
5.1 CENH3
CENP-A
 improves pDNA vector retention in HEK 293 
cells 
To investigate pDNA vector retention in the mammalian cell culture system I started with 
plasmid rescue assays as described before (Figure 5.1 A). For my experiments in human 
cells I used the well-established pCON system, relying on the interaction of the 
TetOperator sites on the reporter vectors and the scTetR:CENH3
CENP-A
 protein to 
investigate the function of pDNA vector retention of an oriP-based pDNA vector. A 
detailed introduction and illustration about the pCON system is given in chapter 1.1.2. 
On the pDNA reporter vector 40 TetOperator binding sites replaced the functional domain 
of vector retention of oriP, the family of repeats (Figure 5.1 B). The wildtype dyad 
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symmetry element was present on the pDNA reporter vector to guarantee DNA replication. 
HEK 293 cells stably expressed EBNA1 to support DS function. In addition these cells 
stably expressed the scTetR:CENH3
CENP-A
 fusion protein, which was targeted to the 
TetOperator sites on the pDNA reporter vector. With this set-up I investigated, if 
scTetR:CENH3
CENP-A
 substitutes the function of FR by induction of a neocentromere on 
the pDNA vector. 
 
 
Figure 5.1 Experimental set-up of the plasmid rescue assay and map of the 40 TetOperator 
reporter vector. 
A) HEK 293 EBNA1-scTetR:CENH3
CENP-A
 cells were transfected with the pDNA reporter vector 
and selected with 150 µg/ml hygromycin until indicated times. After lysis, bulk chromatin was 
precipitated with 1.25 M NaCl and the plasmid-enriched supernatant was phenol/chloroform 
extracted. DNA was digested with DpnI, to eliminate dam-methylated input pDNA vectors derived 
from generation in bacteria and RNase for enhanced purity of DNA samples. 350 ng of low 
molecular weight DNA were electroporated into competent DH10B bacteria and plated on Amp
+
 
agar plates. The result of the assay was obtained after overnight incubation at 37 °C by counting 
outgrowing colonies on agar plates. B) The pDNA reporter vector contained an ampicillin 
resistance cassette for selection in bacteria and a hygromycin resistance cassette for selection in 
HEK 293 cells. DS was present on the pDNA vector in its wildtype status and 40 TetOperator sites 
were introduced instead of FR to test for pDNA vector retention efficiency with the 
scTetR:CENH3
CENP-A
 fusion protein. 
 
Plasmid rescue experiments were performed with cells expressing scTetR:CENH3
CENP-A
 at 
more than five-fold increased levels compared to endogenous CENH3
CENP-A
 expression 
(Figure 5.3, lane 6) and cells lacking scTetR:CENH3
CENP-A
 expression. After transfection 
with the pDNA reporter vector, cells were selected with hygromycin (150 µg/ml) and 
harvested at indicated times (Figure 5.1 A). 
The result of the experiment is depicted in Figure 5.2 A. Similar to analyses performed 
with D.melanogaster, the number of rescued pDNA vectors during the first three days after 
transfection was at comparable levels in both cell lines (Figure 5.2 A, day 1 and day 3). 
After seven days of selection scTetR:CENH3
CENP-A
 expressing cells retained the reporter 
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much more efficient than scTetR:CENH3
CENP-A
 lacking cells. These cells have lost almost 
all pDNA vectors at that time (Figure 5.2 A, day 7 and day 14). Cells carrying the selection 
resistance cassette survived under selection pressure, whereas cells that did not maintain 
the pDNA vector encoding for hygromycin resistance died shortly after day 3 under 
selection. 
 
 
Figure 5.2 Plasmid rescue assays in HEK 293 cells displayed an enhanced pDNA vector 
retention after scTetR:CENH3
CENP-A
 expression in the cells. 
A) Cells, which expressed scTetR:CENH3
CENP-A
 at high levels (blue bars) and cells that expressed 
only scTetR (grey bars) were transfected with 40 TetOperator pDNA reporter vectors (Figure 5.1 
B) and plasmid rescue assays were performed (scTetR:CENH3
CENP-A 
cells: n = 4, +/- SEM, scTetR 
cells: n = 5, +/- SEM). Plasmid rescue assay experiments without DpnI digest indicate that the 
initial transfection efficiency of the two cell lines was at similar levels in the beginning of the 
experiment. Plasmid rescue assay experiments of not transfected (n.tr.) cells show the background 
of the experiment. Control experiments are shown in B) for scTetR:CENH3
CENP-A
 cells (n = 3, +/- 
SD) and C) for scTetR cells (n = 3, +/- SD). 
 
Until day 14 after transfection the rescue rates were as expected: scTetR: CENH3
CENP-A
 
expressing cells maintained the pDNA vectors with the highest rescue rate between three 
and seven days post transfection. After a subsequent small loss of pDNA vectors the 
number of rescued pDNA vectors remained stable at a certain level after three weeks post 
transfection. The situation was different for scTetR:CENH3
CENP-A
 lacking cells, which lost 
pDNA vectors quite fast after three days post transfection. Most of these cells died due to 
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selective pressure, but unexpectedly some cells recovered and after cultivation for three 
weeks they were again able to give rise to clones in plasmid rescue assays. After three 
weeks under selection an average number of 96 colonies was detected from 
scTetR:CENH3
CENP-A
 positive cells and 86 colonies were found in assays from scTetR 
cells. At day 28 plasmid rescue assays led to 123 colonies from scTetR:CENH3
CENP-A
 
expressing cells and 77 colonies from scTetR cells (Figure 5.2 A). The background level of 
colonies in the experiment was on average 27 colonies for scTetR:CENH3
CENP-A
 cells and 
30 colonies for scTetR cells (Figure 5.2 B-C). 
From the obtained data I conclude, that (1) the background (colonies from n.tr. cells) had a 
higher impact in the human system, as the overall number of colonies in these assays were 
much lower and (2) after pDNA vector establishment in the cell the copy number of pDNA 
vectors in cells expressing scTetR:CENH3
CENP-A
 drops to a certain level, where it seems to 
remain constant (Figure 5.2, day 21 and day 28). To investigate this hypothesis in more 
detail I performed long-term plasmid rescue assays spanning a period of several months. 
Results from these experiments are presented in chapter 5.3. 
To solve the question, why colonies are growing in scTetR cells after three and four weeks 
one has to also perform long-term experiments with this cell line to see if the number of 
colonies decreases after a prolonged period of time. Additionally restriction enzyme 
analysis has to be done on the rescued clones to check if really the input pDNA vectors are 
rescued from these cells. 
 
5.2 Exploring the potential of the system 
The pCON system allows the independent investigation of DNA replication and pDNA 
vector retention. Within the system it is quite easy to modify certain parameters like 
scTetR:CENH3 expression or the number of targeted binding sites on the pDNA reporter 
vector. A higher expression level of the scTetR-fusion protein might influence the efficacy 
of the system in a positive or negative direction. Similar effects are possible by variation of 
the number of TetOperator binding sites on the pDNA reporter vector. 
To test, if the expression level of scTetR:CENH3
CENP-A
 had any impact on the outcome of 
the experiment I additionally used a cell line expressing scTetR:CENH3
CENP-A
 at a lower 
level than in the short-term experiment (dose-dependency in trans). Further, I was 
interested if the number of TetOperator binding sites on the pDNA reporter vector 
influences the efficacy of the system. The pDNA reporter vector used in the first 
experiment comprised 40 TetOperator sites. Here, I additionally used a pDNA reporter 
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vector with only 20 binding sites, which reflects the number of EBNA1 binding sites in the 
FR element of oriP. A comparison of the two pDNA reporter vectors would elucidate a 
possible dose-dependency in cis. 
 
5.2.1 Dose-dependencies in trans and cis 
5.2.1.1 Cell lines and pDNA reporter vectors 
To determine if the expression level of scTetR:CENH3
CENP-A
 had an impact on pDNA 
vector retention I established cell lines varying in the levels of scTetR:CENH3
CENP-A
 
expression. To this end I used three different expression constructs for stable 
scTetR:CENH3
CENP-A
 cell lines. The expression constructs varied in the promoter type 
controlling scTetR:CENH3
CENP-A
 expression: a mini-CMV promoter (-53 +74) for high 
expression, an E-Cadherin promoter (-178 +92) for medium expression and a mini-E-
Cadherin promoter (-21 +92) for low expression of the artificial protein. The aim was to 
establish a cell line with a scTetR:CENH3
CENP-A
 expression level comparable to the 
endogenous CENH3
CENP-A
 expression, since it has been shown in D.melanogaster that too 
high expression of CENH3
CID
 led to mitotic defects in cells (Heun et al., 2006). Contrary 
to this a too low expression might result in no effect on scTetR:CENH3
CENP-A
 recruitment 
to the TetOperator pDNA reporter vectors. 
Western Blot analysis demonstrated that scTetR:CENH3
CENP-A
 expression levels with all 
promoters tested were high compared to endogenous CENH3
CENP-A
 and so I used the mini-
E-Cadherin promoter for further generation of cell lines. To this end I co-transfection a 
linearised expression plasmid, encoding for scTetR:CENH3
CENP-A
 and a puromycin 
resistance cassette in HEK 293 EBNA1 cells. Cells were kept under selection with 
puromycin (300 ng/ml) for two to three weeks, before single clones were isolated and 
analysed for their expression profile by Western Blot analysis with a CENH3
CENP-A
-
specific antibody. With the mini-E-Cadherin expression cassette I generated five different 
cell clones and their individual expression profiles are illustrated in the Western Blot in 
Figure 5.3. 
Endogenous CENH3
CENP-A
 migrated at 17 kDa (Figure 5.3, grey arrow head) and the 
scTetR:CENH3
CENP-A
 fusion protein was detected at 65 kDa (Figure 5.3, black arrow 
head). The short exposure illustrates the expression differences between the five cell lines 
(Figure 5.3, top panel) and the long exposure allows the comparison of expression levels of 
scTetR:CENH3
CENP-A
 and the endogenous CENH3
CENP-A
 protein (Figure 5.3, middle 
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panel). Not transfected HEK 293 EBNA1 cells (lane 1) were used as negative control and 
tubulin served as loading control (Figure 5.3, lower panel). 
 
 
Figure 5.3 Western Blot of scTetR:CENH3
CENP-A
 expression levels in stable cell lines. 
Stable expression of scTetR:CENH3
CENP-A
 in HEK 293 cells was achieved by co-transfection of 
linearised expression plasmids encoding for scTetR:CENH3
CENP-A
 and a puromycin resistance 
cassette. After two to three weeks of puromycin selection (300 ng/ml) single clones were analysed 
for the expression of scTetR:CENH3
CENP-A
 using a CENH3
CENP-A
-specific antibody. Endogenous 
CENH3
CENP-A 
was detected at 17 kDa and scTetR:CENH3
CENP-A
 was detected at 65 kDa. Short 
exposure illustrates the expression differences between the five cell lines (top panel) and the long 
exposure compares the expression levels of scTetR:CENH3
CENP-A
 and endogenous CENH3
CENP-A
; 
lane 1: non-transfected HEK 293 EBNA1 cells (negative control), lane 2: scTetR:CENH3
CENP-A
 
clone 1, lane 3: scTetR:CENH3
CENP-A
 low, lane 4: scTetR:CENH3
CENP-A
 clone 3, lane 5: 
scTetR:CENH3
CENP-A
 clone 4, lane 6: scTetR:CENH3
CENP-A
 high, tubulin served as loading control. 
Asterisks indicate unspecific bands. Black arrow head: scTetR:CENH3
CENP-A
, grey arrow head: 
endogenous CENH3
CENP-A
. 
 
Additionally to the level of scTetR:CENH3
CENP-A
 expression, the number of TetOperator 
sites on the pDNA reporter vector might have an impact on the effectiveness of the pCON 
system. The number of TetOperator sites could influence e.g. the binding efficiency 
between scTetR:CENH3
CENP-A
 and the TetOperator repeats on the pDNA vector. It has 
been published before that an increase in the number of TetOperator sites on the pDNA 
reporter vector leads to higher copy numbers in a scTetR:HMGA1a cell background 
(Thomae et al., 2008). To test if this dose-dependency also holds true for the 
scTetR:CENH3
CENP-A
 fusion protein and pDNA vector retention I compared three different 
pDNA reporter vectors in the experiment: a wildtype oriP vector and two pDNA reporter 
vectors with differing amounts of TetOperator sites (Figure 5.4). 
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Figure 5.4 pDNA reporter vectors for plasmid rescue assays in HEK 293 cells. 
All three reporter vectors contained an ampicillin resistance gene for propagation in bacteria and a 
hygromycin resistance cassette for selection in human cells. A) wt-oriP vector. The control vector 
contained both elements of oriP in wildtype status. DS and FR function via the viral protein 
EBNA1, which is stably expressed in all used cell lines. B) 20 TetOperator pDNA reporter vector. 
The number of TetOperator sites represents the number of EBNA1 binding sites of the wildtype 
FR element. The DS element is kept in its wildtype configuration and functions via EBNA1 
interaction. C) 40 TetOperator pDNA reporter vector. The reporter pDNA vector contained 40 
TetOperator sites. The DS element is present on the pDNA vector to support DNA replication via 
EBNA1. 
 
5.2.2 No dose-dependencies were detected in the pCONactive model 
From the established cell clones I chose two cell lines to perform plasmid rescue assays, 
namely scTetR:CENH3
CENP-A
 low (Figure 5.3, lane 3) and scTetR:CENH3
CENP-A
 high 
(Figure 5.3, lane 6). Both cell lines exceeded the endogenous CENH3
CENP-A
 expression 
level but differed strongly in regards to scTetR:CENH3
CENP-A
 expression. I performed 
plasmid rescue assays as described before with both pDNA reporter vectors and both cell 
lines (Figure 5.5). 
No substantial difference was detected in the amount of rescued reporters from both 
investigated cell lines (Figure 5.5, A - B). In the case of the 20 TetOperator pDNA reporter 
vector similar numbers of pDNA vectors were rescued from both cell lines after three 
weeks and more pDNA vectors were rescued from scTetR:CENH3
CENP-A
 low expressing 
cells after four weeks under selection. However, also the SEM
37
 value was much higher in 
this case than for the scTetR:CENH3
CENP-A
 high expressing cell line. The 40 TetOperator 
pDNA reporter vector behaved differently: after three weeks more pDNA vectors were 
rescued from scTetR:CENH3
CENP-A
 high expressing cells and after four weeks comparable 
amounts of pDNA vectors were rescued from both cell lines. According to the amount of 
rescued colonies I can state that the number of rescued pDNA vectors was generally lower 
with cells that have obtained the 40 TetOperator pDNA reporter vector. I observed the 
tendency, that 40 TetOperator reporters were lost faster from cells than 20 TetOperator 
                                                 
37
 Standard error mean 
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pDNA reporter vectors, especially in scTetR:CENH3
CENP-A
 low expressing cells (Figure 
5.5 C - D). 
 
 
Figure 5.5 scTetR:CENH3
CENP-A
 expression levels in cells as well as the number of TetOperator 
sites on the pDNA vectors have no impact on pDNA vector retention. 
Plasmid rescue assays were performed with scTetR:CENH3
CENP-A
 low expressing cells (grey bars) 
and scTetR:CENH3
CENP-A
 high expressing cells (blue bars). Experiments were performed with two 
different pDNA reporter vectors after three weeks (3 w) and one month (1 m) under selection with 
150 g/ml hygromycin. The 20 TetOperator pDNA reporter vector and the 40 TetOperator pDNA 
reporter vector were transfected in scTetR:CENH3
CENP-A
 low and high expressing cells. 
scTetR:CENH3
CENP-A
 low: n = 3, +/- SEM, scTetR:CENH3
CENP-A
 high: n = 4, +/- SEM. 
 
I conclude from the experiment, that scTetR:CENH3
CENP-A
 expression levels have no 
impact and the number of TetOperator sites might have little impact on pDNA vector 
retention in cells. 
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5.3 pDNA vectors are maintained in cells over a period of five 
months 
Next I wanted to investigate the extrachromosomal stability of the gene vector over a 
prolonged period of time and to do so I set up a long-term plasmid rescue assay. In 
addition I aimed to determine the requirement of a constitutive antibiotic selection. To this 
end I performed parallel experiments with cells under sustained selection and cells from 
which the selection media was withdrawn after the initial selection period of three weeks. 
The comparison of these two sets of cells in plasmid rescue assays allowed the 
investigation of the epigenetic inheritance of the neocentromeric mark and confirmed the 
results obtained in the Drosophila system (Figure 4.10) with a second experimental 
approach. 
With the experimental set-up illustrated in Figure 5.6 I was able to determine the overall 
pDNA vector retention for a high number of cell generations. HEK 293 cells are fast 
dividing cells and during the experiment I monitored the pDNA vector retention efficiency 
in more than 100 cell generations during five months. 
 
 
Figure 5.6 Long-term experimental set-up of the plasmid rescue assay with and without selection 
pressure. 
HEK 293 cells (scTetR:CENH3
CENP-A
 high and low expressing) were transfected with three pDNA 
reporter vectors (Figure 5.4). Cells were divided into two fractions after selection for three weeks 
with 150 µg/ml hygromycin. One set of cells was continuously kept under the same selection 
conditions as before until the end of the experiment; the other fraction was cultivated without 
selection pressure after an initial selection period of three weeks. Bulk chromatin was precipitated 
with a high salt concentration (1.25 M NaCl) and the pDNA vector-enriched supernatant was 
phenol/chloroform extracted. DNA was digested with DpnI and RNase and 350 ng of DNA were 
electroporated into competent DH10B bacteria and plated on Amp
+
 agar plates. The result of the 
assay was obtained after overnight incubation at 37 °C by counting outgrowing colonies on agar 
plates. 
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As different expression levels of scTetR:CENH3
CENP-A
 might not have an impact in short-
term experiments, but possibly in a long-term set-up, I again tested high and low 
scTetR:CENH3
CENP-A
 expression levels and both pDNA reporter vectors in plasmid rescue 
assays. I used the wt-oriP vector (Figure 5.4 A) as control in the experiment. 
With my experiments I demonstrated that apparently a different mechanism of pDNA 
vector establishment for oriP and TetOperator pDNA reporter vectors led to major 
differences in the amount of rescued pDNA vectors. After three weeks wt-oriP vectors 
were present in 27-fold higher numbers than both TetOperator pDNA reporter vectors 
(Figure 5.7). Again, I confirmed that the level of scTetR:CENH3
CENP-A
 expression as well 
as the number of TetOperator sites on the pDNA reporter vectors have no impact on 
pDNA vector retention also during a longer time span. Not only during the beginning of 
the experiment but also later I observed differences between the wt-oriP vector and the 
TetOperator pDNA vectors. For instance the very high initial copy number of wt-oriP 
vectors was lost quickly whereas the TetOperator reporters remained the level of pDNA 
vectors relatively stable over time and independently of selective pressure. Summing up 
the findings that were obtained from these experiments I conclude that: 
 
(1) Much less TetOperator pDNA reporter vectors were rescued from cells during the first 
month after transfection compared to wt-oriP vectors. A possible reason for this is, that the 
copy number of the TetOperator pDNA reporter vectors in cells is lower than for the wt-
oriP vectors. However, the establishment efficiency of both types of reporters might be 
similar. Additionally the retention mechanism of TetOperator pDNA vectors should be 
altered in comparison to the wt-oriP vectors. 
 
(2) wt-oriP vectors display a faster loss rate as the TetOperator pDNA reporter vectors in 
the presence and absence of selection. The number of rescued pDNA vectors is reduced to 
less than 10 % of the initial wt-oriP vector count within only a few days. Selection 
pressure is required for stable extrachromosomal maintenance of wt-oriP vectors. Cells 
without selection lose the wt-oriP vectors more quickly (93 %) than cells under selection 
(73 %) within a few days (Figure 5.8 C). This very rapid loss of wt-oriP vectors especially 
in the presence of selection is unusual. Normally the vector should have established in the 
cell at that time and display a loss rate of only 3 -5 % per generation afterwards (Leight 
and Sugden, 2001). 
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(3) scTetR:CENH3
CENP-A
-dependent pDNA vectors were maintained throughout the 
complete duration of the experiment. After five months with and without selection pressure 
similar numbers of pDNA vectors were rescued as in the beginning of the experiment. 
 
(4) pDNA vector retention is not dependent on selection pressure in the active segregation 
mechanism. This suggests in accordance with our previous finding from D.melanogaster, 
that CENH3
CENP-A
 establishes an epigenetic mark on the pDNA vector itself, which is able 
to be retained over many generations (Mendiburo et al., 2011). 
 
(5) To summarize these findings, the copy number of TetOperator pDNA reporter vectors 
in the cells is lower than the number of wt-oriP vectors. However, the retention of 
established reporter vectors is much more constant for the TetOperator pDNA vectors and 
enables a much longer stable maintenance of the vectors in the transfected cells. 
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Figure 5.7 Long-term plasmid rescue assay set-up with and without selection pressure. 
Plasmid rescue assays were performed as described before with three different pDNA reporter 
vectors over a period of five months in scTetR:CENH3
CENP-A
 high expressing cells. Transfected 
cells were selected for three weeks in the presence of hygromycin and then divided into half. Half 
of the cells were cultivated without selection (grey bars) and the other half was kept under 
antibiotic selection with 150 g/ml hygromycin (blue bars). Time points 3 w, 3.5 w, 1 m: n = 4 +/- 
SEM, all other time points: n = 1, sel+: selection pressure applied, sel-: no selection pressure 
applied. 
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5.4 Histone H3 variants and mutants 
Different variants of histone H3 exist, namely histone H3.1, H3.2, H3.3, H3T (H3.4), H3.5, 
H3.X, H3.Y and the centromere specific variant CENH3
CENP-A
 (Kurumizaka, 2012). 
Histone H3.3 is most related to CENH3
CENP-A
. The only difference between the histones 
H3.3 and CENH3
CENP-A
 is the CENP-A targeting domain (CATD), which is present only in 
the centromere specific CENH3 variant (Figure 5.8 B-C). The CATD domain spans the 2-
helix and loop1 within the histone fold domain of CENH3
CENP-A
 and is absolutely 
necessary for protein targeting (Black et al., 2007). 
 
 
Figure 5.8 Histone 3 variants and mutants used in this work. 
Different variants and mutants of histone 3 are shown. A) canonical histone 3.1. B) histone H3.3. 
The black bars indicate the positions of H3.3 specific modification compared to H3.1 
modifications. C) CENH3
CENP-A 
wildtype. D) CENH3
CENP-A
CATD
mut
. The N-terminal parts of 
CENH3
CENP-A
, canonical H3.1 and H3.3 differ strongly whereas the C-terminal parts of the proteins 
are highly conserved. HFD: histone fold domain, aa: amino acid, L1: loop1, L2: loop2, 1: -helix 
1, 2: -helix 2, 3: -helix 3, CATD: CENP-A targeting domain, : point mutation 
(Sarma and Reinberg, 2005) 
 
The data presented in the previous chapters demonstrated the ability of CENH3
CENP-A
 to 
support pDNA vector segregation most likely by neocentromere formation on the pDNA 
vector. In fact, the actual formation of a neocentromere on the pDNA vector was so far 
only shown in D.melanogaster by immunofluorescence experiments (Figure 4.9). To 
analyse, whether this function is exclusively dependent on the CATD of CENH3
CENP-A
 or 
other histones might also support pDNA vector retention, I performed plasmid rescue 
experiments with CENH3
CENP-A
 containing a non-functional CATD domain and also with 
the histone variant H3.3. 
  5 RESULTS II – H.sapiens 
76 
5.4.1 The integrity of CEN3CENP-A´s CATD domain is essential for pDNA 
vector retention 
The CATD domain - in interaction with CENH3
CENP-A
 ´s chaperone HJURP - is absolutely 
necessary for binding of the protein to chromatin (Black et al., 2007) and represents the 
only structural difference between histone CENH3
CENP-A
 and H3.3 (Barnhart et al., 2011). 
I investigated the effect of three amino acid exchanges in the CATD domain of 
CENH3
CENP-A
 on pDNA vector retention by performing plasmid rescue assays with cells 
expressing the mutant CENH3
CENP-A
 coupled to scTetR. This loss-of-function CATD 
mutant was generated with three mutations at the amino acid positions 89, 91 and 92 
(Figure 5.8, D) (GENEART AG, Regensburg). The wildtype DNA sequence CAG GCC 
CTA TTG was changed to AGC GCC GTA ATG, which results in a change from amino 
acids QALL to SAVM (Black et al., 2007). The mutations represent the respective 
sequences for histones H3.1 and H3.2 and lead to a mistargeting of CENH3
CENP-A
. The 
mutant protein served as negative control in my assay. 
In my experiments I used HEK 293 EBNA1 cells in which I co-transfected a 40 
TetOperator pDNA reporter vector and either a plasmid for the transient expression of the 
scTetR:CENH3
CENP-A
CATD
mut
 fusion protein or a scTetR:CENH3
CENP-A
 expression 
plasmid as reference. After three weeks of selection with 150 g/ml hygromycin I 
performed plasmid rescue assays with these cells as described before. 
To test the transient expression level of the scTetR:CENH3
CENP-A
CATD
mut
 and the 
scTetR:CENH3
CENP-A
 proteins I performed Western Blot analysis 48 hours post 
transfection using a TetR-specific antibody (Figure 5.9 B). Cell lysates were obtained from 
the same cells as used in plasmid rescue assays 48 hours post transfection. 
scTetR:CENH3
CENP-A
CATD
mut
 and scTetR:CENH3
CENP-A
 were detected at 65 kDa. The 
scTetR element alone was detected at 48 kDa. 
I obtained the highest level of protein expression with the scTetR:CENH3
CENP-A
CATD
mut
 
construct (Figure 5.9, lane 3). Transient expression of scTetR:CENH3
CENP-A
 (Figure 5.9, 
lane 2) resulted in much lower protein expression compared to the expression of this 
construct in stable cell lines (Figure 5.9, lane 1). The Western Blot against tubulin 
demonstrated, that much less extract was loaded in from the latter sample compared to 
other protein samples (Figure 5.9 B, lower panel). 
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Figure 5.9 Mutation of the CATD of CENH3 leads to a massive decrease in retained pDNA 
vectors. 
A) Plasmid rescue assays were performed as described earlier (chapter 3.1.4.1). Experiments in 
cells expressing a mutant version of CENH3
CENP-A
 CATD were only able to rescue 19 % of the 
amount of pDNA vectors of wildtype CENH3
CENP-A
 (n = 2, +/- SD). B) Representative Western 
Blot of the transiently expressed scTetR:CENH3
CENP-A
 and scTetR:CENH3
CENP-A
CATD
mut
 from 
experiment II 48h post transfection. Cell lysates of different cell lines were loaded. Lane 1: 
CENH3
CENP-A
 high (positive control, stable cell line), lane 2: CENH3
CENP-A
-wildtype transient 
transfection; lane 3: CENH3
CENP-A
CATD
mut
, transient transfection, lane 4: HEK 293 EBNA1 
(negative control). Black arrowheads indicate the signal of the scTetR:CENH3
CENP-A
 fusion protein. 
Tubulin was used as loading control and asterisks indicate unspecific bands. 
 
As expected, plasmid rescue assay experiments proved the importance of the CATD 
domain for the functionality of the pCONactive model system. The number of colonies 
obtained with transient expression of the scTetR:CENH3
CENP-A
 was set to 100 %. With the 
scTetR:CENH3
CENP-A 
CATD
mut
 only 19 % of the wildtype CENH3
CENP-A
 level was 
observed (Figure 5.9 A). This finding suggests that a functional CATD domain is required 
for stable pDNA reporter vector segregation, as a non-functional CATD domain does not 
support neocentromere establishment and a quicker loss of the pDNA vectors from the cell 
during cell division. 
5.4.1.1 Genetic integrity of rescued pDNA vectors 
To check if the pDNA reporter vectors remain stable in the cells during the selection 
period I tested the genetic integrity of rescued pDNA vectors with an analytical restriction 
digest. I picked single clones from plates of plasmid rescue assays after three weeks under 
selection (150 µg/ml) and digested the DNA with the restriction enzyme PstI. The 
  5 RESULTS II – H.sapiens 
78 
predicted fragment sizes for the 40 TetOperator pDNA reporter vector after PstI digest are 
shown in Table 5.1 and a vector map with the cut sites is depicted in Figure 5.10. 
 
Table 5.1 Fragment prediction of the 40 TetOperator cut with PstI. 
Predicted fragment size (bp) Annotation 
5719 Amp resistance cassette, TetOperator sites, DS 
2146 part of hygromycin resistance cassette, eGFP 
1071 part of hygromycin resistance cassette, VBB
38
 
 
 
Figure 5.10 pDNA vector map of the 40 TetOperator vector with PstI restriction sites. 
PstI cuts the 40 TetOperator pDNA reporter vector three times, once in the pDNA vector 
backbone, once in the hygromycin resistance cassette and once in the eGFP sequence. The 
predicted fragment sizes and annotations of the vectors after digest are given in Table 5.1. 
 
In the analysis three clones derived from both cell lines (mutant and wildtype) were tested 
(Figure 5.11). The input plasmid was loaded in undigested (Figure 5.11, lane 1) and 
digested status (Figure 5.11, lane 2) as reference. All clones rescued from 
scTetR:CENH3
CENP-A
 cells showed three bands according to the predicted fragment size, 
with the largest fragment migrating slightly higher than expected (Figure 5.11, lanes 3-5). 
Clones rescued from the scTetR:CENH3
CENP-A
CATD
mut
 cells did not reflect the predicted 
fragment pattern (Figure 5.11, lanes 6-8). Clone 6 is not well visible on the gel due to a 
low DNA content in the sample and clones 7 and 8 displayed a dominant pattern, that was 
also obtained with clones from experiments in scTetR:H3.3 cells (fragment sizes:  1200 
bp,  1400 bp,  2700 bp). After sequencing analysis of this vector it turned out that all of 
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these vectors display the same sequence (see appendix 9.1 and 9.2) and that the rescued 
vector is a contamination of the sample with a foreign plasmid. However, the 
contaminating plasmid is only detected in plasmid rescue assays performed with 
scTetR:CENH3
CENP-A
CATD
mut
 cells. This indicates that the colony number of the 
scTetR:CENH3
CENP-A
CATD
mut
 experiment might be indeed even lower than measured in 
Figure 5.11. However, the experiment has to be repeated to confirm this assumption. 
 
 
Figure 5.11 Analytical restriction digest of the 40 TetOperator pDNA reporter vector rescued 
from scTetR:CENH3
CENP-A
 and scTetR:CENH3
CENP-A
CATD
mut
 cells with PstI. 
DNA was isolated from colonies taken from plasmid rescue assay plates and digested with PstI to 
analyze the stability of the transfected pDNA reporter vector after three weeks under selection. 
Predicted fragment sizes for this pDNA vector after PstI digest were: 5719 bp, 2146 bp and 1071 
bp. The dominant fragment pattern of plasmids marked with * represented the pattern of a 
contaminating plasmid (lanes 7 and 8). Marker bands indicate kbp sizes. 
 
5.4.2 The histone variant H3.3 does not support pDNA vector retention 
The histone 3 variant H3.3 is a specialised variant among all histone 3s expressed cell 
cycle-independently. It comprises only a few differences in amino acid composition 
compared to Histone H3.1 (Elsaesser et al., 2010). H3.3 incorporates predominantly at 
active chromatin regions in a replication-independent mechanism (Elsaesser et al., 2010). 
It was demonstrated that H3.3 might even be responsible for initiation of gene transcription 
of IFN
39
-inducible genes (Tamura et al., 2009). During S-phase, no CENH3
CENP-A
 but H3.3 
is incorporated at centromeres, leading to a dilution of CENH3
CENP-A
 during the cell cycle. 
The centromeric H3.3 is only replaced afterwards in the following G1 phase (Dunleavy et 
al., 2011). 
To compare the two histone H3 variants I performed plasmid rescue assays with cells 
expressing scTetR-H3.3 and scTetR:CENH3
CENP-A
 during a period of ten weeks. In 
addition I investigated the role of selection pressure in the experiment by keeping one set 
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of cells in the presence and a second set of cells in the absence of selection pressure (150 
µg/ml Hygromycin). Plasmid rescue assays were performed as described before. 
5.4.2.1 Generation of scTetR-H3.3 positive cells 
HEK 293 EBNA1 cells were co-transfected with a plasmid encoding for the scTetR:H3.3 
protein under the control of an E-Cadherin promoter as well as a puromycin resistance 
cassette as described in chapter 3.1.5 and selected with puromycin (300 ng/ml) for two to 
three weeks. Single cell clones were isolated from the plates and analysed for the stable 
expression of scTetR:H3.3 by Western Blot using a TetR-specific antibody (Figure 5.12). 
The scTetR:H3.3 protein was detected at 65 kDa. As positive control I used a 
scTetR:HMGA1a stable cell line (Figure 5.12, lane 1). 
 
 
Figure 5.12 scTetR-H3.3 expression levels in different stable cell lines. 
Stable expression of scTetR:H3.3 in HEK 293 cells was achieved by co-transfection of linearised 
expression plasmids encoding for scTetR:H3.3 and a puromycin resistance cassette. After two to 
three weeks of puromycin selection (300 ng/ml puromycin) single clones were analysed for the 
expression of scTetR:H3.3 using a TetR–specific antibody. scTetR:H3.3 was detected at 65 kDa. As 
a control I loaded a scTetR positive cell line in lane1. Cell lysates from four scTetR-H3.3 positive 
clones with different expression levels were loaded in lanes 2-5 and the lysate from a scTetR-
negative clone was loaded in lane 6. 
5.4.2.2 Ability of H3.3 to support pDNA vector retention 
I started these experiments with the initial idea to use histone H3.3 as a negative control for 
the model of scTetR:CENH3
CENP-A
 induced neocentromere formation and active pDNA 
vector segregation. I expected H3.3 to be non-functional in supporting pDNA vector 
retention due to the fact that the CATD domain of CENH3
CENP-A
, which is missing in H3.3, 
is specifically required for the pDNA vector retention function of CENH3
CENP-A
. As 
outlined above, this domain is the major structural difference between CENH3
CENP-A
 and 
H3.3 and the loss-of-function CATD mutant reduced the efficacy of the system 
significantly to 19 % (Figure 5.9). 
I tested the wt-oriP reporter vectors as well as the two TetOperator pDNA reporter vectors 
(Figure 5.4) in plasmid rescue assays with HEK 293 EBNA1-scTetR:H3.3 cells. I 
transfected cells with the pDNA reporter vectors and cultivated them under selection (150 
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µg/ml Hygromycin) for three weeks. Afterwards I divided the culture in two groups, one of 
which was kept in antibiotic-free medium and the other group under continuous selective 
pressure until the end of the experiment. Samples were taken in addition at three and seven 
weeks (overall duration of the experiment 10 weeks) and plasmid rescue assays were 
performed. 
In contrast to my expectations the results I obtained were surprising, as the scTetR:H3.3 
fusion allowed the rescue of a high number of pDNA vectors after three weeks (Figure 
5.13, black bars). After the initial three weeks of selection the amount of rescued pDNA 
vectors was similar between the EBNA1-oriP system and the TetOperator pDNA reporter 
vectors targeted by scTetR:H3.3. 
 
 
Figure 5.13 Results of plasmid rescue assays performed with scTetR-H3.3 expressing cells. 
Plasmid rescue experiments were performed as indicated before (chapter 3.4.1). Cells were selected 
for an initial period of three weeks, afterwards the culture was divided in two parts, from which one 
part was further kept under constitutive selection (plain bars) and the other part was cultured 
without selection antibiotics (dashed bars). Cells were harvested after three and seven additional 
weeks and analysed in plasmid rescue assays (n = 3, +/- SEM). Control experiments were 
performed without DpnI digest and not transfected cells (n = 3, +/- SEM). +: with selection, -: 
without selection 
 
The wt-oriP vector functions via a scTetR:H3.3 independent mechanism, only reliant on 
EBNA1. The result that I obtained for the wt-oriP vector was according to previous 
experiments in our lab, even though the pDNA vector loss happened more slowly than 
expected. In the presence of hygromycin (150 µg/ml), the amount of rescued pDNA 
vectors dropped to 20 % between the first and last time point. In the absence of selection 
the wt-oriP vector loss was faster and reduced to about 95 % after ten weeks (Figure 5.13, 
oriP-panel). I expected a rapid loss of the 20- and 40 TetOperator reporters in scTetR:H3.3 
cells, as the mechanism of active pDNA vector retention is not functional in these cells. 
Very high numbers of pDNA reporter vectors were rescued after three weeks similar to the 
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oriP vector (compare black bars). After three weeks of cultivation in the presence of 
hygromycin (150 µg/ml) the number of rescued 20 TetOperator pDNA reporter vectors 
dropped rapidly to approx. 50 % of the initial number. This observation was even more 
pronounced after ten weeks, when more than 95 % of the initial pDNA vectors were lost 
from cells. Interestingly, the withdrawal of selection had no major impact on the number of 
rescued pDNA vectors (Figure 5.13, 20 TetOperator panel, compare filled and dashed 
bars). 40 TetOperator pDNA reporter vectors showed different loss behaviour after six 
weeks with and without selection. Cells under selection maintained the pDNA vectors in 
comparable amounts to the wt-oriP vector, but cells without selection completely rejected 
the pDNA vector. Ten weeks after transfection all pDNA vectors were lost from the cells 
for both cultivation conditions. Control experiments with non-transfected cells revealed 
that the background of the experiments was on average 25 bacteria colonies (Figure 5.13, 
left panel). Summing up the experiment I conclude that H3.3 is not able to substitute the 
function of CENH3
CENP-A
. In fact, the characteristics of pDNA vectors in scTetR:H3.3 cells 
are very similar to the results obtained with wt-oriP vectors. This indicates for a different 
retention mechanism compared to the TetOperator pDNA vectors with very likely have a 
functional neocentromere. Most likely this is also a passive piggyback mechanism, which 
leads to the loss of pDNA reporter vectors after approx. two months. In comparison pDNA 
vectors containing a functional neocentromere are stably maintained over a period of five 
months. 
5.4.2.3 Genetic integrity of rescued pDNA vectors 
To test the genetic integrity of rescued pDNA vectors, vector DNA was isolated and 
digested with PstI. Fragment sizes of the pDNA reporter vectors are shown in Table 5.2. 
 
Table 5.2 Fragment prediction of plasmid digest with PstI. 
Reporter type Predicted fragment size Annotation 
wt-oriP vector 
5602 Amp resistance, oriP 
2146 Hygromycin resistance 
1071 prokaryotic vector backbone 
20 TetOperator pDNA vector 
5466 Amp resistance, TetOperator 
2146 Hygromycin resistance 
1071 prokaryotic vector backbone 
40 TetOperator pDNA vector 
5719 Amp resistance, TetOperator 
2146 Hygromycin resistance 
1071 prokaryotic vector backbone 
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The vector maps with the respective restriction sites of PstI are shown below in Figure 
5.14. 
 
  
Figure 5.14 pDNA vector map of the wt-oriP vector and the 20 TetOperator vector with PstI 
restriction sites. 
pDNA vectors (20 TetOperator reporter vector, right panel and wt-oriP vector, left panel) are both 
cut by PstI three times, once in the vector backbone, once in the hygromycin resistance cassette and 
once in the eGFP sequence. The predicted fragment sizes and annotations of the pDNA reporter 
vectors after the digest are given in Table 5.2 and Figure 5.15 illustrates the analytical restriction 
digest. 
 
After the restriction digest samples were analysed on an agarose gel. One reporter was 
analysed six days post transfection in the presence and absence of hygromycin (+ and - 
selection) and three reporters were analysed ten weeks post transfection (+ and - selection) 
(Figure 5.15). Restriction enzyme analysis confirmed all analysed wt-oriP clones as 
genetically stable for the entire period of the experiment (Figure 5.15 A). The input 
plasmids were loaded undigested (Figure 5.15, lane 1) and digested (Figure 5.15, lane 2) as 
reference. Among the analysed clones only two out of seven of the 20 TetOperator pDNA 
reporter vectors depicted the expected DNA fragment pattern (Figure 5.15 B, lanes 4 and 
5). Furthermore, only one out of nine of the analysed 40 TetOperator pDNA reporter 
vectors displayed the predicted pattern (Figure 5.15 C, lane 7). Again sequencing analysis 
revealed, that these colonies were not recombined pDNA vectors but that they stem from a 
contamination with a foreign plasmid, possibly gained during the preparation of the 
sample. The respective vectors are labelled with an asterisk in Figure 5.15. 
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Figure 5.15 Analytical restriction digest with PstI of clones rescued from scTetR-H3.3 cells. 
Single colonies of plates from plasmid rescue assay were picked, DNA was isolated and digested 
with PstI. Analyses were performed with the wt-oriP vector in A) the 20 TetOperator pDNA 
reporter vector in B) and the 40 TetOperator pDNA reporter vector in C). Predicted fragment sizes 
after PstI digest are shown in Table 5.3. Marker bands indicate kbp sizes. A dominant fragment 
pattern found in several samples does not correspond to the fragment prediction, but represent the 
pattern of a contaminating vector. The respective lanes are marked with asterisks; w: weeks, p. tr.: 
post transfection, sel+: selection pressure applied, sel-: no selection pressure applied. 
 
5.5 All-in-one pDNA vectors 
To further improve our assay in terms of safety issues and to simplify its application I 
aimed to circumvent the need for cells stably expressing the artificial scTetR:CENH3
CENP-A
 
protein. Instead I used an all-in-one pDNA vector, containing both the reporter 
TetOperator sites (20x) as well as the scTetR:CENH3
CENP-A
 fusion protein expression 
cassette. As shown before (Figure 4.10) an initial pulse of scTetR:CENH3
CID
 should 
suffice to establish the epigenetic mark on the pDNA vector for a long time in 
D.melanogaster (Mendiburo et al., 2011) and supposedly this holds also true in H.sapiens. 
For my experiments I transfected the all-in-one pDNA vector and the wt-oriP vector in 
HEK 293 EBNA1 cells. For comparison of the efficacy of this approach I again tested 20 
TetOperator and 40 TetOperator pDNA reporter vectors in scTetR:CENH3
CENP-A
 high 
expressing cells. 
The results obtained with the pDNA reporter vectors described before (20 TetOperator- 
and 40 TetOperator reporter and wt-oriP vector) and the pDNA vector retention of a 
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reporter containing both features, i.e. the TetOperator sites and the scTetR:CENH3
CENP-A
 
expression cassette (all-in-one pDNA vector) are shown in Figure 5.16. 
No difference was detectable between the two systems. In comparison to the wt-oriP 
positive control all other pDNA reporter vectors were rescued from cells at a level of 
approx. 75 %. 
In the future the all-in-one pDNA vector system has to be investigated in more detail. Most 
importantly all rescued pDNA vectors have to be checked in restriction digest analysis as 
this was not yet done and the level of protein expression obtained with the all-in-one 
pDNA vector has to be checked with Western Blot analysis. 
 
 
Figure 5.16 Application of the all-in-one pDNA vector leads to similar vector retention 
efficiencies as transfection of CENH3
CENP-A
 positive cell lines with TetOperator pDNA reporter 
vectors. 
Plasmid rescue assays were performed as previously described with scTetR:CENH3
CENP-A
 EBNA1 
cells transfected with 20 TetOperator and 40 TetOperator pDNA reporter vectors (blue bars) and 
HEK 293 EBNA1 cells transfected with the all-in-one reporter vector (purple bar). The wt-oriP 
vector transfected in HEK 293 EBNA1 cells served as positive control of the system (white bar), 
the 40 TetOperator vector transfected into scTetR cells served as negative control (grey bar). No 
difference was detected between the efficiencies of the all-in-one reporter vector and the 
TetOperator vectors transfected into stable cell lines (n = 1). 
 
5.6  Summary – Results II 
With this second set of experiments performed in human cells I confirmed the previous 
results obtained in the Drosophila system. I was able to show that targeting of 
CENH3
CENP-A
 to pDNA reporter vectors enhances their stability and retention in the cells 
most likely also by neocentromere formation. Over a period of five months I was able to 
rescue steady amounts of pDNA reporter vectors independently of the presence of 
selection pressure. This certifies the epigenetic character of the centromeric mark on the 
pDNA vector. It was furthermore demonstrated in this chapter, that wt-oriP vectors and 
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TetOperator reporters establish with different efficiencies in cells and I tested the 
functionality of CENH3
CENP-A
´s CATD domain as well as the role of H3.3. However, due 
to the fact, that samples prepared from the scTetR:CENH3
CENP-A
CATD
mut
 and scTetR:H3.3 
cells contained a contaminating plasmid the validity of these results is diminished. 
According to my results obtained with the all-in-one pDNA vectors this strategy seems to 
be the most promising for future developments. Artificial transgene expression is reduced 
to a minimum level and only one transfection procedure is necessary in the complete 
protocol. 
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6 DISCUSSION 
 
 
The field of gene therapy is still seen as a young field of science, although people have 
been treated with gene therapeutic approaches for more than twenty years. Although a lot 
of progress has been made concerning therapies with virus-derived gene vectors, the over-
all slow adoption towards a daily-routine application is mostly due to the lack of 
appropriate vehicles for transgenes and guaranteed stable transgene expression (Glover et 
al., 2005). At the moment almost exclusively viral vectors are applied in clinics. Non-viral 
episomal pDNA vectors play a minor role although they offer several advantages 
compared to their virus-based counterparts. Among these advantages are e.g. the 
occurrence of less pathogenic effects, easier production, a decreased risk of insertional 
mutagenesis and larger transgene size capacities (Glover et al., 2005). However, the main 
problem with non-viral vectors is, that they do not sufficiently satisfy the need for stable 
vector maintenance in the cell and reliable long-term transgene expression. The 
requirement for novel, non-viral but persistent gene vectors is getting more and more 
important since the currently available virus-derived vectors do not satisfactorily fulfil the 
needs for routine medical tools; mainly because they harbour the risk of insertional 
mutagenesis and strong immune responses of the patients. During my thesis I aimed to 
elucidate a novel retention mechanism for non-viral gene vectors with the goal to create a 
pDNA vector with prolonged maintenance in transfected cells. 
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Due to several reasons, like e.g. extrachromosomal maintenance and faithful segregation to 
daughter cells, Epstein-Barr virus is a much-valued blueprint for the development of extra-
chromosomal gene vectors. However, whole EBV as well as its smaller version mini-EBV, 
in which most lytic genes are depleted, cannot be used as a gene vector as both of them 
lead to transformation of cells (Kaye et al., 1999; Kempkes et al., 1995). For its 
segregation to daughter cells EBV depends on the viral transactivator EBNA1 and the FR 
element of oriP. The viral genome is attached to the chromosome symmetrically via 
EBNA1 during mitosis and partitioned equally to daughter cells (Kanda et al., 2007). 
Although no progeny virus is produced the number of EBV genome remains fairly stable 
in an infected cell clone during latency (Miller, 1982), although the number of EBV 
particles in a cell can vary between different clones. 10 - 400 EBV molecules were 
detected among different cell lines and no correlation between the number of EBV and 
EBNA1 molecules per cell was observed (Sternas et al., 1990). Also EBV-derived oriP 
vectors are replicated together with and attached to the host cell chromosome using a 
passive piggyback mechanism (Sears et al., 2004). Replication of oriP vectors is, in 
contrast to EBV, solely dependent on oriP’s DS element. Plasmids are replicated once 
each cell cycle using the endogenous replication machinery (Schepers et al., 2001) but 
EBV-derived plasmids get lost from cells over time. This is also due to the fact that a 
rather high number of EBV-derived plasmids (16 %) is not duplicated properly (Nanbo et 
al., 2007). 
In this work I aimed to establish a new pDNA vector segregation mechanism for non-viral, 
extra-chromosomal oriP-derived vectors based on the principle of the pCON system 
(Figure 1.4). To this end I changed the passive distribution mechanism into an active 
segregation system, in which the pDNA vector gains a neocentromere by scTetR:CENH3 
targeting, which turns the pDNA vectors into “quasi-chromosomes”. These autonomous 
entities are incorporated into the mitotic distribution system of chromosomes. Active 
segregation should ideally enhance pDNA vector stability in the cell in a selection-
independent manner. The main questions I addressed in my thesis are: 
 
(1) Is it possible to prolong pDNA vector retention in a cell by turning the pDNA 
vector into a “quasi-chromosome” by CENH3 targeting? 
 
(2) What are the differences concerning pDNA vector loss between active and passive 
pDNA vector segregation? 
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(3) How strong is the impact of the actively segregating pDNA vector on the host cell? 
 
(4) What possibilities are offered by pCONactive in future pDNA gene vector 
development? 
 
6.1 pCONactive – a new generation plasmid-based gene vector 
The pCON system is a well-established gene vector system based on the origin of latent 
replication of Epstein-Barr virus, oriP. DNA replication and/or vector retention can be 
either provided by the two functional domains of oriP, namely the dyad symmetry element 
(DNA replication) and the family of repeats (vector retention) in an EBNA1-dependent 
mechanism, or they are substitutes by an endogenous, cellular protein (Pich et al., 2008). 
Since years our lab is interested in testing endogenous cellular proteins for their ability to 
substitute the functions of DNA replication and/or pDNA vector retention. By replacing 
the wildtype elements DS and FR with TetOperator sites and targeting of scTetR-fused 
endogenous proteins one is able to circumvent the need for EBNA1, the viral transactivator 
of oriP. This is important, because it was described that EBNA1 has carcinogenic potential 
in transgenic mice (Tsimbouri et al., 2002). Although Humme et al. have demonstrated 
that this does not hold true in human cells (Humme et al., 2003), EBNA1 is considered to 
be a factor driving oncogenesis possibly by production of reactive oxygen species and 
therefore induced genomic instability (Gruhne et al., 2009). In this respect the 
circumvention of EBNA1 in the pCON system is clearly an advantage and an ultimate goal 
is to get rid off of any viral component from the vector system. 
Furthermore, by the replacement of EBNA1 with endogenous proteins, it is possible to 
investigate the functions of DNA replication and pDNA vector retention separately. For 
testing the replicative and/or retention function of proteins one has to create fusion proteins 
containing scTetR elements fused to the protein of choice. Via a strong scTetR-TetOperator 
binding the protein is targeted to TetOperator binding sites on the pDNA reporter vector 
replacing DS and/or FR. Plasmid rescue assays or Southern Blot analysis enable to 
determine how efficient the protein of choice can rescue the function of the EBNA1-DS 
and EBNA1-FR interaction. In earlier projects it was found out, that the proteins Orc6 and 
HMGA1a substitute the replicative potential of the DS element (Thomae et al., 2008). Also 
the function of retention has been investigated and HMGA1a (Thomae et al., 2008) as well 
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as HP1 were proven to be capable to confer the function of pDNA vector retention 
(Deutsch M., unpublished). 
During this work, I did not just test another protein for the function of retention, but also 
changed the mechanism of retention from passive to active. The resulting pCONactive 
pDNA vector system offers for the first time a vector segregation mode that is active and 
host-chromosome independent. The results demonstrate that the obtainment of the 
centromeric structure - and therefore the segregation to the daughter cells in a host 
chromosomes-independent mechanism - leads to higher pDNA vector retention 
efficiencies, especially in long-term applications. This in turn might enable a prolonged 
transgene expression in gene therapeutic approaches with non-viral vectors; so far one of 
the most important obstacles in the field. The new system exhibits new qualities compared 
to other plasmid-based gene vectors, illustrated in the model depicted in Figure 6.1. 
 
6.1.1 scTetR:CENH3CENP-A and CENH3CID:GFP:LacI support pDNA vector 
retention 
In this work, I report the establishment of a new pDNA gene vector system, which 
segregates via an active mechanism. It was shown with immunofluorescence experiments, 
that the formation of neocentromeres is achieved by targeting of CENH3
CID
:GFP:LacI to 
LacOperator sites on a pDNA vector (Figure 4.9). Based on these experiments performed 
in D.melanogaster I assume, that the same mechanism of neocentromere induction holds 
true for TetOperator pDNA vectors after a scTetR:CENH3
CENP-A
 protein has been targeted 
to the binding sites in human HEK 293 cells. 
With the induction of a neocentromere on LacOperator and TetOperator (pCON) vectors I 
was able to increase the pDNA vector retention in transfected Drosophila Schneider S2 
and human HEK293 cells, respectively. The expression of scTetR:CENH3
CENP-A
 in HEK 
293 cells and the expression of CENH3
CID
:GFP:LacI in Drosophila Schneider S2 cells and 
the subsequent formation of neocentromeres on the pDNA vectors led to a prolonged 
pDNA vector retention in cells. pDNA vectors with no neocentromeres were lost from the 
cells rapidly after transfection and subsequently the cells died due to selection pressure 
(Figure 4.3 and Figure 5.2). 
For experiments performed in D.melanogaster I used a pDNA vector with LacOperator 
sites and cells expressing CENH3 fused to LacI and GFP. It has to be mentioned that this 
system is not based on the pCON model. Only pDNA vectors used in the human system 
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are pCON vectors and the new pDNA vectors system following the active segregation 
mode, are called pCONactive pDNA vectors throughout this work. 
6.1.1.1 The pCONactive retention model 
A model describing the retention profiles of pCONactive vectors in comparison to wt-oriP 
vectors is given in Figure 6.1. My model of pCONactive is based on the results I obtained 
in the long-term experiments with pCONactive pDNA vectors in human cells (Figure 5.7). 
In the model I am comparing the behaviour of pCONactive pDNA vectors (Figure 6.1, blue 
line) to the behaviour of wt-oriP vectors (Figure 6.1, grey line) as it is described in the 
literature, i.e. a rather fast lost of ≥25 % of the vector during the first two weeks after 
transfection (Figure 6.1, dark blue area) and a subsequently slowed down plasmid loss rate 
after successful establishment of the vector in the cell (Figure 6.1, bright blue area) (Leight 
and Sugden, 2001). Below a certain threshold level a complete vector loss cannot be 
prohibited (Nanbo et al., 2007). Compared to pCONactive pDNA vectors wt-oriP vectors 
are found with much higher copy numbers in cells and get lost over time, whereas 
pCONactive pDNA vectors establish with lower copy numbers but remain stable over a 
period of several months. 
 
 
Figure 6.1 Model of retention profiles of pCONactive and oriP vectors in human cells. 
pCONactive establishes similarly efficient but with lower copy numbers than wt-oriP vectors 
shortly after transfection in the target cells. From two weeks after transfection pCONactive vectors 
remain stable regarding copy numbers for a period of more than five months. In contrast, wt-oriP 
vectors are lost quickly after transfection and are lost beyond recall from cells after the number of 
pDNA vectors has fallen below the threshold level. The copy number of the vector has to be above 
that threshold level to ensure long-term pDNA vector maintenance in the cells (Nanbo et al., 2007). 
Dark blue line: pCONactive, grey line: oriP, red line: threshold level for pDNA vector retention, 
dotted grey line: “point-of-no-return”, dark blue: time from transfection until establishment, light 
blue: time after successful vector establishment, w: weeks, m: months 
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Nanbo et al. demonstrated that a certain threshold of pDNA vectors has to be maintained in 
a cell under selection pressure to ensure stable retention of the vector in the cell. According 
to this publication the majority of pDNA vectors cannot maintain the selective advantage 
and is subsequently lost from cells, if the number of pDNA vectors is falling below the 
threshold level (Nanbo et al., 2007). The threshold level (Figure 6.1, red line) is one 
possible explanation of the differences observed between the retention of wt-oriP vectors 
and pCONactive pDNA vectors over a prolonged period of time. pCONactive might 
represent a pDNA vector type, which is able to keep the copy number in cells above the 
threshold level. Subsequently, due to its stable maintenance pCONactive represents a tool 
to overcome the vector loss problem and guarantees long-term maintenance. wt-oriP 
vectors, however, are constantly lost from cells at rates of 3 - 5 %; until a certain “point-of-
no-return” is reached (dotted blue line, Figure 6.1). By reaching this “point-of-no-return” 
complete vector loss cannot be prohibited. 
Table 6.1 illustrates the role of selection pressure on pCONactive. The number of rescued 
pDNA vectors was comparable for cells kept under selection and cells cultivated in 
medium without selection pressure. As pointed out before the fact that pCONactive is not 
dependent on selection criteria demonstrates the ability of scTetR:CENH3
CENP-A
 to 
establish self-propagation, arguing for an artificial and inherited epigenetic centromeric 
mark. After an initial targeting of scTetR:CENH3
CENP-A
 to the pDNA reporter vector the 
neocentromere is inherited by the daughter pDNA vector. 
 
Table 6.1 Results of long-term plasmid rescue assays with and without selection. 
Numbers indicate the amount of colonies. 
pDNA vector type 3 weeks  5 months + selection 5 months - selection 
20 TetOperator 128 165 193 
40 TetOperator 106 88 140 
 
6.1.1.2 wt-oriP vector loss in scTetR:CENH3CENP-A expressing cells 
In my experiments the majority of wt-oriP vectors was lost from cells five months post 
transfection, no matter if they are kept under selection or not (Figure 5.7). The fact that wt-
oriP vectors are lost from cells over time makes these results not unexpected as five 
months represent a rather long experimental set-up. However, as pointed out before, the 
pace of wt-oriP vector loss especially in the beginning of my experiment is unusual. 
Commonly wt-oriP vectors are lost faster from cells cultivated without selection pressure, 
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but in my experiment the vector loss happened during a similar time under both conditions. 
After a high number of wt-oriP vectors was rescued after three weeks under selection, this 
number dropped to approx. 150 and 300 rescued vectors after one month for both 
conditions. As stated above, the vector loss rate after establishment is usually at 3 -5 % per 
generation (Leight and Sugden, 2001). The experiment with wt-oriP transfected into 
scTetR:H3.3 cells illustrated in Figure 5.13 shows a more likely plasmid loss behaviour of 
this vector type. According to these results one can speculate that the overexpression of 
scTetR:CENH3
CENP-A
 might influence wt-oriP vector loss or that technical issues, like e.g. 
the DNA preparation, influenced the results. 
6.1.1.3 Dose-dependencies in cis and trans 
Experiments conducted by Thomae et al. showed a dose-dependency of pCON vectors in 
cis when testing the replicative potential of HMGA1a. This means more TetOperator sites 
on the pDNA vector led to an increased replicative potential of HMGA1a (Thomae et al., 
2008). However, proteins that have been tested for the support of DNA retention, like 
HMGA1a (Thomae et al., 2008) and HP1 (data not published) did not show a dose-
dependent behaviour. 
Also in the case of scTetR:CENH3
CENP-A
 I did not detect a dose-dependency in cis, i.e. 
increased numbers of colonies in the plasmid rescue assay when using pDNA reporter 
vectors with 40 TetOperator sites instead of 20 TetOperator sites (Figure 5.5). More 
colonies would mean that more pDNA vectors were rescued from transfected cells, which 
in turn stands for the fact, that more pDNA vector are present in the cells. 
Double the amount of TetOperator sites on the pDNA reporter vector can possibly lead to 
double the amount of scTetR:CENH3
CENP-A
 being recruited to the respective site on the 
pDNA reporter vector. One conclusion of such a scenario is, that more than one 
neocentromere establishes at the TetOperator sites on the pDNA vector. However, also on 
monocentric chromosomes areas of 10 - 50 kbp of centromeric DNA with incorporated 
CENH3 are present, building the base for only one centromere/kinetochore. It was shown 
that the actual size of CENH3 occupied areas at inner kinetochore plates of endogenous 
centromeres and neocentromeres are similar (Marshall et al., 2008b) although the amount 
of CENH3 at neocentromeres is greatly reduced (Irvine et al., 2004). 
The second possibility of a dose-dependency, namely a higher expression of the 
scTetR:CENH3
CENP-A
 fusion protein (dose-dependency in trans), did also not lead to 
differences in results of plasmid rescue assays (Figure 5.5). My results lead me to the 
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assumption that only a certain and constant amount of scTetR:CENH3
CENP-A
 is recruited to 
TetOperator binding sites, independently of how much protein is available in the cell. This 
means that with a certain amount of protein the system is saturated and an increase in 
CENH3
CENP-A
 expression does not lead to an increased amount of rescued pDNA vectors 
any more. 
In the, presumably very rare, case of the establishment of more than one 
neocentromere/kinetochore per pDNA vector, I am not able to detect this phenomenon 
with my experimental approach. If more than one centromere/kinetochore exists on the 
pDNA vector this will lead to severe segregation complications during mitosis. More than 
one microtubule attachment site per pDNA vector leads to its complete disruption and 
ultimately pDNA vector loss from the cells. Eventually no increased amount of rescued 
pDNA vectors is detectable in the plasmid rescue assay. 
6.1.1.4 DNA replication of pDNA vectors 
pDNA vector replication is a bidirectional process following  the theta replication principle 
and using mainly the replication machinery of the host (del Solar et al., 1998; Gahn and 
Schildkraut, 1989). It is known that for achieving proper vector maintenance DNA 
replication is less important than vector retention (Pich et al., 2008). However it is 
interesting to know, if the expression of CENH3
CID
:GFP:LacI influences the pDNA vector 
replication in cells. The fact that cells with and without CENH3
CID
:GFP:LacI both led to 
increased and comparable amounts of bacteria colonies during the first week after 
transfection already indicated, that pDNA vectors are able to replicate even in the absence 
of CENH3
CID
:GFP:LacI (Figure 4.3 grey bars until day 7). 
The hypothesis, that replication of the pDNA vector is CENH3 independent, was checked 
by performing Meselson-Stahl experiments. In this assay active DNA replication is 
detected by the incorporation of BrdU and the subsequent weight differences of the DNA 
molecule, which is detectable in a density gradient (Figure 4.8). 
The data I gained indicate, that DNA replication of the pDNA vector is integrated into the 
cell cycle machinery of the host cell. The experiments were performed in the Drosophila 
cell system, which does not reflect the pCONactive experimental set-up (scTetR:TetO 
targeting) and a DS element for DNA replication. Instead replication of the LacOperator 
pDNA vector in these cells happens sequence independently, possibly starting in the 
proximity of CpG islands on the pDNA vector as it was described to happen on 
chromosomes (Delgado et al., 1998). Once-per-cell-cycle mutual and semi-conservative 
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replication of genomic DNA and pDNA vectors occurs and I assume that this hold also 
true in the human system. The only difference is that in this case, DNA replication of 
pCONactive pDNA vectors depends on the DS element of oriP, which recruits the 
components of the cellular replication machinery (Schepers et al., 2001). I conclude that 
for both vector types (LacOperator, TetOperator) replication is autonomous of 
CENH3
CID
:GFP:LacI and scTetR:CENH3
CENP-A
 expression, respectively, in the cell. 
 
6.1.2 Implications of pCONactive on the cellular level 
pCONactive is an improved version of pCON, designed to serve as a new generation 
pDNA vector. Eventually the retention mechanism of pCONactive shall be utilised as a 
helpful tool in the design of non-viral pDNA vectors and help improve current plasmid-
derived vectors by the enabling of active vector segregation. A careful consideration of 
cellular consequences following pDNA vector application is indispensable. 
6.1.2.1 Nuclear localization of the pDNA vector 
An interesting issue is the localization of pCONactive pDNA vectors in the cells, 
especially in regards to specific higher-order nuclear domains in the nucleus. Also the 
epigenetic status of the pDNA vector itself needs to be analysed in the future. It is known, 
that virus genomes prefer certain areas of the nucleus when residing in the cell during 
interphase. E.g. Epstein-Barr virus genomes in interphase are preferentially found at the 
open-structure perichromatin. Perichromatin constitutes the area between higher order 
chromatin and interchromatic regions. It was demonstrated by Immuno-FISH experiments 
in our lab that EBV was detected at the same sites as EBNA1, indicating that the presence 
of the protein is crucial for the stability of the virus. 
Also for EBV-derived pDNA vectors the epigenetic localization is important, since 
successful establishment of the vector only happens when it is located in a specific region 
of the nucleus. It has been demonstrated further in our lab with immunofluorescence 
experiments, that EBV-derived wt-oriP vectors are preferentially tethered to H3K4me3
40
 
and H3K9ac
41
 enriched sites, i.e. active chromatin, during interphase. The results were 
confirmed by ChIP experiments at wt-oriP, which revealed the same modification pattern 
at wt-oriP on the vector (Deutsch et al., 2010). The episomal gene vector pEPI also locates 
preferentially at certain areas of the nucleus. The fact, that the episome, once it is 
                                                 
40
 Histone 3 lysin 4 trimethylation 
41
 Histone 3 lysin 9 acetylation 
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established in a cell, is stably maintained also without selection pressure indicates for 
epigenetic influence on it retention (Piechaczek et al., 1999). Indeed, it was proven that 
pEPI is found at highly transcribed and early replicating chromatin, especially enriched in 
H3K9ac and H3K14ac
42
 (Schaarschmidt et al., 2004). pEPI is located at the interchromatin 
compartment or at perichromatin close to condensed domains (Stehle et al., 2007). 
In the case of oriP vectors DS plays only a minor role regarding vector localization in the 
cell; FR, however, is essential for tethering to specific loci (Deutsch et al., 2010). On the 
one hand, since FR is missing on pCONactive pDNA vectors it is questionable if the same 
pattern is found on pCONactive pDNA vectors. On the other hand also these pDNA 
vectors might use the same nuclear compartment for successful establishment in the cell, 
maybe through another underlying mechanism. Yet, the exact epigenetic pattern on the 
pCONactive vectors remains to be elucidated. 
6.1.2.2 Transfection of foreign DNA 
Clearly it also has an impact, when foreign DNA is transfected into a cell. First of all, it 
can happen that the pDNA particle integrate into the host’s genome. The integration rate of 
episomal pDNA vectors is generally expected to be very low, especially when the 
transfected DNA is circular and not linearized. The latter conformation is disadvantageous 
not only because it is more susceptible to integration but also because following this event 
genes on these vectors are mostly silenced. Interestingly, e.g. integrated pEPI vectors were 
not found at active chromatin compartments like their circular and episomal counterparts 
(Stehle et al., 2007) (chapter 6.1.2.1). It was furthermore found out, that cells that 
presented an integrated copy of pEPI usually contained only one to two copies of the 
vector, whereas cells containing episomal pEPI vectors displayed a higher copy number 
(Stehle et al., 2007). Quite likely circular, supercoiled pCONactive pDNA vectors are not 
prone to integration into the cell’s genome, but the possibility cannot be entirely excluded. 
Additionally to the problem of integration, transfection of foreign, bacterial DNA leads to 
immunological reactions in the cell. On the one hand, the presence of unmethylated CpG 
pairs on the bacterial vector backbone activated the TLR9-mediated immune response 
(Hemmi et al., 2000) (chapter 1.1.1). On the other hand, CpG pairs can cause silencing of 
the transgene when they are methylated. One possibility to overcome this problem is the 
depletion of CpG sequences in the pDNA vector backbone, as e.g. seen in the pEPito 
vector (Haase et al., 2010) and minicircles (Kobelt et al., 2013) (chapter 6.4.2). 
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6.1.2.3 Artificial protein expression 
pCONactive and LacI:LacO mediated targeting for active pDNA vector segregation are 
based on two main functional components: a reporter vector with TetOperator and 
LacOperator sites as cis-acting element and the cellular expression of scTetR:CENH3
CENP-
A
 and CENH3
CID
:GFP:LacI fusion proteins, respectively, as trans-acting factor. However, 
CENH3 overexpression in cells results in severe effects on chromosome segregation as 
CENH3
CID
 incorporates at ectopic sites resulting in mitotic defects and chromosome 
aberrations (Heun et al., 2006). The fact, that an initial CENH3
CID
:GFP:LacI expression 
pulse is sufficient for neocentromere formation and it’s subsequent epigenetic inheritance 
(Mendiburo et al., 2011) offers the possibility of lower or even exclusively transient 
protein expression concomitant with pDNA vector application. After the optimal duration 
of protein expression has been determined expression of the scTetR:CENH3
CENP-A
 and 
CENH3
CID
:GFP:LacI protein can be stopped, e.g. with the help of induced promoter 
silencing. Another possibility is the transient co-transfection of an expression plasmid 
encoding for the scTetR and LacI fusion protein, respectively, as it was shown before in 
Figure 4.10 (Mendiburo et al., 2011). 
A second protein that needs to be expressed in cells in the case of the pCONactive system 
is EBNA1. EBNA1 is essential for DNA replication provided by DS on the pCONactive 
pDNA vector, but the presence of the protein is connected to tumour development (Gruhne 
et al., 2009). pCON as well as pCONactive are modular pDNA vector systems in which the 
EBNA1-dependent functions of DNA replication and retention can both be substituted by 
endogenous protein. The DNA replication function can be substituted e.g. with HMGA1a 
(Thomae et al., 2008) whilst retention is substituted with CENH3. The only requirement 
for such a double-substitution is the usage of two different targeting systems for both 
functions. In this way the expression of EBNA1 is obsolete and DNA replication and 
retention of the pDNA vector are both supported by endogenous proteins. After all, the 
expression of artificial protein tags for tethering (scTetR, LacI) cannot be circumvented in 
the system. 
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6.1.3 Prolonged maintenance of the pDNA vector is only provided by 
scTetR:CENH3
CENP-A
 but not by scTetR:H3.3 and scTetR:CENH3
CENP-A
 
CATD
mut
 
CENH3
CENP-A
 is a histone variant that differs from canonical histone H3.3 only in one 
domain – the CENP-A targeting domain (CATD). This domain is responsible for 
CENH3
CENP-A
´s crucial function in centromere identity and needed for the proteins 
targeting (Black et al., 2007). In my experiments I used H3.3 but also a plasmid encoding 
for CENH3
CENP-A
 with three point mutations at amino acids 89, 91 and 92 inside of the 
CATD. These mutations represent the sequences of H3.1/2, which do not possess the 
targeting function and do not ensure proper CENH3
CENP-A
 localization (Black et al., 2007). 
This of course has an immense negative impact on the functionality of pCONactive. 
Without this functional domain, 81 % of pDNA vectors are lost after three weeks 
compared to the situation when the CENH3
CENP-A
 wildtype protein is expressed with the 
scTetR tag in cells (Figure 5.9). This illustrates, that the initial targeting of 
scTetR:CENH3
CENP-A
 to the TetOperator sites and the resulting neocentromere are really 
the driving forces in this process. Due to the fact that a part of the rescued pDNA vectors 
turned out to originate from a foreign plasmid stock, which has most likely happened to 
contaminate the sample during the preparation step the experiment has to be evaluated 
carefully. Interestingly, the contamination was only detectable in pDNA vectors rescued 
from mutant scTetR-fused CENH3
CENP-A
 cells, but not from cells expressing the 
scTetR:CENH3
CENP-A
 protein. 
The results that I obtained with scTetR:H3.3 cells in this context were surprising. The 
experiments with the CATD mutant revealed a drastic loss of pDNA vectors from the cells. 
For the reason that the CATD is the only difference between CENH3
CENP-A
 and H3.3 I 
expected a similar result for the experiments I performed with the H3.3 variant, but as 
pointed out before in chapter 5.4.2.2 I obtained ambiguous results. After three weeks I 
detected no difference in plasmid rescue assays performed with the wildtype 
scTetR:CENH3
CENP-A
 and the scTetR:H3.3 fusion proteins, but over a prolonged period of 
time scTetR:H3.3 cells lost the reporter pDNA vectors completely. Also here, the 
contaminating plasmid was detected in the rescued clones from scTetR:H3.3 cells. The 
contamination was only detected in TetOperator samples but not in the samples of the wt-
oriP vector. For the latter all rescued pDNA vectors showed the expected fragment sizes 
after digestion with the restriction enzyme. 
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6.1.4 Genetic stability of the pDNA vector 
It is important to ensure that the genetic stability of the pDNA vector is maintained 
throughout the experimental procedure, i.e. during propagation in cells. To check if the 
rescued pDNA vectors had lost certain elements or gained e.g. endogenous sequences I 
performed restriction digest analyses on the DNA isolated form the rescued clones. I 
compared the obtained pattern with the input plasmid, which was transfected in the 
beginning of the experiment. 
The genetic stability of the LacOperator pDNA reporter vector was provided in 
D.melanogaster cells throughout the experiment for a period of three weeks in cells with 
and without CENH3
CID
:GFP:LacI expression (Figure 4.6). Only one minor reduction in the 
size of LacOperator cassette was detected in one out of eight analysed rescued pDNA 
vectors in CENH3
CID
:GFP:LacI expressing cells. This difference is due to the fact that 
highly repetitive sequences are prone to recombination. As there are 256 LacOperator sites 
on the respective reporter vector it is not surprising that one clone has lost some of the 
repeats during propagation in the Drosophila cells. More importantly the pDNA vector 
backbone remained stable in all investigated clones; as this is the potential site of the 
pDNA vector where a transgene would be located this result is satisfying. 
pDNA vectors transfected into human cells expressing scTetR:CENH3
CENP-A
 were also not 
altered but displayed the same pattern as the input vector, except for a slight increase in the 
size of the biggest fragment (Figure 5.11, lanes 3 - 5). The results I obtained with rescued 
vectors from scTetR:CENH3
CENP-A
CATD
mut
 and scTetR:H3.3 cells cannot be evaluated due 
to the fact that a contamination with a foreign plasmid occurred most likely during the 
preparation of the sample. 
 
6.1.5 pDNA vectors segregate via microtubule attachment to the 
kinetochore/neocentromere and similar to chromosomes 
wt-oriP-derived vectors are segregated via a passive piggyback mechanism attached to the 
host’s chromosome (Sears et al., 2004). As this mechanism is inefficient over a prolonged 
amount of time leading to a high vector loss after several weeks, we tried to establish a 
new and active mechanism of pDNA vector retention in the cell. To achieve this, the 
EBNA1-dependent mechanism of wt-oriP vector retention has been changed into an 
EBNA1-independent and active mode. I was able to achieve this goal by inducing a 
neocentromere on the pDNA vector, which turns the pDNA vector into a “quasi-
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chromosome”. An active kinetochore assembles on the neocentromere, which enables the 
pDNA vector integration into the cell cycle machinery, so that pDNA vectors and 
chromosomes use the same mechanism of segregation to daughter cells but segregate as 
autonomous entities during mitosis (Figure 1.1 C). Integration of the pDNA vector into the 
cell cycle machinery is the ideal segregation situation for pDNA reporter vectors, since this 
mechanism is very efficient, stable and provides long-term maintenance. 
To investigate, whether the pDNA vectors are really recognised and bound by the 
microtubules during mitosis, and to check, if our proposed model of chromosome 
independent segregation is working, I transfected Drosophila Schneider S2 cells with 
LacOperator pDNA reporter vectors and immunofluorescence experiments were 
performed
43
. These experiments impressively demonstrated, that the microtubules 
recognize neocentromeres/kinetochores on pDNA vectors similar to the kinetochores on 
chromosomes during mitosis (Figure 4.9 B). 
An interesting phenomenon we observed was, that pDNA vectors are able segregate prior 
to host cell chromosomes (Figure 4.9 C). Why chromosomes and pDNA vectors can 
segregate at different times during the cell cycle is not yet understood. It is possible, that 
pDNA vectors do not have to pass through the spindle assembly checkpoint (SAC) at the 
transition from metaphase to anaphase. During mitosis this checkpoint inhibits anaphase 
onset by prohibiting the activation of the anaphase-promoting complex (APC) through 
Cdc20 blocking until all chromosomes are properly attached to the spindle apparatus 
(Cleveland et al., 2003). Possibly, pDNA vectors, which are excluded from this control 
mechanism, segregate independently and earlier than chromosomes. In the case, that the 
APC activation has not to be delayed because all chromosomes are immediately ready to 
segregate, differences in segregation timing between chromosomes and pDNA vectors 
might not be as pronounced as depicted in Figure 4.9 C. However, the lack of a proper 
segregation control mechanism can also mean that, even though pDNA vectors segregate 
like chromosomes, the long-term maintenance is less secure for pDNA vectors than for 
chromosomes. Additionally it can be, that microtubules reach extrachromosomal pDNA 
vectors earlier than chromosomes, due to the fact, that thy might not only assemble at the 
metaphase plate but localize also elsewhere in the cell, e.g. closer to the centrosome. As 
the APC can start just after assembly of the chromosomes at the metaphase plate and 
proper kinetochore binding to all chromosomes, but independently of pDNA vector 
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assembly at the metaphase plate, this strengthens the idea that the pDNA vector is 
excluded from the checkpoint control. As stated above this might lower the safeness of the 
system, since an uncontrolled segregation mechanism can possibly lead to the loss of the 
pDNA vector over time due to a random segregation to daughter cells. 
It was demonstrated by FISH experiments that the majority of oriP vectors following the 
piggyback mechanism is attached to the host’s chromosomes symmetrically and vectors 
are found as co-localizing pairs in cells, which was detectable by a duplication of the FISH 
signals at these spots. After S-phase, 84 % of vectors are duplicated, from which 88 % are 
found as co-localised pairs in cells. These pairs of vectors are subsequently segregated 
symmetrically to two daughter cells. Only 16 % of EBV-derived vectors did not replicate 
properly and segregate randomly to only one daughter cell (Nanbo et al., 2007). 
It is not yet clear, if also active pDNA vector segregation (i.e. the pDNA vector is not 
attached to the host chromosome) occurs symmetrically like Figure 4.9 C suggests. Here, 
two signals for pDNA vectors are detected near to each of the two spindle poles. However, 
one has to keep in mind that this experiment represents a single cell. I hypothesise, that a 
symmetrical segregation of pDNA vectors in all cells is rather unlikely due to the fact, that 
there is no connection to the host cell chromosomes and because pDNA vectors themselves 
do not provide a chromosome-like structure of two equal elements (i.e. the chromatids), 
which are separated and subsequently segregated to the daughter cells symmetrically 
during mitosis. 
pDNA vector segregation was so far only illustrated in D.melanogaster cells with 
immunofluorescence. It would be interesting so follow the pDNA vectors throughout one 
complete cell cycle and additionally it would be helpful to stain the centrosome of the cell 
to see, if the sites of pDNA vector localization really are the spindle poles. A near-term 
goal in this project is to determine whether or not this mechanism hold also true in human 
cells and to check if we can see the same effects and time course there. Experiments in this 
direction are currently underway. 
 
6.2 Differences between the human and Drosophila system 
For reaching my aim to investigate the ability of CENH3 to support pDNA vector retention 
I performed plasmid rescue assays in two different model organisms, namely 
D.melanogaster and H.sapiens and the bottom line of my experiments in both models is 
the same: targeting of CENH3 to pDNA vectors prolongs vector retention in cells. 
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However, I also observed some differences between the two systems, which are discussed 
in the following paragraphs. 
When comparing results of short-term experiments over a period of one month almost nine 
times more bacteria colonies were formed on agar plates after electroporation with 
D.melanogaster derived samples than with samples from human HEK 293 cells seven days 
post transfection (3440 colonies in D.m. and 385 colonies in H.s.). During the first week 
post transfection pDNA vectors are still in the course of establishmen in the cell, so the 
more important question is, if pDNA vectors establish with different copy numbers in 
D.melanogaster compared to the human system. This question can only be solved by 
comparing samples from later time points. 
Generally it is known, that only 1 - 5 % of episomal vectors establish efficiently in cells 
after transient transfection and only from these clones, cells with stable episomal vectors 
derive (Leight and Sugden, 2001; Stehle et al., 2007). When looking at the following data, 
one has to remember that here the results from experiments in two different model 
organisms are compared and that the 256 x LacOperator pDNA vector does not represent a 
derivate of the pCON system like the TetOperator pCONactive pDNA vectors. These 
factors might contribute to the differences between the two systems. 
Four weeks post transfection there is still a 6.6-fold difference in colony numbers between 
the two systems (817 colonies in D.m. and 123 colonies in H.s). The amounts of lost 
pDNA vectors from Drosophila cells were different to the amounts of lost TetOperator 
pDNA reporter vectors from HEK 293 cells. During day 7 and day 14 14.5 % of 
LacOperator pDNA vectors and 49.1 % of TetOperator pDNA vectors were lost from 
cells. Between day 14 and day 28 however, the loss of LacOperator pDNA vectors 
increased to 72.2 % (or 26.1 % per week) whereas only 37 % of TetOperator pDNA 
vectors were lost during the same time (18.6 % per week). It is important to note, that the 
numbers of cell generations during this time is not taken into account in the calculation of 
these values. This means, that these values cannot be compared to plasmid loss rates 
mentioned earlier in this work (e.g. chapter 6.1.1.1). Although these numbers suggest a 
better establishment of TetOperator pDNA vectors in human HEK 293 cells compared to 
LacOperator pDNA vectors in Drosophila Schneider S2 cells, one has to be careful with 
drawing conclusions, since this preliminary suggestion is waiting to be verified with the 
help of proliferation curves and generation times. 
In the human cell system cells lacking the scTetR:CENH3
CENP-A
 protein died due to the 
loss of the pDNA vector and therefore in response to antibiotic selection (Figure 5.2 A). 
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This happened much faster than in the Drosophila system, already after one week under 
selection, whereas in the latter the effect was only detected after more than two weeks 
under selection. The reason for this is, that the generation time of HEK 293 cells is faster 
and therefore also the response to the antibiotic treatment is faster than in Drosophila cells. 
It is known that the selection of D.melanogaster cells with G418 is a rather continuous 
process with a slow response of the cells (Figure 4.4). 
The higher level of bacteria colonies in Drosophila made the background of the assay (i.e. 
colonies derived from plasmid rescue assays with not transfected cells) negligible. In HEK 
293 cells the background colony number was comparable to the one obtained in 
Drosophila cells (in both cell lines around 25 colonies), however the number of rescued 
pDNA vectors was much lower in these cells and therefore has a stronger impact on the 
results. Also the fact, that pDNA vectors were rescued from scTetR:CENH3
CENP-A
-lacking 
cells after three and four weeks was restricted to the human HEK 293 cell system (Figure 
5.2 A, days 21 and 28). I think that these colonies are also background colonies and that 
the effect was just smaller in samples from days 7 and 14. 
 
6.3 pCONactive all-in-one reporter vectors 
The experimental set-up that I used for the confirmation that plasmids with neocentromeres 
remain in transfected cells for a prolonged time comprises two main functional 
components: a reporter plasmid with TetOperator and LacOperator sites as cis-acting 
elements, respectively, and cell lines stably expressing the scTetR:CENH3
CENP-A
 and 
CENH3
CID
:GFP:LacI fusion protein, as trans-acting factors. Contrary to this set-up, 
pCONactive all-in-one reporter vectors encode for both segregation features on the same 
vector, i.e. TetOperator sites and the expression cassette of the scTetR:CENH3
CENP-A
 
fusion protein. 
The question was, if it is possible to establish the centromeric mark on the pDNA vector 
with this system. I compared TetOperator reporter vectors in scTetR:CENH3
CENP-A
 
expressing cells with pCONactive all-in-one reporter vectors in HEK 293 EBNA1 cells in 
plasmid rescue assays and detected no differences between the efficiency of both systems 
(Figure 5.16). In fact, I was able to rescue very similar amounts of pDNA vectors from the 
different sets of experiments three weeks post transfection. The pDNA vector rescue level 
was at approx. 75 % compared to wt-oriP vectors rescued from the same cells. For the 
DNA replication function of the DS element on the pCONactive all-in-one vector, EBNA1 
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still has to be expressed in the cells, but currently a version of the pDNA vector is cloned 
in our lab, that additionally encodes for EBNA1. With this further development the vector 
provides all necessary elements for its own functionality and the tested cells obtain only 
the pCONactive all-in-one reporter and no other expression plasmids before. For example 
one possible development in this direction would be the construction of a vector containing 
the scTetR:CENH3 expression cassette and TetOperator sites replacing FR and a 
LacI:Orc6 (or HMGA1a) expression cassette and LacOperator sites replacing DS for DNA 
replication. The functions of this pDNA vector would only rely on endogenous proteins 
and the expression of any viral component can be avoided. 
 
6.4 Outlook 
6.4.1 Does CENH3CENP-A´s chaperon HJURP confer pDNA vector retention? 
In the course of this project I started to investigate the role of CENH3
CENPA
´s chaperon 
HJURP
44
 in regards to pDNA vector retention. HJURP is an essential chaperon for proper 
CENH3
CENP-A
 deposition at the centromere during late telophase/early G1 phase (Dunleavy 
et al., 2009). It has been demonstrated, that HJURP is sufficient to establish functional de 
novo kinetochores and that a LacI:HJURP fusion protein targets CENH3
CENP-A
 to 
integrated LacOperator sites in the genome of U2OS cells (Barnhart et al., 2011). 
Interestingly, the mechanism of recruitment is different for centromeric chromatin and 
LacOperator sites. The Mis18 complex is needed for the recruitment of HJURP to 
centromeric sites on the genome, but for HJURP-targeting to LacOperator site this 
interaction is dispensable. It was furthermore demonstrated, that CENH3
CENP-A
 is stably 
maintained at these sites even after the removal of LacI:HJURP from the system (Barnhart 
et al., 2011). It is very likely, that HJURP fulfils the requirements for targeting endogenous 
CENH3
CENP-A
 to the TetOperator sites on the pDNA vectors and enhances pDNA vector 
retention in cells. If this model can be verified in the future, this will demonstrate for the 
first time that HJURP is sufficient for neocentromere formation on pDNA vectors. 
So far I was not successful in generating a HEK 293 cell line stably expressing scTetR-
HJURP. The reason for this might be the choice of promoter (E-Cadherin) on the scTetR-
HJURP expression plasmid used for the transfection. I am in the process of generating an 
expression vector using the endogenous HJRUP promoter (1500 bp upstream of 
transcription start site of HJURP). This construct will then be used to generate stable HEK 
                                                 
44
 Holliday junction recognition protein 
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293 scTetR:HJURP cell lines as well as all-in-one pDNA vectors to perform plasmid 
rescue assays. 
One has to keep in mind, that HJURP overexpression in human HeLa cells leads to mitotic 
defects (Mishra et al., 2011). An option to reduce the overexpression of scTetR:HJURP 
protein in cells would be the transient transfection of two pDNA vectors – the TetOperator 
pDNA reporter vector and a plasmid for the transient expression of scTetR:HJURP. After 
the pDNA reporter vector has gained the centromeric mark it is stably maintained in the 
cell even after the loss of the scTetR:HJURP expression plasmid like demonstrated by 
Mendiburo et al. in Drosophila Schneider S2 cells (Mendiburo et al., 2011). To this end I 
transfected the scTetR-HJURP expression plasmid transiently together with the pDNA 
reporter vector (similar to the experiment in Figure 5.9). The experiment was performed 
twice with quite different outcome. In the first experiment the pDNA rescue rate from 
scTetR:HJURP expressing cells was 12 % and in the second 72 % compared to 
scTetR:CENH3
CENP-A
 expressing cells (data not shown). Experiments need to be repeated 
in scTetR:HJURP expressing cells, since possibly the short transient expression pulse of 
the fusion protein is too low for a successful establishment of the neocentromere on the 
pDNA vector. 
 
6.4.2 Combining pCONactive and the minicircle technology 
Many different transgene vehicles have been established over the years and each and every 
one of them has its advantages and disadvantages. This fact suggests itself to think about 
sophisticated combinations of two ore more different vector systems to increase the 
positive factors of gene delivery vehicles through combinatory effects. In the case of 
pCONactive a combination of the pDNA vector with the minicircle technology could 
improve performance and transgene expression of the system. 
Minicircles are small pDNA vectors depleted of unnecessary elements for expression in 
human cells (Gracey Maniar et al., 2013). In the introduction of this work the negative 
influence of CpG islands in the pDNA vector backbone on e.g. transgene expression and 
tolerance in the patient after application was discussed. The modifications of pDNA vector 
backbones in minicircles lead to higher transgene expression by avoiding silencing effects 
after CpG depletion and also immunogenic reactions of the patient are reduced. As other 
pDNA vectors also minicircles are usually segregated to daughter cells passively. It would 
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be very interesting to see, if our new technology of active segregation via a neocentromere 
is feasible on minicircles. 
The production of minicircles is a labour-intensive technology, because the pDNA vectors 
cannot be generated in bacteria for the above-mentioned reasons. To avoid this effort and 
to get a faster hint if the system works a rational project to start with is the creation of a 
“minicircle-like” pCONactive pDNA vector. First this could be achieved by size-reduction, 
as minicircles are usually much smaller than conventional plasmid vectors. In the case of 
pCONactive a size reduction from 8683 bp for the 20 TetOperator reporter and 8936 bp for 
the 40 TetOperator pDNA reporter vector, respectively, can easily be done by further 
depletion of TetOperator sites. As shown in the Results II section of this work (chapter 
5.2.1) I did not observe any dose-dependency in cis comparing 40 TetOperator sites and 20 
TetOperator sites on the reporter. A further reduction of TetOperator binding sites is self-
evident and would reduce the pDNA vector size for 42 bp per binding site. Also I observed 
no diminished efficiency of the system with recombined pDNA vectors that have lost 
TetOperator sites. 
Second, a more “minicircle-like” status of the pCONactive pDNA vector system is 
achieved by reduction of the number of CpG pairs in the backbone of the pDNA reporter 
vector. This service is offered by several companies and would further decrease to size and 
in addition lead to better transgene expression profiles and to a smaller immunogenic 
reaction potential. 
A comparison of this new “minicircle-like” pDNA vector to our current pDNA reporter 
vectors and further experiments especially in regards to transgene expression levels in 
different cell systems should provide an indication of the efficiency of the new system and 
show us, whether or not this strategy is worth to be followed up. Eventually minicircles 
with neocentromeres should represent a new group of pDNA gene vectors with a host 
chromosome independent retention mechanism, stable, long-term transgene expression, 
extrachromosomal maintenance and a good acceptance of the pDNA vector in the target 
cell. 
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EBV-derived wt-oriP vectors are segregated to daughter cells via a passive piggyback 
mechanism. wt-oriP vectors are targeted to the host cell chromosomes with the help of the 
viral transactivator EBNA1. At the chromosomes wt-oriP vectors remain attached and they 
replicate and segregate in synchrony with the host cell chromosomes during S-phase and 
mitosis. However, this system is leaky and during each cell division wt-oriP vectors are 
lost from cells until, after a certain number of cell generations, the vectors are not 
detectable in the host cells any more. 
The aim of this work was to develop an entirely new pDNA vector segregation mechanism 
with the help of the centromere specific histone variant CENH3 (pCONactive). The main 
difference between this new model and the wildtype segregation mechanism of oriP 
vectors is, that segregation of the pCONactive pDNA vector is an active mechanism and 
independent of host chromosome segregation. Segregation of pCONactive happens similar 
to the mechanism of chromosome segregation mediated via a centromere-microtubule 
interaction during mitosis. The approach also comprises a long-term goal, namely the 
improvement of non-viral, plasmid-based gene vectors for gene therapeutic applications. 
By targeting CENH3
CID
:GFP:LacI to LacOperator sites and scTetR:CENH3
CENP-A
 to 
TetOperator sites, respectively, I aimed to induce the formation of a neocentromere on 
plasmid DNA. The feasibility of this mechanism was proven with immunofluorescence 
experiments in D.melanogaster and is supposed to work in a similar manner also in human 
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cells. The induced neocentromere on the reporter DNA turns the pDNA vector into a 
“quasi-chromosome” and makes it host chromosome-independent during segregation to the 
daughter cells in mitosis. With this mechanism I am able to increase pDNA vector stability 
in the cell and provide a prolonged retention of episomal pDNA vectors in target cells in 
comparison to passively retained pDNA vectors. 
I demonstrated in D.melanogaster and H.sapiens that induced neocentromerization leads to 
enhanced pDNA vector retention and maintenance profiles in cells. In the human system 
the mechanism was followed over a period of five months and I was able to demonstrate 
that the number of rescued pDNA vectors is stable during this time course with and 
without selection pressure. In contrast to wt-oriP vectors, pCONactive pDNA vectors 
display much lower copy numbers in transfected cells during the first weeks after 
transfection. However, over an elongated time span it turns out that wt-oriP vectors are lost 
steadily, whereas pCONactive reporters are evenly maintained and therefore also guarantee 
prolonged transgene expression. Further characterization of the system revealed that 
CENH3 does not interfere with plasmid DNA replication, that the pDNA vectors are 
maintained as concatemeric entities in the cells and that the genetic integrity of the pDNA 
vector is stable in scTetR:CENH3
CENP-A
 and CENH3
CID
:GFP:LacI positive cells. 
Furthermore I could prove the essential role of the CATD domain of CENH3
CENP-A
 for 
maintaining the functionality of the system. Relying on the results I obtained with all-in-
one pDNA vectors, I suggest the application of this vector type in future applications, as 
there was no reduction in plasmid rescue efficiencies observed. 
I am able to state that the pCONactive (all-in-one) pDNA vector system has the potential 
to highly impact in the field of non-viral, plasmid-based gene therapy. In this respect I 
expect the most promising future development in a combination of the CENH3-dependent 
segregation mechanism with the minicircle technology. 
 
8 REFERENCES 
109 
 
 
 
 
 
 
 
 
 
 
8 REFERENCES 
 
 
Aiyar, A., Tyree, C., and Sugden, B. (1998). The plasmid replicon of EBV consists of multiple 
cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element. 
EMBO J 17, 6394-6403. 
Allshire, R.C., and Karpen, G.H. (2008). Epigenetic regulation of centromeric chromatin: old 
dogs, new tricks? Nat Rev Genet 9, 923-937. 
Alonso, A., Hasson, D., Cheung, F., and Warburton, P.E. (2010). A paucity of heterochromatin at 
functional human neocentromeres. Epigenetics and Chromatin 3, doi:10.1186/1756-8935-1183-
1186. 
Arents, G., and Moudrianakis, E.N. (1995). The histone fold: A ubiquitous architectural motif 
utilized in DNA compaction and protein dimerization. PNAS 92, 11170-11174. 
Argyros, O., Wong, S.P., Fedonidis, C., Tolmachov, O., Waddington, S.N., Howe, S.J., Niceta, 
M., Coutelle, C., and P., H.R. (2011). Development of S/MAR minicircles for enhanced and 
persistent transgene expression in the mouse liver. J Mol Med 89, 515-529. 
Baiker, A., Maercker, C., Piechaczek, C., Schmidt, S., Bode, J., Benham, C., and Lipps, H. 
(2000). Mitotic stability of an episomal vector containing a human scaffold/matrix-attached 
region is provided by association with nuclear matrix. Nat Cell Biol 3, 182-184. 
Barnhart, M.C., Kuich, P.H., Stellfox, M.E., Ward, J.A., Bassett, E.A., Black, B.E., and Foltz, 
D.R. (2011). HJURP is a CENP-A chromatin assembly factor sufficient to form a functional de 
novo kinetochore. J Cell Biol 194, 229-243. 
Baum, C., Schambach, A., Bohne, J., and Galla, M. (2006). Retrovirus vectors: toward the 
plentivirus? Mol Ther 13, 1050-1063. 
8 REFERENCES 
110 
Bergmann, J.H., Martins, N.M., Larionov, V., Masumoto, H., and Earnshaw, W.C. (2012). 
HACking the centromere chromatin code: insights from human artificial chromosomes. 
Chromosome Res 20, 505-519. 
Black, B.E., Foltz, D.R., Chakravarthy, S., Luger, K., Woods Jr., V.L., and Cleveland, D.W. 
(2004). Structural determinants for generating centromeric chromatin. Nature 430, 578-582. 
Black, B.E., Jansen, L.E., Maddox, P.S., Foltz, D.R., Desai, A.B., Shah, J.V., and Cleveland, 
D.W. (2007). Centromere identity maintained by nucleosomes assembled with histone H3 
containing the CENP-A targeting domain. Mol Cell 25, 309-322. 
Blower, M.D., Sullivan, B.A., and Karpen, G.H. (2002). Conserved organisation of centromeric 
chromatin in flies and humans. Dev Cell 2, 319-330. 
Bode, J., Kohwi, Y., Dickinson, L., Joh, T., Klehr, D., Mielke, C., and Kohwi-Shigematsu, T. 
(1992). Biological significance of unwinding capability of nuclear matrix-associating DNAs. 
Science 255, 195-197. 
Bradford, M.M. (1976). A rapid and sensitive method for the quantitation of microgram quantities 
of protein utilizing the principle of protein-dye binding. Anal Biochem 72, 248-254. 
Buchwitz, B.J., Ahmad, K., Moore, L.L., Roth, M.B., and Henikoff, S. (1999). A histone-H3-like 
protein in C. elegans. Nature 401, 547-548. 
Burrack, L.S., and Berman, J. (2012). Neocentromeres and epigenetically inherited features of 
centromeres. Chromosome Res 20, 607-619. 
Calos, M.P. (1998). Stability without a centromere. PNAS 95, 4084-4085. 
Chan, F.L., Marshall, O.J., Saffery, R., Kim, B.W., Earle, E., Choo, K.H., and Wong, L.H. 
(2012). Active transcription and essential role of RNA polymerase II at the centromere during 
mitosis. PNAS 109, 1979-1984. 
Chan, F.L., and Wong, L.H. (2012). Transcription in the maintenance of centromere chromatin 
identity. Nucleic Acids Res 40, 11178-11188. 
Cheeseman, I.M., and Desai, A. (2008). Molecular architecture of the kinetochore-microtubule 
interface. Nat Rev Mol Cell Bio 9, 33-46. 
Chen, Z.Y., He, C.Y., Ehrhardt, A., and Kay, M.A. (2003). Minicircle DNA vectors devoid of 
bacterial DNA result in persistent and high-level transgene expression in vivo. Mol Ther 8, 495-
500. 
Choo, K.H., Vissel, B., Nagy, A., Earle, E., and Kalitsis, P. (1991). A survey of the genomic 
distribution of alpha satellite DNA on all the human chromosomes, and derivation of a new 
consensus sequence. Nucleic Acids Res 19, 1179-1182. 
Church, G., and Gilbert, W. (1984). Genomic sequencing. PNAS 81, 1991-1995. 
Cim, A., Sawyer, G.J., Zhang, X., Su, H., Collins, L., Jones, P., Antoniou, M., Reynes, J.P., 
Lipps, H.J., and Fabre, J.W. (2012). In vivo studies on non-viral transdifferentiation of liver cells 
towards pancreatic β cells. J Endocrin 214, 277-288. 
Clarke, L., Baum, M., Marschall, L., Ngan, V., and Steiner, N. (1993). Structure and function of 
Schizosaccharomyces pombe centromeres. Cold Spring Harb Symp Quant Biol 58, 687-695. 
8 REFERENCES 
111 
Cleveland, D.W., Mao, Y., and F., S.K. (2003). Centromeres and Kinetochores: From Epigenetics 
to Mitotic Checkpoint Signaling. Cell 112, 407-421. 
Copenhaver, G.P., Nickel, K., Kuromori, T., Benito, M.I., Kaul, S., Lin, X., Bevan, M., Murphy, 
G., Harris, B., Parnell, L.D., et al. (1999). Genetic definition and sequence analysis of 
Arabidopsis centromeres. Science 286, 2468-2474. 
Cottarel, G., Shero, J.H., Hieter, P., and Hegemann, J.H. (1989). A 125-base-pair CEN6 DNA 
fragment is sufficient for complete meiotic and mitotic centromere functions in Saccharomyces 
cerevisiae. Mol Cell Biol 9, 3342-3349. 
Daya, S., and Berns, K.I. (2008). Gene therapy using adeno-associated virus vectors. Clin 
Microbiol Rev 21, 583-593. 
De Rop, V., Padeganeh, A., and Maddox, P.S. (2012). CENP-A: the key player behind 
centromere identity, propagation, and kinetochore assembly. Chromosoma 121, 527-538. 
del Solar, G., Giraldo, R., Ruiz-Echevarría, M.J., Espinosa, M., and Díaz-Orejas, R. (1998). 
Replication and Control of Circular Bacterial Plasmids. Microbiol Mol Biol Rev 62, 434-464. 
Delecluse, H.J., and Hammerschmidt, W. (2000). The genetic approach to the Epstein-Barr virus: 
from basic virology to gene therapy. Mol Path 53, 270-279. 
Delgado, S., Gómez, M., Bird, A., and Antequera, F. (1998). Initiation of DNA replication at 
CpG islands in mammalian chromosomes. EMBO J 17, 2426-2435. 
Deutsch, M.J., Ott, E., Papior, P., and Schepers, A. (2010). The latent origin of replication of 
Epstein-Barr virus directs viral genomes to active regions of the nucleus. J Virol 84, 2533-2546. 
Diehl, V., Henle, G., Henle, W., and Kohn, G. (1968). Demonstration of a Herpes Group Virus in 
Cultures of Perioheral Leukocyctes from Patients with Infectious Mononucleosis. J Virol 2, 663-
669. 
Dunleavy, E.M., Almouzni, G., and Karpen, G.H. (2011). H3.3 is deposited at centromeres in S 
phase as a placeholder for newly assembled CENP-A in G(1) phase. Nucleus 2, 146-157. 
Dunleavy, E.M., Beier, N.L., Gorgescu, W., Tang, J., Costes, S.V., and Karpen, G.H. (2012). The 
cell cycle timing of centromeric chromatin assembly in Drosophila meiosis is distinct from 
mitosis yet requires CAL1 and CENP-C. PLoS Biol 10, e1001460. 
Dunleavy, E.M., Roche, D., Tagami, H., Lacoste, N., Ray-Gallet, D., Nakamura, Y., Daigo, Y., 
Nakatani, Y., and Almouzni-Pettinotti, G. (2009). HJURP is a cell-cycle-dependent maintenance 
and deposition factor of CENP-A at centromeres. Cell 137, 485-497. 
Earnshaw, W.C., Allshire, R.C., Black, B.E., Bloom, K., Brinkley, B.R., Brown, W., Cheeseman, 
I.M., Choo, K.H., Copenhaver, G.P., Deluca, J.G., et al. (2013). Esperanto for histones: CENP-A, 
not CenH3, is the centromeric histone H3 variant. Chromosome Res 21, 101-106. 
Earnshaw, W.C., and Migeon, B.R. (1985). Three related centromere proteins are absent from the 
inactive centromere of a stable isodicentric chromosome. Chromosoma 92, 290-296. 
Edwards, N.S., and Murray, A.W. (2005). Identification of xenopus CENP-A and an associated 
centromeric DNA repeat. Mol Biol Cell 16, 1800-1810. 
8 REFERENCES 
112 
Ehrhardt, A., R., H., Schepers, A., Deutsch, M.J., Lipps, H.J., and A., B. (2008). Episomal 
Vectors for Gene Therapy. Curr Gene Ther 8, 147-161. 
Elsaesser, S.J., Goldberg, A.D., and Allis, C.D. (2010). New functions for an old variant: no 
substitute for histone H3.3. Curr Opin Genet Dev 20, 110-117. 
Escors, D., and Breckpot, K. (2010). Lentiviral vectors in gene therapy: their current status and 
future potential. Arch Immunol Ther Exp (Warsz) 58, 107-119. 
Gahn, T.A., and Schildkraut, C.L. (1989). The Epstein-Barr virus origin of plasmid replication, 
oriP, contains both the initiation and termination sites of DNA replication. Cell 58, 527-535. 
Gerhardt, J., Jafar, S., Spindler, M.P., Ott, E., and Schepers, A. (2006). Identification of new 
human origins of DNA replication by an origin-trapping assay. Mol Cell Biol 26, 7731-7746. 
Gill, D.R., Pringle, I.A., and Hyde, S.C. (2009). Progress and prospects: the design and 
production of plasmid vectors. Gene Ther 16, 165-171. 
Glover, D.J., Lipps, H.J., and Jans, D.A. (2005). Towards safe, non-viral therapeutic gene 
expression in humans. Nat Rev Genet 6, 299-310. 
Gotlieb-Stematsky, T., Vonsover, A., Ramot, B., Zaizov, R., Nordan, U., Aghal, E., Kende, G., 
and Modan, M. (1975). Antibodies to Epstein-Barr virus in patients with Hodgkin´s disease and 
leukemia. Cancer 36, 1640-1645. 
Gracey Maniar, L.E., Maniar, J.M., Chen, Z.Y., Lu, J., Fire, A.Z., and Kay, M.A. (2013). 
Minicircle DNA vectors achieve sustained expression reflected by active chromatin and 
transcriptional level. Mol Ther 21, 131-138. 
Gruhne, B., Sompallae, R., Marescotti, D., Kamranvar, S.A., Gastaldello, S., and Masucci, M.G. 
(2009). The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of 
reactive oxygen species. PNAS 106, 2313-2318. 
Haase, R., Argyros, O., Wong, S.P., Harbottle, R.P., Lipps, H.J., Ogris, M., Magnusson, T., 
Vizoso Pinto, M.G., Haas, J., and Baiker, A. (2010). pEPito: a significantly improved non-viral 
episomal expression vector for mammalian cells. BMC Biotechnol 10, doi: 10.1186/1472-6750-
1110-1120. 
Haase, R., Magnusson, T., Su, B., Kopp, F., Wagner, E., Lipps, H., Baiker, A., and Ogris, M. 
(2013). Generation of a tumor- and tissue-specific episomal non-viral vector system. BMC 
Biotechnol 13, 49. 
Hanahan, D. (1983). Studies on transformation of Escherichia coli with plasmids. J Mol Biol 166, 
557-580. 
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, 
K., Wagner, H., Takeda, K., et al. (2000). A Toll-like receptor recognizes bacterial DNA. Nature 
408, 740-745. 
Henikoff, S., Ahmad, K., Platero, J.S., and B., v.S. (2000). Heterochromatic deposition of 
centromeric histone H3-like proteins. PNAS 97, 716-721. 
8 REFERENCES 
113 
Heun, P., Erhardt, S., Blower, M.D., Weiss, S., Skora, A.D., and Karpen, G.H. (2006). 
Mislocalization of the Drosophila centromere-specific histone CID promotes formation of 
functional ectopic kinetochores. Dev Cell 10, 303-315. 
Hirt, B. (1966). Evidence for semiconservative replication of circular polyoma DNA. PNAS 55, 
997-1004. 
Houben, A., and Schubert, I. (2003). DNA and proteins of plant centromeres. Curr Opin Plant 
Biol 6, 554-560. 
Howman, E.V., Fowler, K.J., Newson, A.J., Redward, S., MacDonald, A.C., Kalitsis, P., and 
Choo, K.H.A. (2000). Early disruption of centromeric chromatin organisation in centromere 
protein A (Cenpa) null mice. PNAS 97, 1148-1153. 
Humme, S., Reisbach, G., Feederle, R., Delecluse, H.J., Bousset, K., Hammerschmidt, W., and 
Schepers, A. (2003). The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization 
several thousandfold. PNAS 100, 10989-10994. 
Hung, S.C., Kang, M.S., and Kieff, E. (2001). Maintenance of Epstein-Barr virus (EBV) oriP-
based episomes requires EBV-encoded nuclear antigen-1 chromosome-binding domains, which 
can be replaced by high-mobility group-I or histone H1. PNAS 98, 1865-1870. 
Irvine, D.V., Amor, D.J., Perry, J., Sirvent, N., Pedeutour, F., Choo, K.H., and Saffery, R. (2004). 
Chromosome size and origin as determinants of the level of CENP-A incorporation into human 
centromeres. Chromosome Res 12, 508-815. 
Jansen, L.E., Black, B.E., Foltz, D.R., and Cleveland, D.W. (2007). Propagation of centromeric 
chromatin requires exit from mitosis. J Cell Biol 176, 795-805. 
Jenke, B.H.C., Fetzer, C.P., Stehle, I.M., Jönsson, F., Fackelmayer, F.O., Conradt, H., Bode, J., 
and Lipps, H.J. (2002). An episomally replicating vector binds to the nuclear matrix protein SAF-
A in vivo. EMBO Reports 3, 349-354. 
Kanda, T., Kamiya, M., Maruo, S., Iwakiri, D., and Takada, K. (2007). Symmetrical localization 
of extrachromosomally replicating viral genomes on sister chromatids. J Cell Sci 120, 1529-1539. 
Kaye, K.M., Izumi, K.M., Li, H., Johannsen, E., Davidson, D., Longnecker, R., and Kieff, E. 
(1999). An Epstein-Barr Virus That Expresses Only the First 231 LMP1 Amino Acids Efficiently 
Initiates Primary B-Lymphocye Growth Transformation. J Virol 73, 10525-10530. 
Kazuki, Y., Hoshiya, H., Takiguchi, M., Abe, S., Iida, Y., Osaki, M., Katoh, M., Hiratsuka, M., 
Shirayoshi, Y., Hiramatsu, K., et al. (2011). Refined human artificial chromosome vectors for 
gene therapy and animal transgenesis. Gene Ther 18, 384-393. 
Kempkes, B., Pich, D., Zeidler, R., and Hammerschmidt, W. (1995). Immortalization of human 
primary B lymphocytes in vitro with DNA. PNAS 92, 5875-5879. 
Kim, J.H., Kononenkoa, A., Erliandria, I., Kimb, T.A., Nakanoc, M., Iidad, Y., Barrette, J.C., 
Oshimurad, M., Masumotoc, H., Earnshawf, W.C., et al. (2011). Human artificial chromosome 
(HAC) vector with a conditional centromere for correction of genetic deficiencies in human cells. 
PNAS 108, 20048-20053. 
8 REFERENCES 
114 
Kobelt, D., Schleef, M., Schmeer, M., Aumann, J., Schlag, P.M., and Walther, W. (2013). 
Performance of High Quality Minicircle DNA for In Vitro and In Vivo Gene Transfer. Mol 
Biotechnol 53, 80-89. 
Krysan, P., Haase, S.B., and Calos, M.P. (1989). Isolation of Human Sequences That Replicate 
Autonomously in Human Cells. Mol Cell Biol 9, 1026-1033. 
Kurumizaka, H., Horikoshi, N., Tachiwana, H., & Kagawa, W. (2012). Current progress on 
structural studies of nucleosomes containing histone H3 variants. Curr Opin Struct Biol 23, 109-
115. 
Laemmli, U.K. (1970). Cleavage of structural proteins during the assembly of the head of 
bacteriophage T4. Nature 227, 680-685. 
Larin Monaco, Z., and Moralli, D. (2006). Progress in artificial chromosome technology. 
Biochem Society Transactions 34, 324-327. 
Leight, E.R., and Sugden, B. (2001). Establishment of an oriP replicon is dependent upon an 
infrequent, epigenetic event. Mol Cell Biol 21, 4149-4161. 
Lipps, H.J., Jenke, A.C.W., Nehlsen, K., Scintele, M.F., Stehle, I.M., and Bode, J. (2003). 
Chromosome-based vectors for gene therapy. Gene 304, 23-33. 
Lufino, M.M., Edser, P.A., and Wade-Martins, R. (2008). Advances in high-capacity 
extrachromosomal vector technology: episomal maintenance, vector delivery, and transgene 
expression. Mol Ther 16, 1525-1538. 
Lufino, M.M., Manservigi, R., and Wade-Martins, R. (2007). An S/MAR-based infectious 
episomal genomic DNA expression vector provides long-term regulated functional 
complementation of LDLR deficiency. Nucleic Acids Res 35, e98. 
Maggert, K.A., and Karpen, G.H. (2001). The activation of a neocentromere in Drosophila 
requires proximity to an endogenous centromere. Genetics 158, 1615-1628. 
Malik, H.S., and Henikoff, S. (2000). Adaptive Evolution of Cid, a Centromere-Specific Histone 
in Drosophila. Genetics 157, 1293-1298. 
Manzini, S., Vargiolu, A., Stehle, I.M., Bacci, M.L., Cerrito, M.G., Giovannoni, R., Zannoni, A., 
Bianco, M.R., Forni, M., Donini, P., et al. (2006). Genetically modified pigs produced with a 
nonviral episomal vector. PNAS 103, 17672-17677. 
Maresca, T.J. (2011). Chromosome Segregation: A Kinetochore Missing Link Is Found. Curr 
Biol 21, 261-263. 
Marshall, O.J., Chueh, A.C., Wong, L.H., and Choo, K.H. (2008a). Neocentromeres: new insights 
into centromere structure, disease development, and karyotype evolution. Am J Hum Genet 82, 
261-282. 
Marshall, O.J., Marshall, A.T., and Choo, K.H. (2008b). Three-dimensional localization of 
CENP-A suggests a complex higher order structure of centromeric chromatin. J Cell Biol 183, 
1193-1202. 
Martin Dani, G., and Zakian, V.A. (1983). Mitotic and meiotic stability of linear plasmids in 
yeast. PNAS 80, 3406-3410. 
8 REFERENCES 
115 
Mayerhofer, P., Schleef, M., and Jechlinger, W. (2009). Use of Minicircle Plasmids for Gene 
Therapy. Gene Ther Cancer 542, 87-104. 
Mellone, B.G., Grive, K.J., Shteyn, V., Bowers, S.R., Oderberg, I., and Karpen, G.H. (2011). 
Assembly of Drosophila centromeric chromatin proteins during mitosis. PLoS Genet 7, 
e1002068. 
Mendiburo, M.J., Padeken, J., Fulop, S., Schepers, A., and Heun, P. (2011). Drosophila CENH3 
is sufficient for centromere formation. Science 334, 686-690. 
Middleton, T., and Sugden, B. (1992). EBNA1 can link the enhancer element to the initiator 
element of the Epstein-Barr virus plasmid origin of DNA replication. J Virol 66, 489-495. 
Miller, G. (1982). Immortalization of Human Lymphocytes by Epstein-Barr Virus. Yale J Biol 
Med 55, 305-310. 
Mishra, P.K., Au, W.C., Choy, J.S., Kuich, P.H., Baker, R.E., Foltz, D.R., and Basrai, M.A. 
(2011). Misregulation of Scm3p/HJURP causes chromosome instability in Saccharomyces 
cerevisiae and human cells. PLoS Genet 7, e1002303. 
Moehle, E.A., Rock, J.M., Lee, Y.L., Jouvenot, Y., DeKelver, R.C., Gregory, P.D., Urnov, F.D., 
and Holmes, M.C. (2007). Targeted gene addition into a specified location in the human genome 
using designed zinc finger nucleases. PNAS 104, 3055-3060. 
Morissette, G., and Flamand, L. (2010). Herpesviruses and chromosomal integration. J Virol 84, 
12100-12109. 
Mullis, K., Faloona, F., Scharf, S., Saiki, R., Horn, G., and Erlich, H. (1986). Specific enzymatic 
amplification of DNA in vitro: the polymerase chain reaction. Cold Spring Harb Symp Quant 
Biol 51, 263-273. 
Murata, M. (2013). Arabidopsis Centromeres. (Wiley-Blackwell). 
Nakano, M., Cardinale, S., Noskov, V.N., Gassmann, R., Vagnarelli, P., Kandels-Lewis, S., 
Larionov, V., Earnshwas, W.C., and Masumoto, H. (2008). Inactivation of a Human Kinetochore 
by Specific Targeting of Chromatin Modifiers. Dev Cell 14, 407-522. 
Nanbo, A., Sugden, A., and Sugden, B. (2007). The coupling of synthesis and partitioning of 
EBV´s plasmid replicon is revealed in live cells. EMBO J 26, 4252-4262. 
Nehlsen, K., Broll, S., and J., B. (2006). Replicating minicircles: Generation of nonvirol episomes 
for the efficient midification of dividing cells. Gene Ther Mol Biol 10, 233-244. 
Nishikawa, M., and Huang, L. (2001a). Nonviral vectors in the New Millenium: Delivery Barriers 
in Gene Transfer. Hum Gene Ther 12, 861-870. 
Nishikawa, M., and Huang, L. (2001b). Nonviral Vectors in the New Millenium: Delivery 
Barriers in Gene Transfer. Hum Gene Ther 12, 861-870. 
Nonoyama, M., Huang, C.H., Pagano, J.S., Klein, G., and Singh, S. (1973). DNA of Epstein-Barr 
Virus Detected in Tissue of Burkitt´s Lymphoma and Nasopharyngeal Carcinoma. PNAS 70, 
3265-3268. 
8 REFERENCES 
116 
Okada, M., Okawa, K., Isobe, T., and Fukagawa, T. (2009). CENP-H-containing complex 
facilitates centromere deposition of CENP-A in cooperation with FACT and CHD1. Mol Biol 
Cell 20, 3986-3995. 
Olszak, A.M., van Essen, D., Pereira, A.J., Diehl, S., Manke, T., Maiato, H., Saccani, S., and 
Heun, P. (2011). Heterochromatin boundaries are hotspots for de novo kinetochore formation. 
Nat Cell Biol 13, 799-808. 
Palmer, D.K., O´Day, K., Trong, H.L., Charbonneau, H., and Margolis, R.L. (1991). Purification 
of the centromere-specific protein CENP-A and demonstration that it is a distinctive histone. 
PNAS 88, 3734-3738. 
Pich, D., Humme, S., Spindler, M.P., Schepers, A., and Hammerschmidt, W. (2008). Conditional 
gene vectors regulated in cis. Nucleic Acids Res 36, e83. 
Piechaczek, C., Fetzer, C., Baiker, A., Bode, J., and Lipps, H.J. (1999). A vector based on the 
SV40 origin of replication and chromosomal S/MARs replicate episomally in CHO cells. Nucleic 
Acids Res 27, 426-428. 
Prud'homme, G.J., Draghia-Akli, R., and Wang, Q. (2007). Plasmid-based gene therapy of 
diabetes mellitus. Gene Ther 14, 553-564. 
Przewloka, M.R., Venkei, Z., Bolanos-Garcia, V.M., Debski, J., Dadlez, M., and Glover, D.M. 
(2011). CENP-C is a structural platform for kinetochore assembly. Curr Biol 21, 399-405. 
Rattner, J.B. (1991). The structure of the mammalian centromere. Bioessays 13, 51-56. 
Ribeiro, S.C., Monteiro, G.A., and Prazeres, D.M.F. (2008). Evaluation of the effect of non-B 
DNA structures on plasmid integrity via accelerated stability studies. J Pharm Sci 98, 1400-1408. 
Rocchi, M., Archidiacono, N., Schempp, W., Capozzi, O., and Stanyon, R. (2012). Centromere 
repositioning in mammals. Heredity 108, 59-67. 
Saitoh, Y., and Laemmli, U.K. (1994). Metaphase chromosome structure: Bands arise from a 
differential folding path of the highly AT-rich scaffold. Cell 76, 609-622. 
Sambrook, J., and Russell, D.W. (2001). Molecular cloning : a laboratory manual., 3rd edn (Cold 
Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press). 
Santaguida, S., and Musacchio, A. (2009). The life and miracles of kinetochores. EMBO J 28, 
2511-2531. 
Sarma, K., and Reinberg, D. (2005). Histone variants meet their match. Nat Rev Mol Cell Biol 6, 
139-149. 
Schaarschmidt, D., Baltin, J., Stehle, I.M., Lipps, H.J., and Knippers, R. (2004). An episomal 
mammalian replicon: sequence-independent binding of the origin recognition complex. EMBO J 
23, 191-201. 
Schakowski, F., Gorschlüter, M., Junghans, C., Schroff, M., Buttgereit, P., Ziske, C., Schöttker, 
B., König-Merediz, S.A., Sauerbruch, T., Wittig, B., et al. (2001). A Novel Minimal-Size Vector 
(MIDGE) Improves Transgene Expression in Colon Carcinoma Cells and Avoids Transfection of 
Undesired DNA. Mol Ther 3, 793-800. 
8 REFERENCES 
117 
Schepers, A., Ritzi, M., Bousset, K., Kremmer, E., Yates, J.L., Harwood, J., Diffley, J.F.X., and 
Hammerschmidt, W. (2001). Human origin recognition comples binds to the region of the latent 
origin of DNA replication of Epstein-Barr virus. EMBO J 20, 4588-4602. 
Schuh, M., Lehner, C.F., and Heidmann, S. (2007). Incorporation of Drosophila CID/CENP-A 
and CENP-C into centromeres during early embryonic anaphase. Curr Biol 17, 237-243. 
Screpanti, E., De Antoni, A., Alushin, G.M., Petrovic, A., Melis, T., Nogales, E., and Musacchio, 
A. (2011). Direct binding of Cenp-C to the Mis12 complex joins the inner and outer kinetochore. 
Curr Biol 21, 391-398. 
Sears, J., Kolman, J., Wahl, G.M., and Aiyar, A. (2003). Metaphase Chromosome Tethering Is 
Necessary for the DNA Synthesis and Maintenance of oriP Plasmids but Is Insufficient for 
Transcription Activation by Epstein-Barr Nuclear Antigen 1. J Virol 77, 11767-11780. 
Sears, J., Ujihara, M., Wong, S., Ott, C., Middeldorp, J., and Aiyar, A. (2004). The amino 
terminus of Epstein-Barr Virus (EBV) nuclear antigen 1 contains AT hooks that facilitate the 
replication and partitioning of latent EBV genomes by tethering them to cellular chromosomes. J 
Virol 78, 11487-11505. 
Shen, M.H., Ross, A., Yang, J., de las Heras, J.I., and Cooke, H. (2001). Neo-centromere 
formation on a 2.6 Mb mini-chromosome in DT40 cells. Chromosoma 110, 421-429. 
Shibata, D., and Weiss, L.M. (1992). Epstein-Barr Virus-associated Gastric Adenocarcinoma. Am 
J Pathol 140, 769-774. 
Southern, E.M. (1975). Detection of specific sequences among DNA fragments separated by gel 
electrophpresis. J Mol Biol 98, 503-517. 
Stehle, I.M., Postberg, J., Rupprecht, S., Cremer, T., Jackson, D.A., and Lipps, H.J. (2007). 
Establishment and mitotic stability of an extra-chromosomal mammalian replicon. BMC Cell 
Biol 8, 33. 
Stehle, I.M., Scinteie, M.F., Baiker, A., Jenke, A.C., and Lipps, H.J. (2003). Exploiting a minimal 
system to study the epigenetic control of DNA replication: the interplay between transcription and 
replication. Chromosome Res 11, 413-421. 
Stellfox, M.E., Bailey, A.O., and Foltz, D.R. (2012). Putting CENP-A in its place. Cell Mol Life 
Sci 70, 387-406. 
Sternas, L., Middleton, T., and Sugden, B. (1990). The average number of molecules of Epstein-
Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus 
(EBV) DNA molecules per cell among different clones of EBV-immortalized cells. J Virol 64, 
2407-2410. 
Stimpson, K.M., and Sullivan, B.A. (2010). Epigenomics of centromere assembly and function. 
Curr Opin Cell Biol 22, 772-780. 
Stoler, S., Keith, K.C., Curnick, K.E., and Fitzgerald-Hayes, M. (1995). A mutation in CSE4, an 
essential gene encoding a novel chromatin-associated protein in yeast, causes chromosome 
nondisjunction and cell cycle arrest at mitosis. Genes Dev 9, 573-586. 
8 REFERENCES 
118 
Sullivan, B.A., and Karpen, G.H. (2004). Centromeric chromatin exhibits a histone modification 
pattern that is distinct from both euchromatin and heterochromatin. Nat Struct Mol Biol 11, 1076-
1083. 
Sullivan, K.F., Hechenberger, M., and Masri, K. (1994). Human CENP-A contains a histone H3 
related histone fold domain that is required for targeting to the centromere. J Cell Biol 127, 581-
592. 
Sun, X., Wahlstrom, J., and Karpen, G. (1997). Molecular Structure of a Functional Drosophila 
Centromere. Cell 91, 1007-1019. 
Talbert, P.B., Ahmad, K., Almouzni, G., Ausió, J., Berger, F., Bhalla, P.L., Bonner, W.M., 
Cande, W.Z., Chadwick, B.P., Chan, S.W., et al. (2012). A unified phylogeny-based 
nomenclature for histone variants. Epigenet & Chromatin 5, doi: 10.1186/1756-8935-1185-1187. 
Tamura, T., Smith, M., Kanno, T., Dasenbrock, H., Nishiyama, A., and Ozato, K. (2009). 
Inducible deposition of the histone variant H3.3 in interferon-stimulated genes. J Biol Chem 284, 
12217-12225. 
Telenius, H., Szeles, A., Keresö, J., Csonka, E., Praznovszky, T., Imreh, S., Maxwell, A., Perez, 
C.F., Drayer, J.I., and Hadlaczky, G. (1999). Stability of a functional murine satellite DNA-based 
artificial chromosome across mammalian species. Chromosome Res 7, 3-7. 
Teo, C.H., Lermontova, I., Houben, A., Mette, M.F., and Schubert, I. (2013). De novo generation 
of plant centromeres at tandem repeats. Chromosoma 122, 233-241. 
Thomae, A.W., Baltin, J., Pich, D., Deutsch, M.J., Ravasz, M., Zeller, K., Gossen, M., 
Hammerschmidt, W., and Schepers, A. (2011). Different roles of the human Orc6 protein in the 
replication initiation process. Cell Mol Life Sci 68, 3741-3756. 
Thomae, A.W., Pich, D., Brocher, J., Spindler, M.P., Berens, C., Hock, R., Hammerschmidt, W., 
and Schepers, A. (2008). Interaction between HMGA1a and the origin recognition complex 
creates site-specific replication origins. PNAS 105, 1692-1697. 
Thomas, C.E., Ehrhardt, A., and Kay, M.A. (2003). Progress and problems with the use of viral 
vectors for gene therapy. Nat Rev Genet 4, 346-358. 
Torras-Llort, M., Moreno-Moreno, O., and Azorin, F. (2009). Focus on the centre: the role of 
chromatin on the regulation of centromere identity and function. EMBO J 28, 2337-2348. 
Towbin, H., Staehelin, T., and Gordon, J. (1979). Electrophoretic transfer of proteins from 
polyacrylamide gels to nitrocellulose sheets: procedure and some applications. PNAS 76, 4350-
4354. 
Tsimbouri, P., Drotar, M.E., Coy, J.L., and Wilson, J.B. (2002). bcl-xL and RAG genes are 
induced and the response to IL-2 enhanced in EmuEBNA-1 transgenic mouse lymphocytes. 
Oncogene 21, 5182-5187. 
Voullaire, L.E., Slater, H.R., Petrovic, V., and Choo, K.H.A. (1993). A Functional Marker 
Centromere with No Detectable Alpha-Satellite, Satellite III, or CENP-B Protein: Activation of a 
Latent Centromere? Am J Hum Genet 52, 1153-1163. 
Waehler, R., Russell, S.J., and Curial, D.T. (2007). Engineering targeted viral vectors for gene 
therapy. Nat Rev Genet 8, 573-587. 
8 REFERENCES 
119 
Warburton, P.E. (2004). Chromosomal dynamics of human neocentromere formation. 
Chromosome Res 12, 617-626. 
Warburton, P.E., Cooke, C.A., Bourassa, S., Vafa, O., Sullivan, B.A., Stetten, G., Gimelli, G., 
Warburton, D., Tyler-Smith, C., Sullivan, K.F., et al. (1997). Immunolocalization of CENP-A 
suggest a distinct nucleosome structure at the inner kinetochore plate of active centromeres. Curr 
Biol 7, 901-904. 
Waye, J.S., and Willard, H.F. (1987). Nucleotide sequence heterogeneity of alpha satellite 
repetitive DNA: a survey of alphoid sequences from different human chromosomes. Nucleic 
Acids Res 15, 7549-7569. 
Welburn, J.P., and Cheeseman, I.M. (2008). Toward a molecular structure of the eukaryotic 
kinetochore. Dev Cell 15, 645-655. 
White, R.E., Wade-Martins, R., and James, M.R. (2002). Infectious Delivery of 120-Kilobase 
Genomic DNA by an Epstein-Barr Virus Amplicon Vector. Mol Ther 5, 427-435. 
Wiens, G.R., and Sorger, P.K. (1998). Centromeric chromatin and epigenetic effects in 
kinetochore assembly. Cell 93, 313-316. 
Wong, S.P., Argyros, O., Coutelle, C., and Harbottle, R.P. (2011). Non-viral S/MAR vectors 
replicate episomally in vivo when provided with a selective advantage. Gene Ther 18, 82-87. 
Wutzler, P., Färber, I., Sauerbrei, A., Helbig, B., Wutke, K., Rüdiger, K.D., Scheibner, K., 
Brichàcek, B., and Vonka, V. (1986). Demonstration of Epstein-Barr virus in malignant non-
Hodgkin´s lymphomas. Oncology 43, 224-229. 
Wysokensko, D.A., and Yates, J.L. (1989). Multiple EBNA1-Binding Sites Are Required To 
Form an EBNA1-Dependent Enhancer and To Activate a Minimal Replicative Origin with oriP of 
Epstein-Barr Virus. J Virol 63, 2657-2666. 
Yates, J.L., Camiolo, S.M., and Bashaw, J.M. (2000). The Minimal Replicator of Epstein-Barr 
Virus oriP. J Virol 74, 4512-4522. 
Zeitlin, S.G., Baker, N.M., Chapados, B.R., Soutoglou, E., Wang, J.Y., Berns, M.W., and 
Cleveland, D.W. (2009). Double-strand DNA breaks recruit the centromeric histone CENP-A. 
PNAS 106, 15762-15767. 
Zuo, Y., Wu, J., Xu, Z., Yang, S., Yan, H., Tan, L., Meng, X., Ying, X., Liu, R., Kang, T., et al. 
(2011). Minicircle-oriP-IFNgamma: a novel targeted gene therapeutic system for EBV positive 
human nasopharyngeal carcinoma. PLoS One 6, e19407. 
 
 
 
APPENDIX 
120 
 
 
 
 
 
 
 
 
 
 
9 APPENDIX 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
APPENDIX 
121 
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9.2 ClustalW alignment of sequenced clones with Primer 256 
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9.3 Kinetochore proteins in H.sapiens and D.melanogaster 
(Murata, 2013) 
 Species 
Localization network H.sapiens D.melanogaster 
inner centromere 
INCENP INCENP 
Aurora B IPLI 
CENP-A CID 
CENP-B - 
inner kinetochore – CCAN
45
 
CENP-C CENP-C 
CENP-H  
CENP-I  
CENP-K  
CENP-L  
CENP-M  
CENP-N  
CENP-O  
CENP-P  
CENP-Q  
CENP-R  
CENP-U  
CENP-S  
CENP-X  
CENP-T  
CENP-W  
outer kinetochore – KMN network
46
 
hMis12 CG18156 
DSN1  
NNF1 CGI13434 
NSL1 CGI1558 
Hec1/NDC80 Ndc80 
NUF2 Nuf2 
SPC24 (GI12063) 
SPC25 CG7242 
KNL1  
facultative 
CENP-E CENP-meta 
CENP-F Spn 
CENP-V  
CENP-A chromatin establishment HJURP (CAL1?) 
                                                 
45
 constitutive centromere-associated network 
46
 KNL1/Mis12 complex/Ndc80 complex network 
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Mis18  
Mis18  
M18BP1  
RbAp48 RbAp48 
RbAp46  
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